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Summary 
Mammalian cells usually co-express several integrins, which can recognize different ECM proteins, 
become activated and trigger their own intracellular signalling events. Those cues might also inter-
sect and cross-talk with other signalling cascades initiated and/or modulated by other integrins or 
even by other receptors like growth factor receptors (GFRs). Almost all integrins bind to ECM pro-
teins such as Collagen (Coll), Vitronectin (VN), and Fibronectin (FN). Hereby VN and FN are bound 
through the tri-peptide motif Arg-Gly-Asp (RGD), which mediates binding to β1- (α5β1, α8β1), all αV-
class (αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8) heterodimers and αIIbβ3, an integrin specific for platelets. 
In vivo and in vitro studies indicated that these Integrin classes exert both specific and redundant 
roles. However, how these distinct FN-binding heterodimers accomplish their individual functions 
and if they cooperate was unclear when I started my thesis. To make it possible to investigate and 
dissect integrin subtype-specific signalling events of FN-binding heterodimers, it is necessary to re-
duce the integrin complexity. For my studies, I therefore utilized pan-integrin-null kidney fibroblasts 
where either the αV- and/or β1- chain was/were re-expressed to gain reconstitution with either αV- 
(αVβ3, αVβ5) or β1-class (α5β1) integrins or both. 
 
In my first paper I performed a functional analysis of β1- and αV-class integrins expressed in pan-
integrin-null fibroblasts seeded on FN. A quantitative proteomics approach allowed for the first time 
a non-biased analysis of the molecular composition of FAs assembled by a single integrin class using 
biochemical isolation protocols in combination with quantitative mass spectrometry and biochemi-
cal assays, like immunoblotting, -staining, and -precipitation. We could assign specific functions to 
distinct FN-binding integrins; α5β1 integrins are responsible for force generation, whereas αV-
class integrins induce the generation of actin filaments, which enables cells to transduce force and 
to sense the substrate rigidity of FN-based microenvironments.  
 
In my second paper I investigated whether and if yes, how αV- and/or β1-class integrins can mediate 
changes in gene expression in order to regulate cell proliferation and differentiation. I could show 
that integrins compass these long-term effects by regulating cytoskeletal dynamics and thus releas-
ing the interaction of the transcriptional co-activator Megakaryocyte Acute Leukemia protein (MAL; 
also known as MRTF-A or MKL1) with g-Actin to drive MAL/SRF-mediated gene expression. I found 
that αV- and β1-class integrins synergize to regulate expression of MAL/SRF target genes. Further-
8 |  Summary  
more, the small ubiquitin-like modifier Interferon-specific gene 15 (ISG15) was identified as one of 
the MAL/SRF target genes. ISG15 binds covalently to specific lysine residues of numerous MAL/SRF 
target gene products including Vinculin, Talin and Eplin and thereby preventing their ubiquitination 
and degradation. The study shows that αV-/β1-class integrins/MAL/SRF/ISG15 assign a novel auto-
regulatory feed-forward loop that precisely adjusts adhesion- and actin-remodelling required for 
cell spreading, migration and invasion. Finally, we are providing a prognostic value of high αV-/β1-
class integrin, ISG15 and nuclear MAL levels useful for breast cancer diagnosis. 
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Abbreviations 
aa Amino acid 
DAPI 4’, 6-Diamidin-2-phenylindol-dihydrochloride 
ABS Actin binding site 
ADF Actin depolymerizing factor 
Arp2/3 complex Actin-related protein 2/3 complex 
R Arg, Arginine 
D Asp, Aspartic acid 
A-T Ataxia-telangiectasia  
BSA Bovine serum albumine 
CH Calponin homology 
CP Capping protein 
JNK C-Jun N-terminal kinase  
Coll Collagen 
cDNA Complementary DNA 
DNA  Deoxyribonucleic acid 
DMSO Dimethylsulfoxide 
PKR DsRNA-dependent protein kinase  
DMEM Dulbecco’s Modified Eagle Medium 
Ets E twenty-six domain transcription factors  
E Embryonic day 
Ena/Vasp  Enabled/Vasodilator-stimulated phosphoprotein 
ELISA Enzyme-linked Immunosorbent Assay 
EBS Ets binding site 
ECM Extracellular matrix 
ERK Extracellular signal-regulated kinase 
FCS Fetal calf serum 
FN Fibronectin 
f-Actin Filamentous Actin 
FA Focal adhesion 
FAK  Focal adhesion kinase 
e.g. For example 
FERM Four point one, Ezrin, Radexin, Moesin 
g-Actin Globular (monomeric) Actin 
G Gly, Glycin 
GPCR G-protein coupled receptor 
GFR Growth factor receptor 
GAP  GTPase activating protein 
GDI  Guanine nucleotide dissociation inhibitor 
GEF  Guanine nucleotide exchange factor 
GDP  Guanosine diphosphate 
GTP  Guanosine triphosphate 
H/E Hematoxylin/Eosin 
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h Hour(s) 
IPP complex  ILK-PINCH-Parvin complex 
Ig Immunglobulin 
IGF-1 Insulin-like growth factor 1 
IGFR Insulin-like growth factor receptor 
Itg Integrin 
ICAP Integrin cytoplasmic domain-associated protein 1  
ILK Integrin linked kinase 
ICAM-1 Intercellular adhesion molecule-1 
IFN Interferon 
ISG15 Interferon-induced 15 kDa protein 
IL Interleukin 
kDa Kilodalton 
LAP Latency-associated protein  
LDV Leucine-aspartic acidvaline 
LIMK LIM kinase 
LIM Lin11, Isl1, Mec3 
mDia Mammalian diaphanous 
MECs Mammary epithelial cells 
MGDI Mammary-derived growth inhibitor 
Mn2+  Manganese-ion 
MKK4 MAPK/ERK kinase 4  
MEKK1 MAPK/ERK kinase kinase 1  
MMP  Matrix metalloproteinase 
MAL (or MRTF-A) Megakaryocyte acute leukemia protein (or Myocardin related transcription factor A) 
mRNA  messenger RNA 
µg Microgramm 
μm  Micrometer 
Min Minutes 
MAPK Mitogen-activated protein kinase 
MLCK  MLC kinase 
MLCP  MLC phosphatase 
M/mM  Molar/millimolar 
MadCAM-1 Mucosal addressin cell adhesion molecule-1 
MEF2 Myocyte enhancer factor-2 
MYPT1  Myosin phosphatase-targeting subunit 1 
MLC  Myosin regulatory light chain 
NA Nascent adhesion 
Net Neuroepithelial cell-transforming gene protein 
PINCH Particularly interesting Cys-His-rich protein 
NPxY  Peptide motif asparagine (N), proline (P), any aa (x), tyrosine (Y) 
GFFKR Peptide motif glycine (G), phenylalanine (F), lysine (K), arginine (R) 
PTB Phosphotyrosinebinding 
PM Plasma membrane 
PH  Pleckstrin homology 
PCR Polymerase chain reaction 
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Src Proto-oncogene tyrosine-protein kinase Sarcoma 
RhoA Ras homolog gene family, member A 
Rac1  Ras-related C3 botulinum toxin substrate 1 
Ras  Rat sarcoma 
ROCK  Rho-associated kinase 
RNA Ribonucleic acid 
RSK2 Ribosomal protein S6 kinase 2  
RNAi  RNA interference 
SDS-PAGE SDS polyacrylamid gel electrophoresis 
S Ser, Serine 
SRE Serum response element 
SRF Serum response factor 
SHARPIN Shank-associated RH domain-interacting protein  
shRNA Short hairpin RNA 
SDS  Sodium dodecyl sulphate 
SNX17 Sortin nexin 17  
Sap-1 SRF accessory protein 1 
SILAC Stable isotope labelling by amino acids in culture 
SCAI Suppressor of cancer cell invasion 
THD  Talin head domain 
THATCH Talin/HIP1R/Sla2p Actin-tethering C-terminal homology  
TCF Ternary complex factor 
Tβ4 Thymosin β 4 
TGF-β  Transforming growth factor β 
TM  Transmembrane 
RGD Tripeptide motif Arg-Gly-Asp 
VCAM1 Vascular cell adhesion molecule 1 
DBP Vitamin D-binding protein 
VN Vitronectin 
WAVE  WASP-family verprolin-homologous protein 
WASP  Wiskott-Aldrich syndrome protein 
Y2H  Yeast two hybrid 
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1 Introduction 
1.1 The Integrin Receptor Family 
 
“We propose the name integrin for this protein complex to denote its role as an integral membrane 
complex involved in the transmembrane association between the extracellular matrix and the cyto-
skeleton.” (Tamkun et al., 1986) 
 
Integrins are key cell adhesion molecules that connect the extracellular matrix (ECM) with the Actin 
cytoskeleton (Humphries, 2000; Hynes, 2002). They establish a molecular platform where mechani-
cal forces, cytoskeletal organization and biochemical signals intersect and modulate a plethora of 
cellular functions including cell migration, proliferation, differentiation and survival. Before integrins 
bind ECM they shift from a bent to an extended conformation and adopt high affinity for ligand 
(Hynes, 2002; Legate et al., 2009). ECM bound integrins aggregate and form different types of adhe-
sion complexes, which differ in size, subcellular localization and function (Paszek et al., 2009). Nas-
cent complexes are smaller than 0.5 µm and are usually short lived, while myosin II-mediated ten-
sioning of nascent adhesions triggers their growth into large (1-10µm) multi-protein assemblies 
called focal adhesions (FAs). Around 150 proteins were identified in a data mining screen to be asso-
ciated with FAs either constitutively or transiently (Zaidel-Bar et al., 2007). It has become increasing-
ly apparent that FAs function as signalling hubs that sense the complex chemical and physical nature 
of the ECM (Geiger et al., 2009; Parsons et al., 2010). This exquisite property is required to orches-
trate development and physiology of multicellular organisms.  
 
1.1.1 Structure of Integrins 
1.1.1.1 Extracellular domains and ligand binding 
Integrins undergo one of the most complex and intense conformational changes among cell surface 
receptors. These rearrangements function to transmit bi-directional signals (see following para-
graph) between the ligand-binding integrin headpiece and the Actin cytoskeleton.  
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Integrin heterodimers consist of one α and one β subunit. The subunits contain very large extracellu-
lar domains of up to 1104 amino acids (aa) for α- and 778 aa for β-subunits, a helical transmembrane 
(TM) domain of 25-29 aa and a very short C-terminal cytoplasmic segment of about 20-50 aa 
(Arnaout et al., 2005). The only exception is the β4 subunit which contains a long cytoplasmic seg-
ment of around 1000 aa. β4 subunit found in α6β4 is the only integrin that associates to intermedi-
ate filaments instead of the actin cytoskeleton and play a central role in the formation of hemi-
desmosomes.  
 
In order to understand the activation states of integrins, researchers have elucidated the structural 
interactions of the integrin heterodimers and their different conformation states.  The headpiece of 
the α subunit is composed of β-propeller and thigh domains (Figure 1; green) whereas the β subunit 
headpiece consists of βI, hybrid, and PSI (Plexin, Semaphorin, Integrin) domains (Figure 1; red). The α 
subunit calf-1 and calf-2 (β sandwich domains) (Figure 1; orange) and the β subunit I-EGF-2 to I-EGF-
4 and β tail domains form the lower legs (Figure 1; grey) (Xiong et al., 2001; Zhu et al., 2008). X-ray 
crystal structures of the extracellular domain of the integrin αVβ3 identified a bent conformation of 
the legs (Xiong et al., 2001; Xiong et al., 2002). Based on these findings the prevailing view is that the 
bent conformation represents the physiological low-affinity state, whereas extended ectodomains 
exhibit high affinity for ligands. There are two models proposed for this change in affinity: (a) The 
“switchblade” model: In the low affinity conformation, the headpiece of the integrin folds over its 
legs at the genu and faces down towards the membrane. Separation of the cytoplasmic and TM 
segments causes a jackknife-like knee extension of the bent integrin, which leads to the dislocation 
of the epidermal growth factor (EGF)-like repeat in the β leg. As a consequence the hybrid domain is 
released, swings out and thus switching from a closed (low affinity) to an open (high affinity) con-
formation of the βI domain (Beglova et al., 2002; Kim et al., 2003; Takagi et al., 2002; Tan et al., 
2000). (b) The “deadbolt” model for inside-out activation: Hereby the head is still bent in an activat-
ed integrin and the TM regions perform a piston-like movement that results in sliding of the extracel-
lular legs of α and β subunits. As a result the interaction between headpiece and β legs is disrupted 
just beyond the membrane (Arnaout et al., 2005).  
 
About half of the integrin α subunits (Coll-binding and the leukocyte specific α-subunits) contain a 
domain of about 200 amino acids known as an inserted (I) domain or von Willebrand factor-like A 
domain inserted into their β-propeller (αI domain). In integrins in which it is present, the αI domain 
is the major or exclusive ligand-binding site. It has strong similarity to the βI domain and can also 
change from a closed, low affinity to an open, high affinity state. The βI domain and αI domain con-
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tain a central Mg2+ binding site (MIDAS – metal ion dependent adhesion site), important for regulat-
ing the switch between the affinity states. There are two flanking additional Ca2+ binding sites only 
present in the βI domain: (a) SyMBS (synergistic metal ion binding site) and (b) AdMIDAS (adjacent 
to MIDAS).  
 
 
Figure 1. The three overall integrin conformational states. 
The bent conformation has a closed headpiece and low affinity for ligand. Extension at the α- and β-knees 
releases an interface between the headpiece and lower legs and yields an extended-closed conformation. 
Swing-out of the hybrid domain at its interface with the βI domain is connected through the βI α7-helix (C-
terminal of α7-helix of βI domain; black box) at the βI interface with the β-propeller domain that increase af-
finity for ligand (~1,000-fold) in the extended-open conformation. Two lower β leg conformations (one with a 
dashed line) are shown for the extended states because of their high flexibility. (Modified after Luo et al., 
2007; Springer and Dustin, 2012; Zhu et al., 2008; Zhu et al., 2013) 
 
1.1.1.2 Transmembrane and cytoplasmic domains 
Integrins are TM receptors lacking enzymatic activity or Actin binding motifs. In order to fulfill their 
function, integrins have to recruit adaptor and signalling proteins to their cytoplasmic tails, which 
then trigger posttranslational modifications or interactions with additional proteins that mediate 
signalling. The membrane-proximal regions of both α- and β-subunits contain highly conserved aa 
sequences. The cytoplasmic tail of integrin β-subunits, exhibits strong sequence homology, whereas 
the α-subunit tails show greater variance in sequence apart from the conserved GFFKR motif (De 
Melker et al., 1997). It was shown with mutation studies that this motif is important for the associa-
tion with the β-tail (called heterodimerization), because alterations in this motif activate integrins by 
destabilizing the association of α- and β-TM domain (Lu et al., 2001; O'Toole et al., 1994). However, 
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in β1 heterodimers tyrosine phosphorylation and the membrane-proximal salt bridge between α and 
β1 tails have no apparent function under homeostatic conditions in vivo (Czuchra et al., 2006). A 
large number of cytoskeletal and signalling proteins have been reported to bind to β cytoplasmic 
tails and while only comparably few have been identified to interact with specific α tails (Schiller et 
al., 2013; Takada et al., 2007). A recognition sequence for phosphotyrosine-binding (PTB) domains is 
found on most integrin β tails: a membrane proximal NPxY motif and a membrane distal NxxY motif. 
At these motifs, two integrin activating proteins are known to bind: Talin and Kindlin. Biochemical 
and crystallographic studies established that a complex is formed between the Talin F3 domain and 
the membrane proximal NPxY motif in β-integrin tails which is required for the Talin-mediated in-
side–out activation of integrins in vitro and in vivo (Calderwood et al., 2013). Kindlin binds the mem-
brane distal NxxY motif in β-integrin tails, whereas the conserved, preceding Thr residues are also 
important for Kindlin binding. NPxY/NxxY protein sequences can be found in a large variety of cyto-
skeleton adaptors and signalling proteins, that are necessary to transmit signals from the ECM to the 
cytoskeleton or are critical for integrin activation (Hynes, 2002).  
However, regulation of integrin-ligand interactions is a fine-tuned balance between integrin activa-
tion and inactivation. Hereby integrin-inactivating proteins are crucial for appropriate integrin func-
tions in vitro and in vivo (Bouvard et al., 2013). Proteins mediating integrin inactivation can be classi-
fied into two groups: (a) Direct integrin binding proteins, which interfere with the recruitment of 
activators like Talin and Kindlin; and (b) proteins which inhibit integrins through alternative mecha-
nisms including those that affect the phosphorylation states and the levels of cell surface integrin by 
regulating integrin trafficking.  
Direct β-tail interactors leading to integrin inactivation (Figure 2): (a) NPxY motif binders (Talin 
competitors): Filamin, exists in an autoinhibited state until tension-induced binding to Actin causes 
conformational changes that expose several binding sites for integrins  (Ehrlicher et al., 2011; Kiema 
et al., 2006; Pentikainen and Ylanne, 2009). Notably, the structurally defined Filamin binding site 
overlaps with that of the integrin-regulator Talin, and these proteins compete for binding to integrin 
tails, and thus influencing Talin-dependent integrin activation. Docking protein 1 (DOK1) contains a 
phosphotyrosine-binding (PTB) domain capable of binding integrins and inhibit their activity 
(Calderwood et al., 2003; Wegener et al., 2007). Tyr phosphorylation of the NPxY motif in β1, β3 and 
β7 integrins by Src kinases greatly increases DOK1 binding to the β-integrin cytoplasmic tail. As the 
affinity of Talin for integrins decreases upon Tyr phosphorylation, this phosphorylation event might 
provide a switch for integrin inactivation and a transition from talin-dependent to DOK1‑dependent 
integrin signalling (Oxley et al., 2008). (b) Integrin cytoplasmic domain-associated protein 1 (ICAP1) is 
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a small protein containing also a PTB domain that interacts with the distal NxxY motif of β1 integrin 
by competing with Kindlin binding. ICAP1 does not bind β3 or β5 integrins (Calderwood et al., 2003; 
Chang et al., 1997).  
Direct α-tail interactors leading to integrin inactivation: Shank-associated RH domain-interacting 
protein (SHARPIN) is thought to be a key regulator of integrin activity and thus far the only ubiqui-
tously expressed integrin inhibitor that binds to integrin α tails. SHARPIN binds to the highly con-
served GFFKR sequence of the α-subunit (Figure 2), suggesting that it inhibits most if not all integ-
rins. By binding to the α tail, SHARPIN inhibits integrin activity through competing with Talin binding 
to the β integrin tail. This occurs likely by steric hindrance (Rantala et al., 2011). Further, the mam-
mary-derived growth inhibitor (MDGI), was also shown to bind to the α subunit and inhibiting β1 
integrin (Nevo et al., 2010). 
 
 
Figure 2. Integrin inactivation. 
Binding sites of integrin inhibitory proteins as well as the integrin-activating proteins Talin and Kindlin in the α-
integrin or β‑integrin cytoplasmic tails. The integrin subunits that bind to each of the integrin-inhibiting or -
activating proteins are indicated in brackets. The residues involved in the formation of the inner membrane 
clasp (IMC) between α and β subunits are shown in green, and the proximal NPxY and distal NxxY motifs are 
shown in blue. (Taken from Bouvard et al., 2013) 
 
Proteins, which alter the phosphorylation status and therefore the functionality of integrins or 
integrin inactivators: The Tyr residues of NPxY/NxxY motifs and a Ser residue in the β‑integrin cyto-
plasmic tail are phosphorylated in an Src-dependent manner (Sakai et al., 2001). As already men-
tioned above, DOK1 and ICAP1 contain PTB domains mediating their recruitment to sites which are 
tyrosine phosphorylated. Interestingly, oncogenic activation of Src can lead to cell rounding resulting 
of loss of cell adhesion. This promotes the recruitment of DOK1 to the integrin β tails and thus inhib-
its Talin and Kindlin binding (Bledzka et al., 2010; Oxley et al., 2008). Another example is the phos-
phorylation state of Thr758 of β2 integrins. Here, the integrin inhibitor Filamin can only bind to the 
non-phosphorylated β2-tail (Takala et al., 2008). In addition to integrin phosphorylation, phosphory-
lation of inhibitors regulates their binding to integrins and therefore integrin activation. Filamin is 
phosphorylated by ribosomal protein S6 kinase 2 (RSK2) in response to adhesion and epidermal 
growth factor (EGF) stimulation. RSK2 interacts with β1 and β7 integrins via the membrane proximal 
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NPxY motif. RSK2 becomes activated by phosphorylation through ERK and other kinases leading to 
Filamin phosphorylation and subsequent integrin inactivation (Gawecka et al., 2012).  
Proteins, which affect levels of cell surface integrin by regulating integrin trafficking: Although 
both ligand-bound and ligand-free integrins can be endocytosed; recycling is faster for inactive integ-
rins. Sortin Nexin 17 (SNX17), for example, is important for controlling the balance between recy-
cling and lysosomal degradation of integrins. Upon endocytosis of integrins Kindlin dissociates from 
the β1 integrin tail, and Sortin Nexin 17 (SNX17) binds the NxxY motif in early endosomes to pro-
mote integrin recycling and prevent degradation (Bottcher et al., 2012).  
 
1.1.2 Members of the integrin superfamily 
Members of the integrin superfamily comprise 18 different α- and 8 different β-subunits in mam-
mals. The various combinations of the α and β chains enable cells to form 24 integrin heterodimers, 
each of them capable of recognizing and adhering to a specific set of ECM proteins (Hynes, 2002), 
like (a) RGD (arginine-glycine-aspartic acid) tripepdide sequence containing ECM proteins, (b) Colla-
gen (Coll), (c) Laminin (LN), and (d) LDV (leucine-aspartic acid-valine) tripeptide motif or structurally 
related motifs containing proteins. 
(a) Integrins bind to the RGD sequence found in ECM components such as FN, VN, Osteopontin, 
and Thrombospondin. All αV containing heterodimers (αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8) belong to 
this group. In addition, α5β1, α8β1 as well as αIIbβ3, an integrin specific for platelets bind to the 
RGD motif.  Although a large number of diverse ligands share this subset of integrins, they exhibit 
variable affinity for the receptor, probably to the conformation of the RGD fitting into the binding 
pocket of the integrin headpiece.  
(b) Coll binding integrins are the β1 heterodimers α1β1, α2β1, α10β1 and α11β1. All of these α-
subunits contain a special αI domain, critical for ligand binding. Analogous to the β-subunits of αI-
less heterodimers, β subunits change the conformation upon activation through Kindlin/Talin. These 
changes alter the structure of metal ion-dependent adhesion sites (MIDAS) in αI that bind Glu or Asp 
side chains in extrinsic or intrinsic ligands. Thus, the conformational change results intrinsic ligand 
binding (ligand analogon) by the β-subunit and a subsequent conformational change within the αI 
domain leading to integrin activation (Springer and Dustin, 2012). The different heterodimers vary in 
their preference to different Coll types.  
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(c) LN binding heterodimers are α3β1, α6β1, α7β1 together with α6β4 integrins. It has been demon-
strated that different regions/motifs exist along LN which are recognized by distinct integrin dimers 
(Nishiuchi et al. 2006).  
(d) Integrins binding to the LDV sequence or structurally related motifs are α4β7 and αEβ7 hetero-
dimers as well as the β2 heterodimers αLβ2, αMβ2, αXβ2, αDβ2 specific for leucocytes. In addition 
to FN, this sequence motif is found in VCAM1 (vascular cell adhesion molecule 1), mucosal addressin 
cell adhesion molecule-1 (MAdCAM-1) and intercellular adhesion molecule 1 (ICAM1). VCAM-1, 
MAdCAM-1 and ICAM1 are surface proteins expressed by endothelial cells enabling leucocytes to 
bind to the endothelial layer and transmigrate into the tissue. The related integrins α9β1 and α4β1 
can bind FN and VCAM1. 
Many integrin heterodimers are essential for development (Bouvard et al., 2001), and under certain 
(patho-) physiological conditions when cells have to migrate and invade, they change their integrin 
expression and activation profile (Avraamides et al., 2008; Folkman, 2006; Martin, 1997). For exam-
ple, the de novo expression of the three major FN-binding integrins α5β1 and αVβ3/αVβ5 is associ-
ated with, and in some cases crucial for both (tumor−) angiogenesis and skin wound healing. A 
change in integrin expression patterns and functions is also frequently observed during tumorigene-
sis (Mizejewski, 1999; Plantefaber and Hynes, 1989). Consequently, various anti-integrin agents, 
such as monoclonal antibodies and small-molecule inhibitors, are in clinical development for treating 
solid and hematologic tumors (Junttila and de Sauvage, 2013; Nemeth et al., 2007). It has also been 
shown that downstream signalling events of two different integrins (α5β1 and αVβ3), even when 
bound to the same ligand, are profoundly different (Danen et al., 2002; Danen et al., 2005). The mo-
lecular mechanisms enabling such selective signal transduction is unclear (Figure 3). 
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Figure 3. Integrin – Heterodimers, Specificity, Crosstalk and Cooperativity 
Mammalian genomes contain 18 α subunit and 8 β subunit genes, and to date 24 different α/β combinations 
have been identified at the protein level. Heterodimer combinations in focal adhesions are depicted by differ-
ent colors in a bird`s eye view within a whole cell on the right. Actin connections are presented as blue-lined 
structures. In the blow up picture the bird`s eye view and intersection of heterodimer combinations are pre-
sented in the upper panel. In the lower panel αVβ3 (green) and α5β1 (orange) integrins are shown. Biological 
processes such as cell migration depend on the integration of signals derived from different integrin heterodi-
mers (e.g. α5β1 and αVβ3). Integrin heterodimer-specific signals could exert trans-dominant effects on or 
cooperate with other integrin signals. This allows a fine tuning of complex biological responses to the extracel-
lular environment. The molecular details of this complex regulatory system are unknown. (Modified from 
drawing by Monika Krause, MPIB, Public Relations) 
 
An important caveat in most experimental systems used in the past is that αVβ3/αVβ5 and α5β1 are 
co-expressed on most cells. For instance, during wound repair-induced angiogenesis, endothelial 
cells up-regulate the expression of αVβ3/αVβ5 and α5β1 and of FN (Brooks et al., 1994; Parsons-
Wingerter et al., 2005; Silva et al., 2008). Therefore, it is crucial to reduce this complexity and ex-
press both integrins subsets separately in the same cellular background in order to study and com-
prehend their function.  
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1.1.3 Bi-directional signalling and Focal Adhesion proteins 
As already mentioned above, integrin tails have no catalytic activity of their own, they must bind 
accessory molecules, which regulate the highly dynamic interactions with f-Actin and orchestrate the 
cross-talk with growth factor receptor signalling pathways to achieve a desired outcome (Legate et 
al., 2009). Intracellular changes arising from integrin-ligand binding consist of increased tyrosine 
phosphorylation of specific substrates, increased formation of lipid second messengers, and cyto-
skeletal rearrangements that allow cells to adopt their characteristic shape and initiate migration via 
dynamic connections between integrins and f-Actin. The interaction between integrins and their 
various ECM ligands induces so called outside-in signals across the membrane, allowing the cell to 
sense the extracellular environment. Thus, integrins have the ability to signal in both directions (bi-
directionally) across the plasma membrane. Nevertheless, the adhesion force of one integrin is too 
weak to conduct firm adhesion of the cell to the matrix. Lateral association of integrins to adhesion 
(termed as clustering) joins numerous weak links to the ECM in a synergistic manner to an accumu-
lated strength of multiple affinities of individual non-covalent binding interactions (termed as avidi-
ty). It has been shown, that activation of integrins (Takagi et al., 2001) as well as their clustering 
(Bunch, 2010) is required for transmitting signals from the ECM into the cell, but how this integrin 
clustering is mechanistically executed, is not known yet. In one model, freely mobile receptors (in-
tegrins) and repellents (local glycocalyx (Ito, 1969)), bring the membrane into contact with a ligand-
coated planar surface (ECM proteins) leading to the binding of receptors to the ligands in clusters. 
Once a stable integrin ligand bond is formed, the local glycocalyx is compressed. Thus adjacent in-
tegrins will need less glycocalyx compression to allow binding than distant ones and hence the bind-
ing occurs in clusters (Boettiger, 2012). 
Integrin outside-in signalling results in downstream signalling events which can be subdivided into 
three temporal stages (a, b, c) (Figure 4):  
 
(a) In the first stage up-regulation of lipid kinase activity is initiated leading to elevated levels of 
PtdIns-4,5-P2 and PtdIns-3,4,5-P3 as well as the induction of rapid phosphorylation and activation of 
specific protein substrates like important FAK and Src kinases.  
(b) Phosphorylation of additional FA proteins like Paxillin and activation of signalling pathways like 
Ras/MAPK, Rho family GTPases and other Actin regulatory proteins is part of the second stage.  All 
this leads to changes in the dynamics and distribution of the Actin cytoskeleton.  
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(c) The last stage represents the long-term consequences of integrin outside-in signalling, like prolif-
eration, cell survival, alterations in cell morphology, as well as changes in the transcriptional pro-
gram. 
 
What are the integrin adaptor proteins? On the basis of a meta-study of the cell-adhesion literature 
around 180 proteins, including adapters, kinases, phosphatases and various other classes of proteins 
were compiled to be associated with FAs either constitutively or transiently (Zaidel-Bar and Geiger, 
2010; Zaidel-Bar et al., 2007). In studies of adhesion protein isolations, 905 focal adhesion proteins 
were identified. Hereby 459 proteins changed in abundance with Myosin II inhibition, defining the 
myosin-II-responsive focal adhesion proteome (Kuo et al., 2011). In a parallel study by the use of 
chemical crosslinkers, 87 adhesion proteins (termed also as adhesome) were detected in kidney 
fibroblasts, where a subgroup of 64 proteins was found to be enriched on FN and along these set 40 
proteins were myosin-II-responsive (Schiller et al., 2011).  
The linker proteins connecting the cytoplasmic integrin domains to the cytoskeleton are multiple 
and their interaction is complex. The major signal transduction pathways and their key players are 
depicted in Figure 3. These proteins often act in concert with G protein-coupled or kinase receptors 
(Hynes, 2002; Shen et al., 2012). The major sub-membranous, integrin-associated links between 
integrins and these signal transduction pathways are shown within the “cloud” representing the 
adhesome structure and in the grey arrows, respectively (Figure 4). Since the main focus of the sec-
ond manuscript is how cytoskeletal organization can alter the cells` transcriptome, involved proteins 
and signalling processes will be presented in more detail below. 
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Figure 4. Outside-in signalling 
Depicted are the major signal pathways and key players. They often act in concert with G protein-coupled or 
kinase receptors. The major integrin associated proteins are highlighted in the adhesome structure beneath 
the clustered integrins. Direct actin binding proteins are highlighted in red. (Modified after Hynes, 2002) 
 
1.1.4 Actin binding through integrins and the importance of mechanotransduction 
The major structural role of integrins is to mediate the connection of the extracellular matrix envi-
ronment to the Actin cytoskeleton. This can be achieved by a variety of actin-binding proteins that 
bind integrins either directly or indirectly.  
Direct actin-binding proteins include Talin (Critchley, 2000), Filamin (van der Flier and Sonnenberg, 
2001), α-Actinin (Otey et al., 1993), Tensin (Lo, 2004) and Vinculin (Humphries et al., 2007).  All of 
these proteins bind directly to the β tail, with the exception of Vinculin, which binds which interacts 
with integrins via Talin. Further contribution to this connection is achieved by integrin-bound pro-
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teins that indirectly associate with the cytoskeleton or participate in its regulation such as Kindlin, 
IPP complex members, Paxillin, and FAK. A third group of proteins which regulate the interactions of 
the proteins above are a plethora of additional adaptor and signalling molecules (Figure 4).  
During the formation of focal adhesions, the first linkage to the cytoskeleton after integrin-ligand-
binding is the recruitment of Talin to the NPxY motif of integrin β tails. Thereby, a talin-dependent 2-
pN slip bond is established, providing the initial force from the cytoskeleton to the ECM (Jiang et al., 
2003). Since Talin is an important protein in the induction of integrin signalling and mechanical cou-
pling, Figure 5 is presented to summarize modes how it can be activated. 
 
 
 
 
 
Figure 5. Talin activation 
The majority of Talin exists in an inactive cytosolic pool and 
the Rap1-interacting adaptor molecule (RIAM) has been impli-
cated in Talin activation. Further integrin signalling via FAK and 
Src promotes binding of PIPK1γ90 to the Talin F3 subdomain, 
the activation of PIPK1 γ 90 and translocation of the PIPK1γ90-
talin complex to the plasma membrane. The Talin head binds 
acidic phospholipids, and PtdIns(4,5)P2 has been shown to 
activate the integrin-binding sites in Talin. Calpain 2 also in-
creases the binding of Talin to integrins in vitro. (Taken from 
Critchley and Gingras, 2008) 
  
 
Next, Vinculin is recruited to LxxAAxxVAxxVxxLIxxA motifs in the rod of Talin (Critchley and Gingras, 
2008). These binding sites are usually masked (termed as cryptic binding site) and buried in the core 
of a series of helical bundles and probably mechanical stretch is required for exposing these sites. 
Along with this finding, expression of just Talin head in Talin knockout cells, activates integrins but 
fails to form detectable focal contacts because the Vinculin binding site is missing and thus the link 
to the actin cannot be properly established (Zhang et al., 2008). This suggests that Talin is required 
for the initial contacts, whereas Vinculin, by binding of Actin and Talin, is critical for maintaining and 
strengthening this connection. Interestingly, Talin owns a cryptic Actin binding site (ABS) in the C-
terminal region of its rod domain. This Talin/HIP1R/Sla2p actin-tethering C-terminal homology 
(THATCH) is required for dimer formation (Gingras et al., 2008). Interestingly, Actin binds by an un-
known mechanism only to a THATCH dimer, and thus binding of Talin to f-Actin is linked to its dimer-
ization.  
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As force is generated, another Actin binding protein, α-Actinin, is recruited to focal adhesions 
(Laukaitis et al., 2001) via Vinculin, Talin and direct β-integrin interactions. Besides α-Actinin, α-
Parvin uses an α-Actinin-like Actin binding domain to bind f-Actin which consists of two in tandem 
arranged Calponin homology (CH)-domains (Olski et al., 2001). Together with ILK and PINCH, it con-
stitutes a protein hub termed as IPP (ILK/PINCH/Parvin) complex. The link to the integrin β-tails is 
hereby made by ILK which also binds to Paxillin, a direct integrin binder. The IPP complex exemplifies 
the elaborate interactions of FA proteins linking integrins to the Actin cytoskeleton.  
Although sophisticated, there is order to these interactions. A topographical study (using high reso-
lution microscopy) revealed that integrins and Actin are vertically separated by a 40-nm focal adhe-
sion core region consisting of a membrane apposed integrin signalling layer (integrin cytoplasmic 
tails, FAK, Paxillin), an intermediate force transduction layer (Talin and Vinculin), and an uppermost 
actin-regulatory layer (Zyxin, VASP, α-Actinin) (Kanchanawong et al., 2010). 
The connection of the ECM to the Actin cytoskeleton is one crucial task of integrins, it serves to con-
vert mechanical stimuli into chemical activity, a process termed mechanotransduction. Already at 
the very beginning of integrin signalling, with the recruitment of Talin and opening of its cryptic bind-
ing sites for Vinculin and Actin binding (mentioned above), mechanical tension plays an essential 
role. Several other signalling proteins, like Src, P130Cas (130 KDa Crk-associated substrate) (Sawada 
et al., 2006) and Vinculin, exhibit also tension-dependent conformational changes that influence 
their kinase activity, availability of cryptic phosphorylation sites, or target the protein to a specific 
site (membrane, lysosome, etc.) within the cell (termed as intracellular compartimentalization) 
(Moore et al., 2010; Riveline et al., 2001; Sawada et al., 2006). A number of enzymes are known to 
change their kinetics due to mechanical stimulation. The focal adhesion kinase (FAK) for example is 
autoinhibited by its FERM domain, which maintains FAK in an underphosphorylated state. Auto-
phosphorylation of FAK at Y397 is critical for many FAK-dependent functions, including phosphoryla-
tion of FAK on other residues. In addition, phosphorylation of Y397 creates a binding site for several 
SH2 domain-containing molecules, including phosphatidylinositol 3-kinase and Src. Importantly, 
these intramolecular interactions require mechanical activation of FAK in order to carry out its ki-
nase function (Cooper et al., 2003). This is particularly relevant because loss of FAK inhibits the cells` 
ability to sense collagen stiffness (Li et al., 2002). Another example is the receptor-like tyrosine 
phosphatase α (RPTP-α) which interacts with αVβ3/αVβ5 integrins. Upon force application through 
FN-integrin binding an activation of downstream Src family kinases can occur (von Wichert et al., 
2003) (Zheng et al., 2000).  
Thus a variety of primary force-sensing mechanisms could be postulated, including opening of 
cryptic binding sites along cytoplasmic proteins, activation of ion channels, and formation of force-
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stabilized receptor-ligand bonds (catch bonds) (Vogel and Sheetz, 2006), which would then acti-
vate downstream signalling pathways. However, the molecular mechanisms underlying the con-
nection between mechanical elements and chemical signalling processes are still poorly under-
stood. 
1.1.5 Proteins and signalling processes mediating actin distribution and dynamics 
The local accumulation of f-Actin in the form of a dense stress fiber template at the focal adhesion 
plaque was shown to facilitate not only the recruitment and stable association of FA proteins (Oakes 
et al., 2012) but also the well-controlled formation of cell protrusion/retraction during cell migra-
tion, cell morphology regulation, wound healing as well as cell contractility and matrix degradation.  
1.1.5.1 Types of Actin-rich protrusions 
To fulfil these listed functions, motile, invasive cells like cancer cells and fibroblasts express different 
types of actin-rich protrusions when plated on a two-dimensional surface:  
(a) Lamellipodia (from Latin “lamina”, which means “thin sheet”, and “pod”, which stands for “foot”) 
form at the leading edge of cells, consisting of a dendritic Actin network in a thin membrane leaflet. 
(b) Filopodia (or microspikes), are fine cytoplasmic projections which extend beyond the leading 
edge of lamellipodia in migrating cells. They are thought to be involved in sensation of chemical cues 
and directed cell movement. 
(c) Circular dorsal ruffles are characterized as f-Actin-rich membrane projections on the apical cell 
surface and appear as highly dynamic "rings" which then mature and contract centrifugally before 
subsiding. They are thought to conduct a critical role in receptor internalization and cell migration. 
1.1.5.2 Actin modifying proteins 
To build the above mentioned Actin structures, various Actin binding proteins (ABPs) intersect, 
thereby regulating both the assembly and disassembly of globular (g)-Actin into filamentous (f)-Actin 
in a process called Actin (de-)polymerization.  
As short dimeric or trimeric Actin intermediates are very unstable, this process is highly dependent 
on the presence of Actin nucleating proteins. One important nucleating factor is the Arp2/3 com-
plex, which mimics a g-Actin dimer in order to stimulate the nucleation of g-Actin necessary for pol-
ymer growing. However, the isolated Arp2/3 complex has no endogenous actin nucleating activity 
and must be activated by the Wiskott-Aldrich Syndrome protein (WASP) family members (like Neu-
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ronal (N)--WASP, WAVE, WASH) of activator proteins. Although full-length WASP is less effective, its 
activity can be greatly enhanced by Rho family GTPases (see below) and phosphatidylinositol (4,5) 
bisphosphate causing the WASP protein to expose a domain that binds and thus activates the Arp2/3 
complex (Rohatgi et al., 1999). WASP binding leads to a conformational change in Arp2/3 which can 
then form a nucleation core for Actin filament elongation. Arp2/3 is recruited to nascent integrin 
adhesions through interactions with FAK as well as Vinculin to promote Actin polymerization directly 
at the site of adhesion (DeMali et al., 2003). Interestingly, Arp2/3 on the other hand si also required 
to form NAs. There exists apparently a positive forward loop between these molecular complexes. 
To generate force and move membranes, the Arp2/3 complex must collaborate with other actin-
associated proteins, including Capping protein (CP), ADF/Cofilin, Profilin, and Thymosin. CP, which is 
also known as β-Actinin, or CapZ in skeletal muscle, is an αβ heterodimer. CP caps the barbed ends 
of the Actin filament with high affinity, thereby preventing the addition or loss of Actin subunits 
(called Actin capping) (Wear and Cooper, 2004). ADF/Cofilin belong to a family of actin-binding pro-
teins which bind g-Actin monomers and depolymerize Actin filaments by providing free barbed ends 
for further polymerization (termed as Actin severing) and increasing the off-rate for actin monomers 
from the minus end (Actin depolymerizing).  
Actin assembly is further regulated by a selective interaction of Actin monomers with specific mole-
cules that inhibit or promote their polymerization (termed Actin sequestering) by preventing their 
access to other monomers thus regulating Actin pool composition. Two important sequestering fac-
tors are Profilin and Thymosin β4 (Tβ4). Profilin binds to monomeric Actin by occupying an Actin-
Actin contact site which leads to removal of Actin from the pool of polymerizable Actin monomers. 
However, Profilin also catalyzes the exchange of actin-bound ADP to ATP thereby converting poorly 
polymerizing ADP-Actin monomers into readily polymerizing ATP-actin monomers. Tβ4, originally 
isolated from the thymus, forms a 1:1 complex with g-Actin to buffer the polymerization process. 
This buffering is achieved by maintaining a large pool of Actin monomers through Tβ4 interaction 
and thus controlling the assembly and disassembly of Actin filaments that regulate the dynamics of 
the Actin cytoskeleton (Hertzog et al., 2004). Since one of my manuscripts are about MAL/SRF tran-
scriptional regulation I will shortly introduce the influence of Profilin and Tβ4 on MAL-g-Actin inter-
action. The megakaryocyte acute leukemia protein (MAL) binds via its RPEL motif to g-Actin. Through 
this interaction, MAL translocation into the nucleus is inhibited. If it is unbound and translocates, 
MAL binds the transcription factor serum response factor (SRF) in order to initiate transcription of 
target genes. Interestingly, Posern et al. reported that Profilin bound g-Actin cannot interact with 
MAL anymore (Posern et al., 2002). Further, crystal structure analysis revealed unexpected similarity 
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between RPEL motif (found in MAL) and the Actin contacts of vitamin D-binding protein (DBP) 
(Mouilleron et al., 2008). DBPs is a large multi-domain actin-sequestering protein quite unrelated to 
the RPEL motif (Otterbein et al., 2002). The area of Actin covered by DBP within the complex approx-
imately equals the sum of those covered by Profilin and most likely also by Tβ4 (Morita and Hayashi, 
2013). In vivo and in vitro experiments have shown that administration of Tβ4 can promote migra-
tion of cells, formation of blood vessels, maturation and differentiation of stem cells, survival of var-
ious cell types and lowering of the production of pro-inflammatory cytokines. It is believed that 
these short- and long-term effects on cell behavior are due to the maintenance of a dynamic equilib-
rium between g- and f-Actin (Crockford et al., 2010). Thus it is possible that Tβ4-mediated release of 
MAL regulates cytoskeletal dynamics and adhesion through SRF/MAL mediated gene transcription. 
On top of this, Actin crosslinking proteins (for example, α-Actinin and Filamin) can arrange f-Actin 
into distinct networks, such as Actin bundles. In the region directly behind the lamellopodium (this 
area termed as the lamellum), Actin is organized into parallel bundles to establish directed cell motil-
ity and cell stability. There, Actin assembly is mediated by the diaphanous-related formin (DRF) pro-
tein family of Actin polymerizing factors, including mDia or Ena/VASP, which associate with the fast-
growing end (barbed end) of Actin filaments. Formins also prevent the binding of capping proteins to 
the barbed ends of Actin and thus inhibit further polymerization (Zigmond, 2004).  
As already mentioned above, these processes are highly coordinated by an important group of small 
G proteins with 20–25 kDa in size: the Rho family of GTPases (Figure 6). The Rho family is a subfamily 
of the Ras (Rat sarcoma) protein family. Among them Cdc42, RhoA and Rac are the most important 
members. Rho family GTPases are active when GTP-bound and inactive when bound to GDP. Activa-
tion is catalyzed by guanine nucleotide exchange factors (GEFs) and inactivation is promoted by 
GTPase activating proteins (GAPs) that stimulate the intrinsic GTPase activity of the Rho proteins. 
Further regulation is conducted by Rho-GDP dissociation inhibitors (Rho-GDIs), which sequester inac-
tive GDP-bound Rho-GTPases in the cytoplasm and thus removing them from their activation cycle 
by GEFs at the plasma membrane (PM). Rho-GDIs also mediate the cycling of Rho proteins between 
the cytosol and the membrane. Rho proteins contain a conserved CAAX sequence at the C terminus, 
which is modified by isoprenylation (through the addition of a geranyl geranyl moiety in the case of 
RhoA, Rac1 and Cdc42) of the cysteine residue (Seabra, 1998). The binding of Rho GTPases to effec-
tor proteins regulates Actin reorganization, in addition to other crucial biological events, such as 
gene expression and cell growth (Bishop and Hall, 2000). The influence of integrins on Rho GTPase 
signalling is exemplified by Rac binding sites, which can be found within cholesterol-rich membrane 
domains, are internalized when cells are deprived of adhesion. Endocytosis of these domains is me-
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diated by caveolae and regulated Caveolin-1 phosphorylated at tyrosine-14. Further, Cdc42 also 
requires integrin-mediated adhesion for translocation to membranes. This mechanism can account 
for the control of multiple pathways by integrins, thus providing an important mechanism for an-
chorage dependence of growth (Del Pozo et al., 2002; Del Pozo and Schwartz, 2007). 
 
 
 
 
 
 
 
Figure 6. Overview of Rho-GTPases and the 
effector pathways that act downstream of 
integrins in order to regulate Actin 
Through the recruitment and activation of differ-
ent effector proteins (indicated in green), Rho-
GTPases regulate the Actin cytoskeletal dynamics 
that are required for membrane protrusions 
and/or cytoskeletal contractility. (Modified after 
Huveneers and Danen, 2009) 
 
While lamellipodia are built in a Rac and Arp2/3-complex-dependent fashion, filopodia rely on the 
activity of Cdc42, Ena/VASP family formins (Figure 6). The formation of stress fibers and the retrac-
tion of the cellular rear are mediated by RhoA (Hall, 2012; Ridley and Hall, 1992).  
1.1.6 Temporal short- and long-term effects by integrin mediated Actin dynamics 
The above described actin-based features of a cell account for and react to the properties of a cer-
tain microenvironment (e.g. elasticity and ECM composition) via mechanosensitive proteins that are 
subject to molecular forces thereby activating signalling pathways. This bi-directional interplay be-
tween the microenvironment and cellular mechanosensation is increasingly recognized as potent 
regulators of cell decisions that affect proliferation, migration, stem cell identity, apoptosis, and cell 
fate (Halder et al., 2012). Forces are constantly transmitted across cell-ECM and cell-cell adhesion 
sites leading to an adaptation to these external mechanical stimuli by adjusting the stiffness of the 
cells´ cytoskeleton (Janmey and Miller, 2011; Parsons et al., 2010; Vogel and Sheetz, 2006). Hereby 
integrins promote bundling of Actin filaments and activate Myosin II to generate intracellular ten-
sion.  Reciprocally, the activity of Actin modifying proteins, the rate of Actin (de-)polymerization and 
spatial Actin organization influences integrin function and thus the adhesive state of a cell (Gardel et 
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al., 2010). The effects of integrin mediated tensile forces can be temporally subdivided into short- 
and long-term effects of signalling: 
Short-term effects of integrin signalling consist of cytoskeletal rearrangements that allow cells to 
adopt their characteristic shape and initiate migration. ECM stiffness sensed by integrins promotes 
focal adhesion assembly and activation of the Rho family of GTPases. RhoA functions via Rho kinase 
(ROCK) to regulate myosin light chain phosphorylation through inhibitory phosphorylation of Myosin 
phosphatase which results in actin-myosin interaction and cell contractility. Actin modifying mole-
cules, like (de-)polymerizing, capping and severing proteins, intersect and modulate these immedi-
ate adhesion induced signalling effects further.  
Long-term effects of integrin signalling result from changes in gene expression, which regulate cell 
proliferation and differentiation. Integrin-dependent regulation of gene expression has primarily 
been thought to arise from cross-talk between the Rho-ROCK pathway and the epidermal growth-
factor receptor (EGFR), which will lead to oncogene (Ras)-driven extracellular-signal-regulated kinase 
(ERK) activation and the subsequent activation of mitogen activating protein (MAP) kinase pathways 
(Jaalouk and Lammerding, 2009). A recent study, reported that β1-class integrins can change gene 
programs of mesenchymal stem cells involved in lineage commitment to bone, fat or cartilage by 
activating Rho GTPase signalling cascades, which result in the nuclear localization of the transcrip-
tional co-activators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding 
motif (TAZ) (Tang et al., 2013). Another study identified Actin modifying proteins as essential gate-
keepers limiting YAP/TAZ activity in cells experiencing low mechanical load, including attenuation of 
proliferation by contact inhibition (Aragona et al., 2013). YAP (Yes-associated protein)/TAZ (tran-
scriptional co-activator with PDZ-binding motif) are classically regulated by the Hippo cascade but 
also WNT and GPCR signalling were identified to modulate these co-activators of transcription 
(Azzolin et al., 2012; Pan, 2010; Yu et al., 2012). 
In addition to the control of YAP/TAZ, Rho family GTPases can also control gene transcription by 
releasing the association of the transcriptional co-activator MAL (megakaryocyte acute leukemia 
protein; also known as MRTF-A and MKL1) from monomeric or globular (g-) Actin. Once g-Actin is 
assembled into Actin networks, free MAL translocates into the nucleus, where it associates with and 
activates the transcription factor serum response factor (SRF), which regulates mainly the expression 
of cytoskeletal proteins including Actin and FA proteins including Vinculin, Talin and integrins. Thus it 
is possible that integrin-mediated activation of Rho GTPases regulates cytoskeletal dynamics and 
adhesion through both effector proteins and the nuclear localisation and activation of MAL. 
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1.2   Fibronectin and its major integrin receptors 
1.2.1 Fibronectin – Assembly and features 
The extracellular matrix (ECM) constitutes the filling element in all tissues and organs and in addi-
tion, provides a physical scaffolding for cells and initiates crucial biochemical and biomechanical 
signals necessary for tissue morphogenesis, differentiation and homeostasis (Frantz et al., 2010). A 
major fraction of the ECM is composed of Collagens, Laminins and other glycoproteins such as FN, 
which serve as substrates for different adhesion molecules including integrins. Importantly, ECM 
components, especially FN are secreted by cells as non-functional building units, which assemble 
into functional supra-molecular structures in a highly regulated manner (Erickson and Carrell, 1983; 
Rocco et al., 1983).  
In this hierarchical assembling process, FN fulfills several features: FN fibrills  
(a) possess binding sites for multiple ECM components (Figure 7), which are used to assist in the 
assembly of several other ECM proteins (Dallas et al., 2006; Dallas et al., 2005; Sabatier et al., 2009), 
such as collagen types 1 and 3 (Kadler et al., 2008; Leiss et al., 2008); Therefore proper FN deposition 
and assembly might be essential to physiological and pathophysiological cell invasion by cross-linking 
the ECM and by providing a sufficiently dense scaffold for enabling cell migration.   
(b) provide at the same time structural support for cell adhesion and integrins, thereby translating 
biomechanical into biochemical downstream signals (Mao and Schwarzbauer, 2005);  
(c) control the availability of growth factors, for example by regulating their activation from latent 
complexes as shown for TGF-β (Fontana et al., 2005); 
FN matrix assembly (termed as fibrillogenesis) is a multistep, integrin-dependent process. Among 
the FN-binding integrins, α5β1 is considered of major importance for the formation of an elaborate 
meshwork of FN fibrils (Fogerty et al., 1990; Leiss et al., 2008; McDonald et al., 1987). The α5β1 het-
erodimer binds FN, transduces a pulling force onto focal adhesions which leads to integrin separa-
tion, as α5β1 integrin is transported rearward along Actin stress fibers towards the cell centre. This 
leads to the growth of a adhesion structures called fibrillar adhesions (Ali and Hynes, 1978; Wu et al., 
1995), where FN fibrils are aligned with α5β1 integrins, f-Actin filaments and multiple signalling mol-
ecules (Ohashi et al., 2002; Pankov et al., 2000; Zamir et al., 2000). This transduced mechanical 
stress seems to be a prerequisite for FN assembly, because treatments inducing higher contractile 
forces within the cell stimulate matrix assembly, whereas inhibition ofMyosin light chain kinase or 
RhoA GTPase reduces assembly (Zhang et al., 1994; Zhang et al., 1997; Zhong et al., 1998). Further-
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more, it was shown that cells grown on rigid substrates stimulate Rho/ROCK and FN matrix assembly 
while cultures on soft substrates fail to do so (Carraher and Schwarzbauer, 2013).  
 
Figure 7. The modular structure of fibronectin 
Numerous cell types synthesize and secrete FN as a disulfide-bonded dimer composed of 230–270 kDa subu-
nits. These subunits comprise functional domains that mediate interactions with other ECM components, with 
cell surface receptors, GFs and with FN itself. FN consists of three different modules (type I, blue; type II, 
brown; type III, green). The dimer forms via two disulfide bonds at the C-terminus. Integrin binding sites are 
indicated. Binding domains for FN, Collagen, Fibrin, Heparin and bacteria are indicated. Note that the α5β1 as 
well as the αIIbβ3 integrins are believed to require the synergy region to bind to the RGD motif. (Taken from 
Leiss et al., 2008) 
 
1.2.2 The role of Fibronectin in mouse development 
Considering the multiple features and functions of FN, it is not surprising that its constitutive gene 
ablation in mice has dramatic consequences in vivo. As FN null embryos die because of defects in 
mesoderm and neo-vessel formation, I will first define what these structures are.  
"It is not birth, marriage, or death, but gastrulation, which is truly the most important time in your 
life." Lewis Wolpert (1986)  
Gastrulation is a phase in early embryonic development, during which the single-layered hollow 
sphere of cells (called blastomeres) surrounding an inner fluid-filled cavity (this fluid filed cavity is 
referred as blastocoel) forms (this whole structure is termed as blastocyst). The “single-layered” 
blastocyst is then reorganized into a "three-layered" structure known as the gastrula. These three 
germ layers are known as the ectoderm, mesoderm, and endoderm. The endoderm is the most in-
ternal germ layer, which gives rise to the lining of the gut and other internal organs. The ectoderm 
instead, lies most exterior and forms skin, brain, the nervous system, and other external tissues. The 
middle germ layer is called mesoderm. The mesoderm will differentiate into cells of the muscular, 
skeletal and the vascular systems. Thus, the primary function of gastrulation is the correct placement 
of precursor tissues for subsequent morphogenesis (Tam and Behringer, 1997).  
32 |  Introduction  
During de novo vessel formation endothelial progenitor cells (so called angioblasts) differentiate to 
endothelial cells and form a primitive vascular plexus (this process is referred as vasculogenesis) 
(Figure 8). Angiogenesis leads to formation of new vessels from pre-existing capillaries in two differ-
ent ways: Either through sprouting of capillaries or through splitting of a capillary into two. Growth 
factors including VEGF, TGF-β, FGF and PDGF, and importantly integrin interactions with a fibrillar FN 
matrix, in which the endothelial cells are embedded, are indispensable for proper new vessel for-
mation. 
 
 
 
 
 
 
 
Figure 8. Neo-vasculogenesis 
Vasculogenesis and two types of angiogenesis are 
shown: intussusceptive (means the process of blood 
vessel growth by splitting) and sprouting angiogen-
esis. (Modified after ten Dijke and Arthur, 2007) 
 
The expression of FN in mice initiates at the blastocyst stage and remains later in gastrulation, FN 
expression is mainly localized to the ectodermal-mesodermal interface, where it may promote the 
migration of mesodermal cells (Smith et al., 1990). Targeted inactivation of the FN gene in mice 
leads to early embryonic lethality around embryonic day (E) 8.5 due to severe defects in the devel-
opment of the mesoderm and mesoderm-derived tissues. Until E 7.5 in FN null embryos the three 
germlayers and the morphology of extraembryonic membranes seems to develop normally. Abnor-
malities are first visible by E 8.0 and are manifested by shortened anterior-posterior axis, a deficient 
head and vessel mesoderm, a disorganized notochord and a complete absence of somites. At E 8.5, 
the anterior-posterior axis is even more shortened and the head-folds have arrested development 
and appear distorted. In summary, the observed defects are proving the essential requirement of FN 
for normal development and in particular for the development of mesoderm-derived tissues. Inter-
estingly, genetic interactions are important for FN function in vivo, as the genetic ablation on 129/Sv 
compared to C57/BL6 genetic background is more severe (George et al., 1997; George et al., 1993; 
Georges-Labouesse et al., 1996). 
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1.2.3 The major Fibronectin receptors 
1.2.3.1 The β1-class of integrins 
β1 heterodimers constitute the largest subfamily with 12 heterodimers (Figure 9). The critical roles 
of β1 integrins in development are reported by the phenotypic observations produced by a homozy-
gous null mutation of the β1 subunit (Fassler and Meyer, 1995). This knockout results in very early 
embryonic lethality at day E 5.5 through defects in gastrulation. The dramatic phenotype of β1 null 
homozygotes does not appear to result from an absolute requirement for β1 integrins in cell survival 
or differentiation, since experiments with chimeric mice derived from a mixture of marked β1 null 
cells and wild type cells revealed that β1 null cells can contribute to all mature to all organs except 
liver and spleen (Fassler and Meyer, 1995), indicating critical roles of specific β1 heterodimers at 
early stages in development.  
 
Figure 9. The β1-subfamily 
The 12 β1-containing heterodimers constitute the largest integrin family. FN-binding heterodimers are marked 
in orange letters/lines. RGD binding dimers are marked with dashed lines. Their most important respective 
knockout phenotypes with references are described in the boxes. 
 
Among the β1 heterodimers are five integrins capable of binding to FN (Figure 9). Of these, α5β1, 
α8β1 and αVβ1 recognize the RGD sequence in ECM proteins such as FN and VN. The α4β1 and α9β1 
dimers bind to other sequences next to the RGD site in FN molecules (see also Figure 7). 
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1.2.3.2 The αV-class of integrins 
αV-class integrins consist of five heterodimers, namely αVβ1, αVβ3, αVβ5, αVβ6 and αVβ8 (Figure 
10) and one additional integrin, αIIbβ3, found on platelets. All of these members recognize the RGD 
motif in multiple ligands (Hynes, 2002). Crystal structures of αVβ3 and αIIbβ3 complexed with RGD 
ligands have revealed an identical atomic basis for this interaction (Xiong et al., 2002). Each αVβx 
heterodimer has a unique pattern of cell and tissue distribution. Based on in vivo observations and in 
vitro studies utilizing blocking antibodies and peptides, specific αV-class integrins have been sug-
gested to play critical roles in diverse biologic processes including embryo implantation, angiogene-
sis, and wound healing. However, in contrast to mice lacking β1 integrins, mice lacking the αV subu-
nit, and therefore lacking five of the six integrins in this family, survive until E 10 or perinatal due to 
abnormal blood vessel formation in the head region but also due to severe placenta defects at E 10 
(Bader et al., 1998; Reynolds et al., 2002) (Figure 10). A subset of animals can even proceed through 
embryonic development and die after birth because of hemorrhages, indicating that, unlike α5, αV 
integrins are dispensable for vasculogenesis and partly also for angiogenesis (Bader et al., 1998). 
 
Figure 10. The αV-subfamily 
The 5 αV-containing heterodimers recognize the RGD motif and can therefore bind to FN. Their respective 
knockout phenotypes with references are described in the boxes. 
 
Although the α5β1 integrin is considered the major integrin responsible for FN assembly (Fogerty et 
al., 1990; McDonald et al., 1987), and its interaction with the RGD motif is required for this function, 
integrins of the αV subfamily can also compose FN into fibrils. This statement is corroborated by the 
phenotype observed in integrin α5-null mice. This deletion also leads to embryonic lethality and 
vascular defects, but these mice develop significantly further (until E 10.5) than the FN-null mice 
(Yang and Hynes, 1996; Yang et al., 1993). Only a double knockout of the αV and α5 integrin genes 
result in a loss of FN fibrillogenesis (Yang et al., 1999). Interestingly, although the RGD motif is cen-
tral for the interaction of FN with α5β1 and αVβ3, the inactivation of this motif by a RGD to RGE 
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point mutation also allows FN fibrillogenesis in vivo. The knock-in mice carrying this mutation display 
a phenotype closely resembling that of the α5-null mice (Takahashi et al., 2007). This highlights the 
importance of this motif in FN signalling through α5β1, but also shows the ability of other integrin 
interaction sites on FN to take over the role of RGD in FN fibrillogenesis.  
Altogether these studies imply overlapping and independent functions of α5β1 and αVβ3 in early 
mesodermal development (Yang et al., 1999). 
 
1.3 The concept of receptor cross-talk 
Cell surface receptors bind ligands expressed on other cells (in trans) in order to communicate with 
neighboring cells. However, an increasing number of cell surface receptors are found to also interact 
with ligands expressed on the same cell (in cis). Integrins can interact with molecules on neighbour-
ing cells or ECM and in addition, form cis associations with other receptors on the same cell to as-
semble multi-receptor complexes. These complexes recruit signalling molecules to sites of cell-cell or 
cell-matrix adhesions. This allows to cooperate with other cell-surface receptors and to influence a 
variety of signalling cascades. For example, integrins are able to utilize the platelet-derived growth 
factor (PDGF) receptor and its signalling pathway without any PDGF stimulus (Sundberg and Rubin, 
1996). These complexes of integrins and partner receptors can be formed either in response to or 
independent of integrin activation but are able to modulate integrin signalling.  
1.3.1 Integrin-integrin cross-talk 
The downstream signalling events of two different integrin heterodimers binding to the same ligand 
can be profoundly different. For instance, α5β1 and αVβ3 were found to differentially modulate 
RhoA-GTP loading, organization of cell matrix adhesions, and FN fibrillogenesis (Danen et al., 2002). 
In addition, to the obvious selectivity of certain signals to a particular integrin heterodimer, it was 
also shown by using ligands specific for integrin αIIbβ3 induced effects on the functions of target 
integrins α5β1 and α2β1. This experiment exemplifies that the binding of integrin-specific ligands to 
a suppressive integrin (like αIIbβ3) can inhibit the function of other target integrins (like α5β1 and 
α2β1) (trans-dominant inhibition). Trans-dominant inhibition is a blockade of integrin signalling by 
the engagement of another integrin (Diaz-Gonzalez et al., 1996). Thus this finding introduces the 
concept of integrin cross-talk. Further it was shown that α5β1 signals can enhance αVβ3 dependent 
migration towards VN (Kim et al., 2000). In addition, exposure of cells to VN specifically inhibited β1-
driven FN deposition (Hocking et al., 1999). Another example for FN-binding integrin cross-talk is 
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work on integrin recycling pathways. Hereby blocking αV-class integrins result in changes in α5β1 
recycling leading to enhanced α5β1 driven signal transduction and cell invasion (Caswell et al., 2008; 
Caswell et al., 2007; White et al., 2007). Such a cross-talk of αVβ3 and α5β1 implies that in endothe-
lial or cancer cells expressing both αVβ3 and α5β1, ligand binding to αVβ3 could alter FN-
fibrillogenesis, migration toward FN or even long-term, integrin induced changes like differentiation 
and proliferation.  
1.3.2 Integrins and growth factor receptor signalling cross-talk 
The ECM not only provides physical support for cells and tissues, but also serves as an information-
rich structure interpreted by cells for example through integrins and growth factor signalling mem-
bers (Hynes, 2009). Hereby integrins, growth factors and ECM interact and extensively cross-talk 
with each other (Ivaska and Heino, 2010; Streuli and Akhtar, 2009). Integrins transmit information 
about the ECM components and mechanical properties, but also assemble and rearrange ECM pro-
teins. In addition, growth factor signalling up-regulates expression of αVβ3, αVβ5, αVβ6, and several 
β1 integrins (Heino et al., 1989; Heino and Massague, 1989; Ignotz et al., 1989; Sheppard et al., 
1992). Recently it was shown that inactivation of β1 integrin impairs growth factor from stimulating 
the motility of normal and malignant mammary epithelial cells (MECs) and results in robust compen-
satory expression of β3 integrin which restores growth factor induced phenotypes (Parvani et al., 
2013). Many growth factors are stored within the ECM and can be released from ECM-binding. One 
prominent example is the transforming growth factor beta (TGF-β). TGF-β is secreted in a latent 
complex consisting of three proteins: (a) TGF-β; (b) latency-associated protein (LAP) an inhibitor, 
which is derived from the TGF-β propeptide; (c) one of the latent TGF-β binding proteins (LTBPs), an 
ECM-binding protein; LTBPs interact with Fibrillins and other ECM components and thus function to 
localize latent TGF-β in the ECM. LAP contains an integrin-binding site (RGD), thus several RGD-
binding integrins (e.g. αVβ6 and αVβ8) are able to activate latent TGF-β through binding this site 
(Munger et al., 1999). TGF-β activation appears to be the critical step in conducting its effects, which 
include inhibition of proliferation of many cell types, regulation of the immune system (Li et al., 
2006a), manipulation of ECM production, contribution to fibrosis (Sime et al., 1997), skin cancer 
(Rognoni et al., 2014) and breast cancer metastasis (Parvani et al., 2013). In addition, integrins con-
tribute to growth factor receptor signalling pathways by directly acting on downstream components 
of the pathways via catalytic proteins recruited to integrin cytoplasmic tails (Munger and Sheppard, 
2011). Interestingly, mutant mice defective in integrin-mediated activators and with Fibrillin (LTBPs 
and Fibrillins interact non-covalently, these proteins along with LTBPs are critical for proper place-
ment of latent TGF-β in the ECM;) gene mutations, show the critical role of ECM and integrins in 
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regulating TGF-β signalling. This evidence is mirrored by strong overlaps among phenotypes of TGF-
β-null and integrin-null mice (Figure 11). For example: (a) β6 null mice lack the αVβ6 integrin. αVβ6 
is an epithelium-restricted integrin that is up-regulated after epithelial injury. These mice develop 
lymphocytic lung inflammation reminiscent of inflammations in TGF-β1 null mice (Huang et al., 
1996). (b) Mice with a knockin mutation of TGF-β1 that alters  the RGD binding site to a nonfunc-
tional RGE sequence fully reproduce the phenotype of TGF-β null mice indicating that RGD-binding 
integrins are required for TGF-β1 activation during development and early life (Yang et al., 2007). (c) 
Integrin β6 null and Integrin β8 null mice have a high incidence of cleft palate, the main finding in 
TGF-β3 null mice (Aluwihare et al., 2009). 
 
Figure 11. Comparison of phenotypes of mice with TGF-β gene mutations and mice lacking integrin activa-
tors of TGF-β. (Taken from Munger and Sheppard, 2011) 
 
Besides TGF-β, also insulin-like growth factor (IGF-1) receptor (IGF1R) signalling reveals a significant 
degree of cross-talk with integrins that provides another good example of the intimate relationship 
between integrin and growth factor receptor-mediated signalling. Hereby an interaction between β1 
integrin and IGF1R seems to be important for IGF1R activity (Legate et al., 2009). 
1.3.3 Sensing matrix rigidity by integrins 
Besides integrin-integrin and integrin-growth factor receptor cross-talk, there is also cross-talk be-
tween integrins and the ECM. By their linkage to the cytoskeleton, integrins form a scaffold for vari-
ous signalling pathways and intersect into growth factor receptor signalling (described above), as 
they share several signalling intermediates with those receptors (Schwartz and Ginsberg, 2002). 
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Consequently, cells do not react to growth factor treatment in suspension or in very soft compliant 
matrices (Erler and Weaver, 2008). Mounting cytoskeletal tension by increasing matrix rigidity, a 
phenomenon which is frequently found at sites of tumorigenesis, was shown to promote malignant 
transformation by inducing FA formation (Paszek et al., 2005). Furthermore, cells tend to migrate in 
the direction of increasing matrix stiffness and ligand density which might explain the nature of tu-
mors as stiff structures attractive for cells to proliferate (Discher et al., 2005). This implies that not 
only genotypic alterations lead to malignant transformation and invasion of cells, but also the 3-
dimensional, biophysical context within the tumor microenvironment. Mechanotransduction medi-
ated by integrins is central to this phenomenon. Interestingly, several studies suggested that the 
αVβ3/αVβ5 integrins are involved in sensing matrix stiffness by an unknown mechanism (Jiang et al., 
2006; Roca-Cusachs et al., 2009).  
Taking all this information into account, it will be important to understand the qualitative differ-
ences in signals derived from αV- and β1-class integrins, in order to gain progress in understanding 
cellular signalling cross-talk.  
 
1.4 SRF and the co-factor MAL 
An important signalling hub responding to changes in Actin dynamics as well as influencing im-
portant cellular processes including migration and differentiation (Arsenian et al., 1998; Descot et 
al., 2009; Medjkane et al., 2009; Schratt et al., 2002; Sun et al., 2006a) is a transcription machinery 
consisiting of the Serum response factor and the Myocardin-related transcription factor A 
(SRF/MRTF-A or SRF/MAL) (Geneste et al., 2002; Grosse et al., 2003; Mack et al., 2001; Miralles et 
al., 2003; Posern et al., 2002; Sotiropoulos et al., 1999). SRF controls independently of de novo pro-
tein synthesis the transcription of cellular “immediate-early”’ genes, whose expression is activated 
by mitogenic stimuli (e.g. serum addition). Immediate early genes encode signalling molecules, tran-
scription factors and many cytoskeletal components. 
There are two principal families of signal-regulated SRF cofactors, which fall into two classes accord-
ing to their sensitivity to different signalling pathways (Figure 12): (a) Members of the ternary com-
plex factor (TCF) family of Ets domain containing proteins, which are activated by mitogen activated 
protein (MAP) kinase phosphorylation. These proteins make sequence-specific DNA contacts with E 
twenty-six (Ets) motifs (see below) adjoining a consensus sequence (see below) of some immediate-
early genes (like c-fos) leading to a ternary complex formation with SRF and DNA. (b) Members of 
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the Myocardin-related transcription factors (MRTFs) acting as signal-regulated SRF cofactors. The 
activity of MRTF-A (also termed MAL) and MRTF-B is regulated by Rho-family GTPases and mono-
meric Actin, whereas Myocardin, the founding member of this transcription factor family, acts inde-
pendently of g-Actin and hence activates SRF constitutively (Posern and Treisman, 2006). 
 
 
 
Figure 12. Model of two principal pathways 
regulating SRF activity 
Activation of the MAP kinase pathway through Ras, 
Raf, MEK and ERK phosphorylates TCFs, which bind 
Ets DNA recognition sites and SRF (right). Signalling 
through Rho family GTPases (squares, with small 
black squares indicating GTP) and the actin tread-
milling cycle leads to dissociation of MAL from g-
Actin, which then binds and activates SRF (left). 
Overexpression of Profilin or Cytochalasin D treat-
ment activates MAL. Treatment of cells with Latrun-
culin B, which prevents f-Actin assembly without 
dissociating the Actin–MAL complex, inhibits MAL 
activation. (Taken from Posern and Treisman, 2006) 
1.4.1 SRF and MADS-box transcription factors 
SRF belongs to the MADS (the name refers to four of the originally identified members: MCM1 
(Transcription factor of morphogenesis), Agamous, Deficiens, SRF) family of transcription factors, 
which share homology in a 57-amino-acid MADS-box that mediates homo-dimerization and DNA 
binding to AT-rich DNA consensus sequences (Shore and Sharrocks, 1995b). Of interest, each mem-
ber of the MADS family of TFs apparently possesses a distinct binding specificity. Moreover, several 
MADS-box proteins recruit other transcription factors into multi-component regulatory complexes. 
The only MADS-box proteins found in multicellular, mitochondrial eukaryotes (metazoans) are SRF 
and members of the MEF2 (Myocyte enhancer factor-2) (Black and Olson, 1998). The crystal struc-
tures of SRF and MEF2 revealed similar modes of DNA binding, which are reflected by similar se-
quences of their binding sites: (a) SRF binds to CC(A/T)6GG (known as a CArG-box); (b) MEF2 recog-
nizes CTA(A/T)4TAG; The conserved N-terminal region of the MADS-box forms an α-helical structure, 
which becomes oriented in an antiparallel manner within homodimers leading to the formation of a 
bipartite DNA-binding domain.  
SRF, like other MADS-box transcription factors, interacts with a diverse array of transcriptional regu-
lators to generate tissue-specific and signal-responsive patterns of gene expression (Messenguy and 
Dubois, 2003). The majority of SRF target genes are involved in cell growth, migration, cytoskeletal 
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organization and muscle development. Strikingly, the number of CArG-boxes as well as their degree 
of consensus sequence determine specificity of gene regulation: (a) The promoter of the prototypi-
cal SRF target gene, the oncogene c-fos, is controlled by a single CArG-box, referred to as a SRE (se-
rum response element), which acts in concert with surrounding cis-regulatory elements (Norman et 
al., 1988). C-fos in involved in cell growth. (b) SRF-dependent genes involved in cell contractility and 
actin cytoskeletal dynmics are controlled by duplicated CArG-boxes (Chow and Schwartz, 1990; 
Miwa and Kedes, 1987). In addition, there is cell-type specific expression of CArG-box-dependent 
muscle genes. However, the mechanism underlying their specificity is still not understood. Addition-
al modulatory proteins acting on/together with SRF are likely to drive transcriptomes. (c) The SRF 
target genes involved in cell growth can often be distinguished from those involved in myogenesis by 
the degree to which their CArG-boxes fit the perfect consensus. CArG-boxes in the promoters of 
several muscle genes deviate from the consensus sequence by one or more residues, resulting in a 
reduction in SRF-binding affinity (Chang et al., 2001), whereas the CArG-box upstream of c-fos per-
fectly fits the consensus. Thus, it appears that cell growth genes are permanent SRF targets, as they 
contain a perfect consensus CArG-box that binds SRF with high affinity. Myogenic SRF targets on the 
other hand, have only non-consensus CArG-boxes that require additional co-activation of SRF bind-
ing to activate their expression. 
SRF expression in mouse embryos occurs in all germ layers at times before and after onset of meso-
derm formation. At E 7.5, the SRF protein is detected in all three germ layers of wild-type embryos 
(Arsenian et al., 1998). Interestingly, subsequent to the onset of organogenesis at E 8.5 onwards, 
domains of localized, strong SRF protein expression are found in heart myocardium and the myo-
tome (Arsenian et al., 1998). Given this broad expression pattern, it is not surprising that SRF dele-
tion leads to embryonic lethality with a phenotype that is manifested at E 7.5. Knockout embryos are 
smaller in size, lack a primitive streak and, histologically, also mesodermal cells are missing (Arsenian 
et al., 1998). Towards E 8.5 knockout embryos consist of misfolded ectodermal and endodermal cell 
layers, lack a primitive streak or detectable mesoderm and fail to express developmental marker 
genes. After E 12.5 no SRF null embryos can be detected. Further, activation of the SRF-regulated 
“immediate early” genes and the α-Actin gene are severely impaired (Arsenian et al., 1998).  
 
1.4.2 Ternary complex factors and SRF 
The three ternary complex factors (TCFs) Elk-1, Net (neuroepithelial cell-transforming gene protein) 
and Sap-1 (SRF accessory protein 1) form a subfamily of the Ets domain transcription factors (Dalton 
and Treisman, 1992). Their characteristic property is the ability to form a ternary nucleoprotein 
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complex with SRF over the SRE of the c-fos promoter. The TCFs share four similar regions, A–D (Fig-
ure 13A), which were identified by sequence comparison between Elk-1 and Sap-1 (Dalton and 
Treisman, 1992).  
The A domain corresponds to the Ets DNA binding domain. It has also been demonstrated to act as a 
transcriptional inhibitor in Elk-1 by recruiting co-repressors and DNA binding inhibitors (Yang et al., 
2001; Yates et al., 1999).  
The B domain interacts with the MADS box transcription factor family member SRF and allows ter-
nary complex formation (Shore and Sharrocks, 1995a; Shore and Sharrocks, 1995b).  
The C domain is an activation domain that is activated by phosphorylation by mitogen-activated 
protein (MAP) kinases. It contains multiple MAP kinase phosphorylation sites (Gille et al., 1995; 
Janknecht et al., 1993; Marais et al., 1993).  
The D domain is a docking site for MAP kinases as well as a nuclear localization signal in Net 
(Buchwalter et al., 2004). 
The F domain (FXFP motif) is an additional MAP kinase docking site with different binding properties 
(Jacobs et al., 1999). 
Beside these domains, which are present in all three TCFs, there are other domains that are specific 
to one or two TCFs. The J box in Net is a JNK docking site, and phoshorylation of an adjacent export 
motif leads to nuclear export (Ducret et al., 2000). The presence of distinct docking sites in the TCFs 
generates a modular system, which allows complex integration of the signals from different MAP 
kinase pathways. The R motif in Elk-1 is a repressor domain that dampens the activity of the C-
terminal activation domain (Yang et al., 2002). Net contains two inhibitory domains, the net inhibito-
ry domain and the C-terminal binding protein (CtBP) inhibition domain (Figure 13A). Of interest is 
that this domain organization is modified in alternative forms of the TCFs. When it comes to TCF/SRE 
binding, the Ets DNA binding domain binds specifically to Ets binding sites (EBSs) (Figure 13B). Here-
by the TCFs form complexes with SRF dimers on SREs, as shown for example for the c-fos promoter 
(Treisman et al., 1992). Further regulation of TCF DNA binding can be achieved by intramolecular 
interactions of the Ets DNA binding domain (A in Figure 13A) with the B box (SRF interaction do-
main), the C box (transactivation domain) and the NID (inhibitor of transcription and DNA binding 
inhibitor) which inhibit DNA binding (Figure 13A and B). As already indicated by the domain features 
of the TCFs, phosphorylation by MAP kinases stimulates their transcriptional activity. This activation 
is particularly striking for Net, which is converted from a strong repressor to an activator. Activation 
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by phosphorylation does not directly inactivate repression but rather masks it, suggesting that other 
mechanisms may regulate the activity of the repression domains (Criqui-Filipe et al., 1999).  
There are at least four MAP kinase pathways, of which the best known are the ERK (ERK1 and ERK2; 
extracellular signal regulated kinase), JNK (JNK1, JNK2 and JNK3; c-Jun N-terminal kinase) and p38 
cascades (Robinson and Cobb, 1997). The ERK cascade responds to growth factors and mitogens, 
whereas the JNK and p38 cascades are triggered by cytokines and stress. 
A
 
B
 
 
Figure 13. Structure of TCF subfamily members. 
(A) The three TCFs (Elk-1, Sap-1a and Net) and their isoforms (sElk-1, DElk-1, Sap-1b, Net b and Net c) are rep-
resented. They share several conserved domains. The A box (grey) is the Ets DNA-binding domain whose loca-
tion at the N-termini is one of the characteristics of the TCF subfamily. The B box (yellow) is the SRF interaction 
domain. The C box (green) is responsible for transcriptional activation and contains MAP kinase phosphoryla-
tion sites. The D box (blue) and F box (black) are docking sites for MAP kinases. Net also contains a specific 
docking site for JNK kinase (J box; blue). The NID, CID and R boxes (red) are repression domains. Hatched boxes 
in represent altered amino-acid sequences.  
(B) Schematic representation of ternary complex formation. The SRF dimer interacts with the CArG box. 
The A domain of the TCF binds to an EBS. The B domain of the TCF contains the interface for the protein-
protein interaction with SRF. The represented EBS and CArG sequences correspond to the c-fos promoter SRE. 
(Taken from Buchwalter et al., 2004) 
 
1.4.3 Myocardins and the unique feature of MAL 
The association of transcriptional co-activators with sequence-specific DNA-binding proteins pro-
vides versatility and specificity to gene regulation. Members of the Myocardin family of co-activators 
activate transcription of genes involved in cell proliferation, migration, and myogenesis by associat-
ing with SRF. The partnership of Myocardin family members and SRF controls genes encoding com-
ponents of the Actin cytoskeleton and confers responsiveness to extracellular growth signals and 
changes in the Actin distribution and dynamics, thereby creating a transcriptional-cytoskeletal regu-
lation circuit (Pipes et al., 2006). Each of the Myocardin family members possesses a conserved N-
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terminal region containing three actin-binding RPEL motifs (RPEL1 to RPEL3; the “RPEL domain”, 
Figure 13).  
MAL (or MRTF-A) is cytoplasmic, accumulating in the nucleus upon activation of RhoGTPase signal-
ling, which alters interactions between g-Actin and the RPEL domain (Cen et al., 2003; Miralles et al., 
2003). Of interest, Myocardin, the founding member, but also MRTF-B, are nuclear proteins and do 
not shuttle between cytoplasm and nucleus. The unique shuttling feature of MAL is based on the 
RPEL domain, which binds Actin more avidly than that of other Myocardins. RPEL1 and RPEL2 of oth-
er Myocardins bind Actin weakly compared with those of MAL, while RPEL3 is of comparably low 
affinity in the two proteins. Thus, differential Actin occupancy of multiple RPEL motifs regulates nu-
cleo-cytoplasmic transport and activity of MAL.  
A depletion of g-Actin levels results in diminished g-Actin-MAL interaction. As a consequence the 
nuclear export of MAL is inhibited because this requires binding to Actin and the exportin Crm1 
(Vartiainen et al., 2007). In contrast, when the g-Actin concentration in unstimulated cells is artifi-
cially increased, the nuclear import of MAL is inhibited, because g-Actin binding displaces importin 
α-importin β dimers from a bipartite nuclear localization signal (NLS) in the RPEL domain (Nakamura 
et al., 2010; Pawlowski et al., 2010). In unstimulated cells, inactivation of the exportin Crm1 by its 
specific inhibitory drug Leptomycin B leads to nuclear accumulation of MAL and this required the 
putative NLS within MAL. This shows that MAL continuously shuttles through the nucleus (Miralles et 
al., 2003; Vartiainen et al., 2007). The assembly of g-Actin into filamentous structures during Actin 
polymerization results in a release of MAL from g-Actin binding. As a consequence MAL is accessible 
for transcription factor activation. As already described above, MAL interacts with g-Actin via its 
RPEL motif. Through this interaction MAL is retained in the cytoplasm thus preventing translocation 
into the nucleus, binding to SRF, and initiation of transcription. Profilin and Tβ4 compete with MAL 
for g-Actin binding by binding the same Actin contacts leading to enhanced SRF/MAL activity and 
subsequent target gene expression. Thus, alternations in Actin dynamics are both necessary and 
sufficient for the activation of SRF by extracellular signals or in the absence of any stimuli (Mack et 
al., 2001; Sotiropoulos et al., 1999).  
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Figure 13. Domain organization and actin-binding motifs of Myocardins 
Upper panel: Domain organization of MAL and Myocardin: B1, basic region 1; Q, Q(Gln)-rich region; SAP (after 
SAF-A/B, Acinus and PIAS) motif is a putative DNA/RNA binding domain found in diverse nuclear and cytoplas-
mic proteins; LZ, leucine zipper motif; TAD, transcription activation domain;  
Lower panel: Schematic of MRTF-A domain organization and alignment of the MRTF-A sequences with the 
corresponding MRTF-B and Myocardin sequences from Mus musculus. RPEL motifs are highlighted in red, 
spacer sequences in gray, and the two basic elements of the bipartite nuclear import signal, B3 and B2, in dark 
gray. Colored bars indicate the major contacts with RPEL-actins R1, R2, and R3 (pale blue, pale green, and ma-
genta) and spacer-actins S1 and S2 (pale yellow and orange). The secondary structure of six helices (α1 to α6) 
is indicated by twisted lines. (Modified after Mouilleron et al., 2011) 
MAL binding to SRF regulates the expression of signalling molecules, other transcription factors, 
cytoskeletal and contractile genes but also FA proteins (Balza and Misra, 2006; Cen et al., 2003; 
Cooper et al., 2007; Descot et al., 2009; Leitner et al., 2011; Miralles et al., 2003; Philippar et al., 
2004; Posern and Treisman, 2006; Schratt et al., 2002; Selvaraj and Prywes, 2004; Sun et al., 2006a; 
Zhang et al., 2005). Sequence analysis of the mouse and human β1 integrin gene revealed a CArG 
box proximal to the translation start (Brandt et al., 2009a; Sun et al., 2006a) and β1 integrin was 
shown to be indeed a SRF/MAL target gene. A recent study showed that suppressor of cancer cell 
invasion (SCAI) inhibits the transcriptional activator complex by forming a ternary complex with 
MAL/SRF, resulting in reduced expression of β1-integrins and loss of invasive potential (Brandt et al., 
2009a). Other SRF/MAL target proteins are Actin cytoskeleton regulators affecting cell migration, 
differentiation and survival, and therefore implying a strong link of this transcriptional machinery 
towards cancer development and progression (Crowley et al., 2009; Leitner et al., 2010; Liang et al., 
2011; Medjkane et al., 2009; Verdoni et al., 2010).  
 
MAL mutant mice show defective differentiation and function of mammary myoepithelial cells, 
which are required for maintenance of lactation (Li et al., 2006b; Sun et al., 2006b). Despite the im-
portance of Srf in multiple transcriptional pathways and widespread MAL expression (Wang et al., 
2002), the degree of abnormalities associated with MAL depletion appears surprisingly restricted. 
Of note, analysis of homozygous but also heterozygous MAL knockout intercrosses reveal that only a 
small population of the progeny was born. This partial fetal wastage is probably due to MAL’s role in 
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development of muscle lineages from mesodermal tissues (Sun et al., 2006b). Analysis of the MRTF-
B knockout phenotype, which showed a specific failure in neural crest-derived vascular smooth mus-
cle cells, indicated that at least in some situations MAL apparently cannot functionally substitute for 
MRTF-B (Li et al., 2005; Oh et al., 2005). This suggests that MAL and MRTF-B have distinct but also 
redundant functions and/or targets in specific cells. Thus it is possible that the knockout of either 
MAL or MRTF-B reduces total MRTF activity in the affected cells below a functional threshold. 
1.5  ISG15 and ISGylation 
The interferon-stimulated gene 15 (ISG15) protein is the first reported ubiquitin-like protein. Its ex-
pression and conjugation to target proteins is induced by type I interferons (IFNs), genotoxic stress, 
and pathogen infections, suggesting that ISG15 plays an important role in innate immune responses 
(Der et al., 1998; Haas et al., 1987; Yuan and Krug, 2001). It can be conjugated to protein substrates 
in a process similar to ubiquitin modification, termed ISGylation. The E1 enzyme responsible for 
ISG15 activation is the ubiquitin-activating enzyme E1-like (UBE1L, also UBA1 can activate ISG15 but 
also ubiquitin) which is specific for ISG15. Ubiquitin-conjugating enzyme in humans (UbcH) 6 and 
UbcH8 (UBE2L6 in mouse) are E2 enzymes for ISG15 but also serve as conjugation enzymes for Ubiq-
uitin, demonstrating an overlap between the ISG15- and ubiquitin-modification machinery (Takeuchi 
et al., 2005; Zhao et al., 2004). Reported E3 ligases for the ISGylation process are the HECT E3 ligases 
HERC5 and HERC6, Estrogene-responsive finger protein (EFP) and Human homolog of drosophila 
ariadne (HHARI) (Dastur et al., 2006; Ketscher et al., 2012; Kim et al., 2004; Okumura et al., 2007; 
Oudshoorn et al., 2012; Wong et al., 2006; Zou and Zhang, 2006). HERC5 is thought to be the major 
E3 ligase in the human and Herc6 the major ISG15 E3 ligase in the murine system. Appropriately, all 
of the enzymes identified in the ISGylation pathway are induced in a coordinated manner by type I 
IFNs. Importantly, ISG15 modification can be reversed by the ISG15 specific isopeptidase UBP43 but 
also by proteases like USP2, USP5, USP13 and USP14 (Catic et al., 2007; Malakhov et al., 2002). Be-
sides MAL, also ISG15 was reported to play an important role in tumorigenesis. It is still enigmatic 
how ISG15 regulates tumorigenesis and furthermore, also the consequences of ISGylation within the 
context of the whole organism are not known. Cell culture based experiments have provided evi-
dence for four different modes of action: (a) ISGylation of proteins alter target protein functions. 
For example ISGylation of Filamin B led to the release of Rac1, MAPK/ERK kinase kinase 1 (MEKK1) 
and MAPK/ERK kinase 4 (MKK4) from the scaffold protein and thus to the prevention of JNK-
mediated apoptosis. (Jeon et al., 2009). (b) Competition with ubiquitin modification and therefore 
proteasomal degradation. For instance, recent studies revealed that the constitutively elevated 
ISG15 pathway impairs ubiquitin (Ub)-targeted proteasomal protein degradation in Ataxia-
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telangiectasia (A-T, is a cerebellar neurodegenerative disorder) cells (Desai et al., 2013). Further, E2 
Ub ligase Ubc13 forms a unique ubiquitin-conjugating enzyme (Ubc) complex with ubiquitin enzyme 
variant Mms2 and generates atypical Lys63-linked ubiquitin conjugates, as one of the targets of 
ISG15 modification. Ubc13 gets ISGylated leading to disruption of its ability to form thioester bond 
with ubiquitin. (Zou et al., 2005). (c) Functions mediated by unconjugated ISG15. For example, free 
ISG15 is specifically bound to E3 Ub ligase Nedd4 and blocked its interaction with Ub E2 molecules, 
thus preventing further Ub transfer from E2 to E3. Therefore, Nedd4 is negatively regulated by 
ISG15. (Malakhova and Zhang, 2008). On top of this, free ISG15 inhibits budding of Ebola virus by 
interaction with Nedd4 ubiquitin ligase and inhibits ubiquitination of VP40 virus-like particles of Ebo-
la virus (Okumura et al., 2008). (d) ISGylation alters protein translation capacity. The mRNA 5' cap 
structure-binding protein 4EHP acts as a translation suppressor and is modified by ISG15. ISGylated 
4EHP increases cap structure-binding activity. Recently it was shown that ISG15-modified dsRNA-
dependent protein kinase (PKR) is more active compared to non-ISG15-conjugated form, and phos-
phorylates eukaryotic translation initiation factor 2 subunit alpha (eIF2α) to down-regulate protein 
translation. (Okumura et al., 2013; Okumura et al., 2007).  
Biochemically ISG15, similar to MAL, was shown to alter cytoskeletal architecture thereby promoting 
motility in human breast cancer cells (Desai et al., 2012). In addition ISG15, similar to MAL, inhibits 
proteasome-mediated turnover of proteins implicated in tumor cell motility, invasion and metastasis 
(Desai et al., 2006). An increasing number of studies identified an up-regulation of either ISG15 and 
its conjugates (Andersen et al., 2006; Bektas et al., 2008; Brandt et al., 2009b; Desai et al., 2006; 
Kiessling et al., 2009) or signalling  (Brandt et al., 2009b; Leitner et al., 2010; Ma et al., 2001; 
Medjkane et al., 2009) in several cancer entities. An important issue to investigate is whether the 
coordinated up-regulation of several interferon-stimulated genes (ISGs), besides ISG15, in tumors is 
cell autonomous or is the outcome of signals from tumor microenvironment, such as IFNs produced 
by infiltrating immune cells or even the stress response to chemotherapy. Microarray studies identi-
fied 50 to 1000 ISGs, with 200 to 500 genes typical of many cell types depending on cell type, IFN 
dose and time of treatment (de Veer et al., 2001; Lanford et al., 2006; Sarasin-Filipowicz et al., 2008). 
Interestingly, microarray data show that levels of several ISGs loose correlation with ISG15 expres-
sion when cells were taken into culture (Hoeflich et al., 2009; Neve et al., 2006; Sgorbissa and 
Brancolini, 2012; Wagner et al., 2007). These findings indicate that the tumor microenvironment also 
regulates ISG protein expression. An explanation why ISG15 still is expressed ex vivo in the absence 
of microenvironment induced IFN production is unknown. 
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2 Aims of the thesis 
An important caveat to most experimental systems used in the past is that αVβ3/β5 and α5β1 are 
co-expressed on cells. For instance, endothelial cells during angiogenesis or keratinocytes during 
wound repair up-regulate the expression of αVβ3/β5 and α5β1 and of FN (Brooks et al., 1994; 
Parsons-Wingerter et al., 2005; Silva et al., 2008). Therefore, it is crucial to reduce this complexity 
and express both integrins separately in the same cellular background in order to study and compre-
hend their function. To do so my studies used pan-integrin knockout cells (αV-/-, β1-/-, β2-/-, and β7-/- ; 
pKO) that were derived from genetically modified mice and engineered in vitro to express αVβ3/β5 
or α5β1 integrin, or both, αVβ3/β5 and α5β1 integrins. 
In my PhD project I analyzed integrin heterodimer-specific signalling events regulated by proteins 
that are recruited to integrin adhesions selectively via either αVβ3/β5 or α5β1. The recent techno-
logical progress in quantitative proteomics allowed for the first time a non-biased analysis of the 
molecular composition of focal adhesions using biochemical isolation protocols followed by quanti-
tative mass spectrometry. Thus, the integrin adhesion-associated molecular complexes but also the 
(phospho-) proteome of pan-integrin-null fibroblasts reconstituted with αV and/or β1 integrin were 
analyzed by quantitative mass spectrometry. These studies led to the identification of integrin-
specific FA components but also to signalling processes which are differentially regulated possibly in 
an integrin subtype-specific manner. 
Aim 1 
Studying the molecular basis of the differential protein recruitment to αVβ3/β5- and α5β1-
containing focal adhesions (e.g. protein-protein interaction networks and their post-translational 
modifications).  
Aim 2 
Investigating the impact of the selected proteins of interest on functional parameters that were 
defined based on the difference between αVβ3/β5 and α5β1 expressing cells, like cell contractility. 
Aim 3 
Identifying the molecular mechanisms leading to differential protein expression and/or modifica-
tion of differential expressed proteins in αVβ3/β5 and α5β1 expressing cells (e.g. regulation of tran-
scription, translation). 
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3 Short summaries of manuscripts 
3.1 First manuscript 
Title: β1- and αV-class integrins cooperate to regulate myosin II during rigidity sensing of fibron-
ectin-based microenvironments. 
How different integrins that bind to the same type of extracellular matrix protein mediate specific 
functions is unclear. In this project the functional properties of β1- and αV-class integrins expressed 
in pan-integrin-null fibroblasts seeded on Fibronectin were analyzed. Reconstitution with β1-class 
integrins promotes myosin-II-independent formation of small peripheral adhesions and cell protru-
sions, whereas expression of αV-class integrins induces the formation of large focal adhesions. Co-
expression of both integrin classes leads to full Myosin activation and traction-force development on 
stiff fibronectin-coated substrates, with αV-class integrins accumulating in adhesion areas exposed 
to high traction forces. Quantitative proteomics linked αv-class integrins to a GEF-H1-RhoA pathway 
coupled to the formin mDia1 but not myosin II, and α5β1 integrins to a RhoA-Rock-myosin II path-
way. This study assigns specific functions to distinct fibronectin-binding integrins, demonstrating 
that α5β1integrins accomplish force generation, whereas αV-class integrins mediate the structural 
adaptations to forces, which cooperatively enable cells to sense the rigidity of fibronectin-based 
microenvironments. 
3.2  Second manuscript 
Title: Integrins synergistically induce the MAL/SRF target gene ISG15 to ISGylate cytoskeletal and 
focal adhesion proteins necessary for cancer cell invasion 
This study reports that αV- and/or β1-class integrin expressing fibroblasts contain different g-Actin 
pools correlating with low nuclear MAL levels and MAL/SRF activities in αV, intermediate in β1 and 
extremely high in αV,β1 double expressing cells. The interferon-stimulated gene 15 (ISG15) was 
identified as one of the most abundant SRF/MAL gene targets without any interferon stimulus. Mass 
spectrometry of ISG15 interacting proteins revealed ISGylation of novel proteins such as Talin and 
Eplin. Mechanistically, multi-layered ISGylation of integrins, adhesion proteins, Actin and its modifi-
ers prevent mainly ubiquitination leading to increased protein stability. High integrin and ISG15 lev-
els correlate with increased human breast cancer cell invasion and poor patient survival. Our find-
ings identify a novel mode how fibronectin-binding integrins synergistically control cell invasion by 
regulating transcription and subsequent ISGylation. Thus, we propose that integrin adhesions, 
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MAL/SRF and ISG15 constitute an a new autoregulatory feed-forward loop that precisely adjusts 
actin- and adhesion-based functions required for cell spreading, migration and invasion. 
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ART I C L E S
β1- and αv-class integrins cooperate to regulate
myosin II during rigidity sensing of fibronectin-based
microenvironments
Herbert B. Schiller1,6, Michaela-Rosemarie Hermann1,6, Julien Polleux1, Timothée Vignaud2, Sara Zanivan3,
Caroline C. Friedel4, Zhiqi Sun1, Aurelia Raducanu1, Kay-E. Gottschalk5, Manuel Théry2, Matthias Mann3
and Reinhard Fässler1,7
How different integrins that bind to the same type of extracellular matrix protein mediate specific functions is unclear. We report
the functional analysis of β1- and αv-class integrins expressed in pan-integrin-null fibroblasts seeded on fibronectin.
Reconstitution with β1-class integrins promotes myosin-II-independent formation of small peripheral adhesions and cell
protrusions, whereas expression of αv-class integrins induces the formation of large focal adhesions. Co-expression of both integrin
classes leads to full myosin activation and traction-force development on stiff fibronectin-coated substrates, with αv-class
integrins accumulating in adhesion areas exposed to high traction forces. Quantitative proteomics linked αv-class integrins to a
GEF-H1–RhoA pathway coupled to the formin mDia1 but not myosin II, and α5β1 integrins to a RhoA–Rock–myosin II pathway.
Our study assigns specific functions to distinct fibronectin-binding integrins, demonstrating that α5β1 integrins accomplish force
generation, whereas αv-class integrins mediate the structural adaptations to forces, which cooperatively enable cells to sense the
rigidity of fibronectin-based microenvironments.
Integrins are α/β heterodimers that mediate cell adhesion to the
extracellular matrix (ECM) and to receptors on other cells1, thereby
regulating numerous biological processes that are essential for
development, postnatal homeostasis and pathology1–4. Themammalian
genome encodes 18 α and 8 β integrin genes, which form 24
heterodimers. Mammalian cells usually co-express several integrins,
which recognize ECM components by binding specific amino-acid
stretches such as the Arg-Gly-Asp (RGD) motif1,5. RGD motifs are
found in many matrix proteins including fibronectin, in which
RGD mediates binding to α5β1 and all αv-class integrins6. In vivo
and in vitro studies indicated that α5β1 and αv-class integrins (for
example, αvβ3) exert both specific and redundant functions7–15;
however, how these distinct integrins accomplish their individual
functions and whether these cooperate remains unclear. The signalling
properties and functions of integrins are executed by specialized
adhesive structures with distinct morphology, subcellular localization,
lifespan and molecular composition. Nascent adhesions are short-lived
adhesive structures in membrane protrusions16 that promote the
activity of Rho–GTPases such as Rac1. Some nascent adhesions
develop into large focal adhesions that initiate multiple signalling
1Department of Molecular Medicine, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany. 2Laboratoire de Physiologie Cellulaire et Végétale, Institut de
Recherche en Technologies et Sciences pour le Vivant, CNRS/UJF/INRA/CEA, 17 Rue des Martyrs, 38054 Grenoble, France. 3Department of Proteomics and Signal
Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany. 4Institute for Informatics, Ludwig-Maximilians-Universität München, 80333 Munich,
Germany. 5Institute of Experimental Physics, University of Ulm, 89069 Ulm, Germany. 6These authors contributed equally to this work.
7Correspondence should be addressed to R.F. (e-mail: faessler@biochem.mpg.de)
Received 2 November 2012; accepted 4 April 2013; published online 26 May 2013; DOI: 10.1038/ncb2747
pathways, which activate effectors including myosin II. Myosin II
exerts contractile forces resulting in adhesion reinforcement and
recruitment of more proteins to focal adhesions, which induces
a further increase in myosin II activity17. This feedback signalling
to myosin II critically depends on biophysical parameters such as
ECM stiffness. The identity of mechanosensor(s) in focal adhesions,
whether it is an integrin, a focal adhesion protein or a combination
of both, is unknown18. Quantitative mass spectrometry (MS) was
previously used to determine the protein composition of adhesion
structures (adhesomes) of cells seeded on fibronectin, and the dynamic
changes on myosin-II-induced adhesion maturation19,20. As cells
recruit different integrin classes to fibronectin-induced adhesions,
these studies did not assign specific proteins and signalling outputs
to particular integrins.
Here we developed a cell system to investigate the protein
composition and signalling properties of adhesion sites anchored
selectively through α5β1 and/or αv-class integrins. We found marked
integrin-class-specific differences in the morphology of focal adhesions,
in their requirement formechanical tension, in the protein composition
of their adhesomes and their signalling capacity. Furthermore, we
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Figure 1 Different morphologies and adhesive functions of pKO-αv, pKO-β1
and pKO-αv/β1 cells. (a) Flow cytometry analysis of β1 and αv cell surface
levels. (b) Immunostaining of indicated cell types plated for 90min on
fibronectin for β1 and β3. The merged images show an overlay of integrin
(β1, blue; β3, green), F-actin (red) and nuclear (DAPI, blue) staining. Scale
bars, 10 µm. (c) Spreading areas of cells seeded on fibronectin. Error
bars represent s.e.m. (n = 20 cells per time point; 1 representative of
2 independent experiments is shown). The P value is derived from a
t -test. (d) Cells were plated on circular fibronectin-coated micropatterns
and immunostained for paxillin (Pxn). The merged images show an
overlay of paxillin (white), F-actin (red) and nuclear (DAPI, blue) staining.
Arrows indicate nascent adhesions (<2 µm2) in the cell periphery. Scale
bar, 10 µm. (e) Boxplots show the distribution of adhesion size classes.
Significance was calculated using a t -test (n =30 cells; 1 representative
of 2 independent experiments is shown; boxplot whisker ends are at 1.5
interquartile range and outliers are shown as dots). (f-h) Migration velocity
(g) and mean persistence time (h) was determined with the MSD values
of cell nuclei (f) by filming migrating cells over a period of 90min with a
1min time lapse (pKO-αv n=12, pKO-β1 n=14, pKO-αv/β1 n=12; data
aggregated over 5 independent experiments). The P value for velocities
(g) was calculated using an unpaired Wilcoxon test and the persistence
time bar graph (g) shows the fit error as implemented in the MatLab
software. NS, not significant. (i) Trailing edge lengths of migrating cells are
shown with mean lengths from the cell rear to the middle of the nucleus.
Error bars represent s.d. and the P values were calculated using a t -test
(pKO-αv n = 51, pKO-β1 n = 66, pKO-αv/β1 n = 40; 1 representative of
2 independent experiments is shown). pKO-αv, green; pKO-αv/β1, blue;
pKO-β1, orange.
identified a functional synergy between α5β1 and αv-class integrin
signalling hubs leading to feedback amplification of myosin II activity
required for focal-adhesion-mediated rigidity sensing.
RESULTS
Differential functions of α5β1 and αv-class integrins in adhesion
formation and cell migration
To obtain cells expressing β1- and/or αv-class integrins we intercrossed
mice carrying conditional null mutations for the αv and β1 integrin
genes and constitutive null mutations for the β2 and β7 integrin
genes (βf/f1 , α
f/f
v , β
−/−
2 , β
−/−
7 mice)
21, isolated kidney fibroblasts and
immortalized themwith the SV40 large T antigen (parental fibroblasts).
Deletion of floxed αv and β1 integrin genes by adenoviral Cre
transduction removed all integrins from the parental fibroblast clones
(pan-knockouts, pKO; Supplementary Fig. S1a–c). Next we transduced
parental fibroblasts with αv or β1 or both complementary DNAs and
simultaneously transduced Cre to delete the floxed integrin alleles.
This produced cells expressing αv (pKO-αv), β1 (pKO-β1) or αv
and β1 (pKO-αv/β1) integrins, respectively (Fig. 1a). The pKO-αv,
pKO-β1 and pKO-αv/β1 cells were sorted for comparable integrin
surface levels to the parental cell clones (Supplementary Fig. S1d,e).
Using western blotting, flow cytometry and MS we identified the
following fibronectin-binding integrins; α5β1 in pKO-β1 cells, αvβ3
and αvβ5 in pKO-αv cells, and α5β1, αvβ3 and αvβ5 in pKO-αv/β1 cells
(Supplementary Fig. S1f,g). Calibration of our flow cytometry analysis
estimated the presence of 170,000 α5β1 and 300,000 αv-class integrins
on the surface of each cell, resulting in approximately equimolar surface
levels for β1, β3 and β5 integrins.
All three cell lines specifically adhered to fibronectin, whereas
adhesion on vitronectin was similar for pKO-αv and pKO-αv/β1 cells
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and absent for pKO-β1 cells (Supplementary Fig. S1h). To compare
the size distribution of focal adhesions we seeded cells for 90min
on fibronectin and immunostained for paxillin, integrin β1 and β3
(Fig. 1b and Supplementary Fig. S2a,b). The percentage of small
nascent adhesions (<2 µm2) was significantly elevated in pKO-β1 and
pKO-αv/β1 cells, whereas large focal adhesions of 6–12 µm2 dominated
in pKO-αv cells (Supplementary Fig. S2a,b). The cell spreading area on
fibronectin was significantly lower in pKO-αv relative to pKO-β1 and
pKO-αv/β1 cells and reduced in pKO-αv/β1 relative to pKO-β1 (Fig. 1c
and Supplementary Fig. S1i). As cell shape and spreading area can affect
cell contractility, focal adhesion size and distribution22, we seeded
cells on circular fibronectin-coated micropatterns surrounded by
non-adhesive polyethylene glycol (PEG), and confirmed the different
adhesion size distribution in the three cell lines (Fig. 1d,e). pKO-αv/β1
cells contained both small nascent adhesions and large focal adhesions
(Fig. 1d). pKO-β1 and pKO-αv/β1 cells showed increased protrusive
activity when compared with pKO-αv cells (Supplementary Fig. S2a,c),
which correlated with increased migration speed. The mean square
displacement (MSD) of cells migrating on fibronectin showed that
pKO-β1 cells migrated significantly faster than pKO-αv cells, and that
pKO-αv/β1 cells exhibited an intermediate migration speed (Fig. 1f,g).
As previously shown13,23,24, expression of αv-class integrins increased
migration persistence (Fig. 1h). pKO-β1 cells exhibited a significant
defect in trailing edge detachment (Fig. 1i and Supplementary Fig. S2c
and Videos S1–S3). These results identify a role for α5β1 in protrusive
activities and nascent adhesion formation, whereas co-expression of
αv-class integrins also promotes the production of large, stable focal
adhesions and trailing edge detachment inmigrating cells.
Differential functions of α5β1 and αv-class integrins synergize
to regulate cell contractility
Adhesion maturation and trailing edge retraction in migrating
fibroblasts requires coordinated control of myosin-II-mediated cell
contractility25. We measured myosin II activity using fibronectin-
coated X- or crossbow-shaped micropatterns, which report subtle
changes in myosin II activity and traction forces along non-
adhesive edges26–28. Parental fibroblasts cultured on X-shaped
fibronectin-coated micropatterns showed a dose-dependent decrease
of phosphoT18/S19-myosin light chain (pMLC), paxillin fluorescence
intensities and cell area following treatment with the myosin II
inhibitor blebbistatin (Supplementary Fig. S2d–g). Crossbow patterns
polarize cells into a low contractile front and a highly contractile
rear28. Immunofluorescence analysis revealed that pMLC and paxillin
intensities were the highest in pKO-αv/β1, lower in pKO-β1 and the
lowest in pKO-αv cells (Fig. 2a). Myosin II activity was low in the cell
front (Fig. 2b) and high in the cell rear (Fig. 2c) and the cooperative
effect of the two integrin classes on pMLC and paxillin intensities in
pKO-αv/β1 was most prominent in the cell rear (Fig. 2a–c). Treatment
with the αv-class-specific small-molecule inhibitor cilengitide reduced
contractility of pKO-αv/β1 cells to intermediate levels (Fig. 2b,c),
confirming that the adhesive function of αv-class integrins is required
for the synergy with α5β1. We corroborated these results with
fibronectin-coated X-shapes, revealing phenotypes that resembled the
rear of crossbow shapes (Supplementary Fig. S2h–j).
The ability to form large focal adhesions and stress fibres indicative
of high contractile forces together with low pMLC levels in pKO-αv
cells was surprising. Traction-force microscopy experiments on
polyacrylamide gels of 35 kPa stiffness revealed good correlation of
traction forces and pMLC levels, confirming that traction forces on
fibronectin-coated crossbow micropatterns are the lowest in pKO-αv,
the highest in pKO-αv/β1 and intermediate in pKO-β1 cells (Fig. 2d).
Along the cell front, traction forces were significantly higher in pKO-β1
cells when compared with pKO-αv cells and the highest in pKO-αv/β1
(Fig. 2e). Similar differences were observed by calculating the total
contractile energy of individual cells (Fig. 2f).
αv-class integrins accumulate in areas of high traction force
and mediate rigidity sensing
αvβ3 integrins are known to become immobilized in large and static
focal adhesions, whereas α5β1 integrins are mobile, separate from
the αvβ3 integrins and translocate rearward to fibrillar adhesions10,29.
To investigate whether α5β1 and αv-class integrins segregate owing
to differential dependence on myosin-II-mediated tension at focal
adhesions we seeded pKO-αv/β1 and parental floxed cells on
fibronectin-coated crossbow shapes and immunostained β1 and β3
integrins. Indeed, β3 heavily accumulated in areas that were shown to
be exposed to the highest traction forces, whereas β1 levels remained
very low at these sites (Fig. 3a,b). The β3 integrins in contractile focal
adhesions at the cell rear were lost following blebbistatin treatment,
whereas small β1-containing focal adhesions in the cell periphery were
still forming (Fig. 3a). To confirm these findings we plated pKO-αv/β1
cells on 1-µm-thin fibronectin-coated lines separated by 3-µm-wide
non-adhesive PEG lines. This set-up allows distinguishing ligand-
bound from unbound integrins, which is impossible on uniformly
coated fibronectin surfaces. Whereas the β1 integrin staining co-
localized with fibronectin lines almost throughout the entire cell length,
small β3 clusters overlaid with lines in the cell periphery associated with
F-actin bundles. Blebbistatin treatment or inhibition of Rock with
Y-27632 disassembled the β3 integrin clusters on fibronectin lines,
whereas β1 remained unchanged (Fig. 3c). The differential dependence
of α5β1 and αv-class integrins on myosin-II-mediated tension at focal
adhesions suggested that tension-dependent stabilization of αv-class
integrins contributes to rigidity sensing. In line with this hypothesis,
traction-force measurements of pKO-β1 and pKO-αv/β1 cells plated
on micropatterned polyacrylamide gels of 3 different rigidities (1.4,
10 and 35 kPa) revealed that only pKO-αv/β1, but not pKO-β1, cells
were able to increase contractile energies concomitantly with the
substrate rigidity. Most notably, the traction forces and contractile
energies generated by pKO-β1 and pKO-αv/β1 cells were similar
on soft, 1.4 kPa substrates, whereas they differed significantly on
stiffer substrates (Fig. 3d,e). We therefore conclude that stabilization
of αvβ3–fibronectin bonds through actomyosin-mediated tension is
required to adjust cell contractility to defined substrate stiffnesses.
Adhesome composition and stoichiometry is controlled by the
integrin class and myosin II activity
Cells sense their environment through integrins and numerous plaque
proteins in focal adhesions17,30. The composition and stoichiometry
of the adhesome in fibronectin-bound fibroblasts is controlled
by myosin II (refs 19,20). We therefore reasoned that specific
binding activities of the integrin cytoplasmic tails and also the
differential myosin II activities in pKO-αv, pKO-β1 and pKO-αv/β1
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Figure 2 αv-class integrins cooperate with α5β1 for myosin II reinforcement
on stiff fibronectin-coated substrates. (a) Averaged confocal images of
immunostainings (Merge: F-actin, red; pMLC, green; paxillin, blue; DAPI,
blue) of the indicated cell lines plated for 3 h on fibronectin-coated
micropatterns (pKO-αv n =55, pKO-β1 n =36, pKO-αv/β1 n =71; data
aggregated over 3 independent experiments). Areas with strong pMLC
and paxillin fluorescent signals are marked with arrows. Scale bar, 10 µm.
(b,c) Intensities of pMLC and paxillin (Pxn) fluorescence in the front (b)
and rear (c) regions of individual cells (pKO-αv n =25, pKO-β1 n =32,
pKO-αv/β1 n = 26; 1 representative of 3 independent experiments is
shown). Optionally, cells were treated with the αv-class integrin inhibitor
cilengitide (1 µM). (d) Average traction-force fields of indicated cell types
(pKO-αv n =54, pKO-β1 n =86, pKO-αv/β1 n =68; data aggregated over
3 independent experiments). Arrows indicate force orientation; colour and
length represent local force magnitude in nanonewtons. Scale bar, 10 µm.
(e) Average integrated traction forces along the cell border (pKO-αv n=54,
pKO-β1 n =86, pKO-αv/β1 n =58; data aggregated over 3 independent
experiments; thin lines represent s.e.m.). (f) Contractile energy of
individual cells (pKO-αv n = 54, pKO-β1 n = 86, pKO-αv/β1 n = 68;
data aggregated over 3 independent experiments). Each data point
corresponds to the total contractile energy of an individual cell measured
by traction-force microscopy. All statistical comparisons were t -tests (error
bars represent s.e.m.). pKO-αv (green); pKO-αv/β1 (blue); pKO-β1 (orange);
pKOαv/β1+1 µM cilengitide (black).
cells may contribute to their specific adhesome composition. To
test this hypothesis we determined the integrin-class-specific protein
composition of focal adhesions. The three cell lines were plated
for 45 or 90min on fibronectin or poly-l-lysine (PLL; permits
integrin-independent adhesion) followed by chemical crosslinking and
purification of focal adhesions, sample elution and quantitative MS as
described previously19 (Supplementary Fig. S4a and Table S1). Isolated
adhesome proteins were quantified using the label-free quantification
algorithm of the MaxQuant software31. We calculated median MS
intensities of 3–4 replicates and performed hierarchical clustering to
compare the three cell lines at different time points with and without
blebbistatin. This approach allowed identifying protein groups with
high correlation of their intensity changes across different substrates,
time points and cell lines. We identified a cluster containing 168
proteins significantly enriched for known (previously annotated) focal
adhesion proteins. In addition to the 168 proteins, we also considered
all previously annotated focal adhesion proteins32 assigned to other
clusters in our analysis. This led to 245 proteins used for further analysis
(Supplementary Fig. S4b). Analysis of variance (ANOVA) tests revealed
thatMS intensities of 62% (152/245) of themwere significantly changed
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Figure 3 αv-class integrins accumulate in adhesion areas exposed to high
traction force and cooperate with α5β1 for rigidity sensing on fibronectin.
(a) pKO-αv/β1 cells were plated on fibronectin-coated crossbow shapes
for 3 h with and without blebbistatin (BLEB) and immunostained for β1
(blue), β3 (green) integrins and F-actin (red). Scale bars, 10 µm. DAPI,
white (left panel, merge). (b) Fluorescence intensity profile of the indicated
stainings along the depicted linescan (3.75 µm). (c) pKO-αv/β1 cells were
plated on 1 µm thin fibronectin-coated lines for 90min with and without
blebbistatin and stained for β1 (blue), β3 (green) integrin and F-actin (red).
Scale bars, 10 µm. DAPI, white (merge). (d) Each data point represents
the total contractile energy of individual cells measured by traction-force
microscopy on gels of indicated rigidities (pKO-β1: soft n =54, medium
n=50, stiff n=86; pKO-αv/β1: soft n=31, medium n=71, stiff n=68;
data aggregated over 3 independent experiments; all pairwise statistical
comparisons from t -tests are shown in Supplementary Table S5; NS, not
significant). (e) Each data point represents the total integrated traction
force in kilo Pascal (kPa) of individual cells measured by traction-force
microscopy on gels of indicated rigidities (pKO-β1: soft n =54, medium
n=50, stiff n=86; pKO-αv/β1: soft n=31, medium n=71, stiff n=68;
data aggregated over 3 independent experiments; P values of pairwise
comparisons were calculated with a t -test). pKO-αv/β1 (blue); pKO-β1
(orange).
in at least one of the three cell lines or one of the two time points
(Supplementary Table S1).
In line with our previous report19, blebbistatin induced different
intensity reductions in floxed fibroblasts for different classes of
adhesome proteins. Following blebbistatin treatment pKO-αv/β1 and
pKO-β1 cells were still able to recruit integrin-proximal proteins such as
Talin-1, Kindlin-2 and ILK, whereas LIM-domain-containing proteins
were reduced to background levels defined by MS intensities from cells
seeded on PLL (Fig. 4a). Strikingly, blebbistatin reduced almost all focal
adhesion proteins to background levels in pKO-αv cells, indicating that
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Figure 4 Composition and stoichiometry of the adhesome is determined by
the individual integrin and myosin II activity. (a) Focal-adhesion-enriched
fractions analysed by MS before and after blebbistatin (BLEB) treatment.
The Z -scores of median MS intensities (n =3–4) are colour coded to show
relative protein abundance. A blebbistatin-insensitive cluster is marked
with a red bar and blebbistatin-sensitive clusters are marked with blue
bars. The arrow highlights the pronounced effect of blebbistatin on pKO-αv
cells. FN, fibronectin. (b) Boxplots showing MS intensity differences of 58
known focal adhesion proteins of the indicated cells relative to pKO-αv cells
cultured for 45min without blebbistatin. A t -test revealed significant MS
intensity changes after blebbistatin treatment. Boxplot whisker ends are at
1.5 interquartile range and outliers are shown as dots. (c) Focal adhesion
proteins with similar Z -score profiles (colour coded) as α5β1 or αv-class
integrins (selection based on Supplementary Fig. S6) were subjected
to hierarchical cluster analysis. Focal-adhesion-enriched fractions were
collected 45 and 90min after plating on fibronectin. (d) SILAC ratio plot
from label-inverted replicates comparing β1 with β3 tail pulldowns. Specific
interactors have high SILAC ratios in the forward experiment (fwd) and low
SILAC ratios in the label swapped reverse experiment (rev). The colour code
shows the percentage of sequence coverage of the proteins identified by MS
analysis (n =4; 2 independent experiments). pKO-αv (green); pKO-αv/β1
(blue); pKO-β1 (orange).
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the protein recruitment to focal adhesions in blebbistatin-treated pKO-
αv/β1 cells was mediated by α5β1 (Fig. 4a). A paired Student’s t -test
for 58 known focal adhesion proteins confirmed a significant reduction
of crosslinked focal adhesion proteins in pKO-αv cells by blebbistatin
(Fig. 4b). Furthermore, comparing the 45 and 90min time points re-
vealed that protein recruitment to focal adhesions was delayed in pKO-
αv cells (Fig. 4a,b). Importantly, blebbistatin did not change the MS in-
tensities of αv-class integrins, excluding inefficient integrin crosslinking
as the cause for the diminished recruitment of focal adhesion proteins,
and indicating that short-lived/weak αv-class integrin–fibronectin
interactions occur in the absence of cell contractility and can be
crosslinked. These findings together with those depicted in Fig. 3
indicate that α5β1 can cluster and induce adhesome assemblies in the
absence of myosin-II-mediated tension, whereas the ability of αv-class
integrins to cluster and recruit adhesome proteins depends onmyosin II
activation and/or the stress fibre architecture at focal adhesions.
ILK and GEF-H1 are required for myosin II reinforcement
on stiff substrates
Consulting published protein–protein interactions within the
adhesome30, we established a putative core interactome of fibronectin-
bound α5β1 or αv-class integrins (Supplementary Fig. S5). Hierarchical
cluster analysis of MS intensities of the 125 core proteins of the
integrin interactome from all conditions tested (Supplementary Fig.
S6) revealed 29 proteins correlating with MS intensities of α5β1 at
both time points and 2 proteins correlating with MS intensities of
αv-class integrins (Fig. 4c). In addition to this integrin interactome,
we analysed the MS intensities of all actin-binding proteins in the
focal-adhesion-enriched fraction and found that WAVE and Arp2/3
complexes, which drive lamellipodia formation, correlated with α5β1,
whereas the RhoA effector mDia1 (Diap1), which drives stress-fibre
formation, correlated with αv-class integrins (Supplementary Fig. S7).
We performed stable isotope labelling with amino acids in cell culture
(SILAC)-based peptide pulldown assays with β1 and β3 integrin tail
peptides and scrambled control peptides followed by MS (ref. 33) to
identify which of the 29 α5β1-enriched and 2 αv-class integrin-enriched
adhesome proteins were enriched through differential associations
with integrin cytoplasmic tails. Comparison of integrin-tail interactors
with scrambled peptide interactors identified common and specific
β1 tail- and β3 tail-binding proteins (Supplementary Fig. S8). Talin-1
showed equal binding to β1 and β3 tails and was therefore used to
control the experiments. In line with the adhesome analysis (Fig. 4c)
we observed very high β1-tail-specific enrichment for Kindlin-2 and a
lower enrichment for the ILK/PINCH/Parvin (IPP) complex, and a high
β3-tail-specific enrichment of the RhoA guanine nucleotide exchange
factor GEF-H1 (Fig. 4d). Thus, the recruitment of Kindlin-2, the IPP
complex and GEF-H1 to focal adhesions is controlled by the integrin
tail sequence rather than the different focal adhesion architecture
in pKO-β1 and pKO-αv cells. Ratiometric analysis of fluorescence
intensities in focal adhesions confirmed higher Kindlin-2 and ILK levels
in pKO-β1 cells and pKO-αv/β1 cells (Fig. 5a–d). To analyse GEF-H1
levels in focal adhesions we first chemically crosslinked and unroofed
the cells to remove the large cytoplasmic and microtubule-associated
GEF-H1 pool, and then performed immunostainings, which revealed
that crosslinked GEF-H1 levels were significantly higher in pKO-αv
and pKO-αv/β1 cells than in pKO-β1 cells (Fig. 5e–g).
To investigate whether the IPP complex and GEF-H1 contribute to
myosin II regulation by α5β1 and αv-class integrins we seeded ILKfl/fl
(control) and ILK−/− fibroblasts34 on fibronectin-coated X-shapes
and stained for pMLC. ILK−/− fibroblasts had similarly low pMLC
signals as pKO-αv cells (Fig. 5h,i). Furthermore, inhibition of α5β1
with blocking antibodies or αv-class integrins with cilengitide in ILKfl/fl
cells significantly reduced pMLC levels (Fig. 5h,i), confirming that both
fibronectin-binding integrin classes are required to activate myosin II.
To examine whether GEF-H1 regulates integrin-mediated activation
of myosin II on fibronectin-coated X-shapes we depleted GEF-H1
messenger RNAusing short interfering RNA (siRNA; Fig. 5j) and found
significantly reduced pMLC levels inGEF-H1-silenced pKO-αv/β1 cells,
slightly reduced levels in pKO-β1 cells and unaffected levels in pKO-αv
cells (Fig. 5k,l) indicating that GEF-H1 reinforces myosin II activity in
a α5β1-dependent manner.
The IPP complex and GEF-H1 have been implicated in cell
contractility regulation by tuning RhoA GTPases35–37. Therefore, we
investigated whether the activity of RhoA and Rac1 are affected in our
cell lines. Seeding the three cell lines for 45min on fibronectin induced a
significantly higher RhoA activity in pKO-αv cells when compared with
pKO-β1 and pKO-αv/β1 cells (Fig. 5m). Rac1 activity was the lowest
in pKO-αv cells, higher in pKO-β1 and the highest in pKO-αv/β1 cells
(Fig. 5n). As the high GEF-H1 and RhoA levels in focal adhesions of
pKO-αv cells are not able to promote high pMLC, we conclude that only
α5β1 can elicit signals formediatingRhoA-drivenmyosin II activation.
Integrin-specific signalling pathways cooperate for feedback
regulation of myosin II
The coupling of active RhoA to its effector Rock requires unknown
signalling events that depend on cell adhesion, cell shape and
cytoskeletal tension22. To uncover integrin-specific regulators of
myosin II upstream and downstream of active RhoA we performed
SILAC-based quantitative phosphoproteomics of adhesion signalling
on fibronectin. We quantified a total of 3,180 proteins (Supplementary
Table S2) and 7,529 phosphorylation sites (Supplementary Table
S3) in the three cell lines seeded for 45min on fibronectin.
ANOVA tests of triplicate experiments identified 150 proteins
and 1,010 phosphorylation events as significantly regulated in
at least one of the three cell lines (Fig. 6a and Supplementary
Fig. S9, Tables S2 and S3). Hierarchical cluster analysis of the
SILAC ratios of the 1,010 phosphorylation events revealed clusters
dominated by α5β1 and clusters dominated by αv-class integrins.
We also observed clusters regulated oppositely by α5β1 and αv-class
integrins, indicating antagonistic regulation, and clusters regulated
by both integrin classes, indicating synergistic regulation. Using
ratio thresholds for the different pairwise comparisons allowed
assignment of 646 of the 1,010 determined phospho-sites into
either the antagonistic, dominant or synergistic category (Fig. 6b and
Supplementary Table S4).
We searched for phospho-sites that influence myosin II activity
in an integrin-dependent manner and found that pKO-β1 and
pKO-αvβ1 cells showed increased phosphorylation of the RhoA/Rock
targets S693-myosin phosphatase-1 (Mypt1; Fig. 6c–e) and S3-cofilin
(Fig. 6c–e). MLC phosphorylation can also be induced by Mlck, whose
activity is controlled by Ca2+ or Erk2 in focal adhesions38,39. We
observed synergistic downregulation of S364-Mlck and synergistic
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Figure 5 αv- and β1-mediated activation of myosin II requires ILK and
GEF-H1. (a–f) Cells were plated on fibronectin-coated glass coverslips for
90min and immunostained for: Talin-1 (Tln; red) and Kindlin-2 (Kind2;
green) (a); ILK (red), paxillin (Pxn; green) and F-actin (white) (b); or
GEF-H1 (red) and paxillin (green) (e); scale bars, 10 µm. DAPI, blue (a,b).
Ratios of thresholded fluorescence intensities (FI) were calculated for
Kindlin-2 and Talin-1 (pKO-αv n=12, pKO-β1 n=22, pKO-αv/β1 n=22;
results are aggregated over 3 independent experiments) (c), and ILK and
paxillin (pKO-αv n=33, pKO-β1 n=40, pKO-αv/β1 n=40; aggregated over
3 independent experiments) (d). The correlation coefficient for GEF-H1
and paxillin staining (pKO-αv n =11, pKO-β1 n =10, pKO-αv/β1 n =15;
aggregated over 3 independent experiments) was determined (f).
(g) Total fluorescence intensity of focal-adhesion-retained GEF-H1 after
crosslinking and unroofing of cells (pKO-αv n = 11, pKO-β1 n = 10,
pKO-αv/β1 n=15; aggregated over 3 independent experiments). (h) ILK−/−
and ILK-floxed fibroblasts plated for 3 h on fibronectin-coated X-shapes
stained for pMLC, F-actin and paxillin were treated with cilengitide (Cil)
to block αv-class integrins and with monoclonal antibody 2575 to block
α5β1. Scale bar, 10 µm. (i) Quantification of the relative fluorescence
intensities for pMLC to untreated ILK-floxed cells (ILK-flox n = 26;
ILK-null n = 17; ILK-flox +Cil n = 24; ILK-null +Cil n = 12; ILK-flox
+anti-α5β1 n = 16, ILK-null anti-α5β1 n = 10; data aggregated over
2 independent experiments). (j) siRNA-mediated depletion of GEF-H1
confirmed by western blotting. (k) Cells were plated on fibronectin-coated
X-shapes and stained for pMLC, F-actin and paxillin. Scale bar, 10 µm.
(l) Quantification of the relative fluorescence intensities for pMLC in
siRNA-treated cells (pKO-αv +control siRNA n = 24, pKO-β1 +control
siRNA n=48, pKO-αv/β1 +control siRNA n=56, pKO-αv + GefH1 siRNA
n=22, pKO-β1 + GefH1 siRNA n=34, pKO-αv/β1 + GefH1 siRNA n=59;
data aggregated over 2 independent experiments). (m) Relative RhoA–GTP
loading in cells plated for 45min on fibronectin (n =9; 1 representative
of 3 independent experiments is shown). (n) Relative Rac1–GTP loading
in cells plated for 45min on fibronectin (n = 9; 1 representative out of
3 independent experiments is shown). Error bars represent s.e.m. and
P values were calculated using a t -test. pKO-αv (green); pKO-αv/β1 (blue);
pKO-β1 (orange).
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Figure 6 Integrin-specific phosphorylation landscapes on adhesion to
fibronectin. (a) Hierarchical cluster analysis of SILAC ratios of 1,010
significantly regulated (ANOVA test and Benjamini/Hochberg false
discovery rate) phosphorylation events in the indicated cells plated for
45min on fibronectin from 3 independent replicates. The colour code
depicts the normalized log2 SILAC ratio between cell lines. (b) The bar
graph shows the number of phosphorylation events grouped into different
modes of regulation based on the indicated SILAC ratio threshold criteria.
AG, antagonistic; DO, dominant; SY, synergistic. (c) SILAC ratios for
selected phosphorylation events. The bar graph depicts the median
of 3 independent experiments with error bars showing the s.d. (d) A
selection of differentially regulated phosphorylation events confirmed by
western blotting using phospho-site-specific antibodies. (e) Signalling
network with differentially regulated phosphorylation events shown to be
functionally relevant in cell protrusion or contraction. Sites dominated
by α5β1 or synergistically upregulated in pKO-αv/β1 cells are shown.
(f,g) Mean pMLC fluorescence intensity (f) and mean cell area (g)
on fibronectin-coated X-shapes before and after treatment with ML-7
(25 µM) to inhibit Mlck, UO126 (50 µM) to inhibit ERK and Y-27632
(10 µM) to inhibit Rock. (pKO-αv: untreated n = 12, +ML-7 n = 10,
+U0126 n = 15, +Y-27 n = 16; pKO-β1: untreated n = 16, +ML-7
n =17, +U0126 n =19, +Y-27 n =21; pKO-αv/β1: untreated n =11,
+ML-7 n = 18, +U0126 n = 19, +Y-27 n = 30; 1 representative of 3
independent experiments is shown; all pairwise statistical comparisons
using t -tests are shown in Supplementary Table S5; error bars represent
s.e.m.). pKO-αv, green; pKO-αv/β1, blue; pKO-β1, orange.
upregulation of pT183/pY185-Erk2 activities in pKO-αv/β1 cells
(Fig. 6c–e). Western blotting using phospho-site-specific antibodies
corroborated these results (Fig. 6d). We uncovered three pathways
(Erk2, Rock,Mlck) that were differentially regulated by the two integrin
classes following adhesion to fibronectin, and reasoned that inhibition
of either one or any combination of these pathways would abrogate
synergistic myosin II reinforcement. Indeed, the cooperative activation
ofmyosin II in pKO-αv/β1 cells was blocked by inhibiting Erk (UO126),
Rock (Y-27632) or Mlck (ML-7; Fig. 6f,g). To confirm the relevance
of this finding, we overexpressed constitutively active (ca-) kinase
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Figure 7 Activation of Rock is α5β1-dependent. (a–c) Total cell lysates
of cells plated for 90min on fibronectin in the indicated conditions and
analysed by western blotting with phospho-specific antibodies. The levels
of pErk2 (b) and pMLC (c) were quantified using densitometry (n=3). (d) A
representative western blot analysis of cells transfected with myc-tagged
ca-RhoA or myc-tagged ca-ROCK constructs and probed with the indicated
antibodies. (e) Densitometric quantification of western blots (n = 3). The
bar graphs show ratios of pMLC signals from cells expressing ca-RhoA or
ca-Rock over the empty vector control. NS, not significant. (f) Confocal
image of indicated cells transfected with a myc-tagged ca-ROCK construct,
seeded on fibronectin-coated crossbow shapes and immunostained with
Myc (red), pMLC (green), F-actin (blue) and DAPI (white). Scale bar, 25 µm.
(g) Pearson correlation coefficient of fluorescence intensities of pMLC and
Myc staining for the three cell lines (pKO-αv n = 30; pKO-β1 n = 25;
pKO-αv/β1 n=25; 1 representative of 3 independent experiments is shown).
All error bars represent s.d. and P values were calculated using a t -test.
pKO-αv (green); pKO-αv/β1 (blue); pKO-β1 (orange). Uncropped images of
blots are shown in Supplementary Fig. S10.
constructs and measured their effects on pMLC. Overexpression of
ca-MEK1 rescued the low pErk2 levels and significantly increased
pMLC in pKO-αv cells (Fig. 7a–c). The high RhoA and low Rock and
pMLC activities in pKO-αv cells (Figs 5 and 6) suggest that αv-class
integrins are unable to couple active RhoA to Rock, which was tested by
overexpressing ca-RhoA or ca-Rock in the three cell lines. Whereas ca-
RhoA significantly increased pMLC in pKO-β1 and pKO-αv/β1, pMLC
levels remained unchanged in pKO-αv cells. In sharp contrast, ca-Rock
increased pMLC twofold in all three cell lines (Fig. 7d,e), indicating
that endogenous Rock in pKO-αv cells remained inactive even in the
presence of high RhoA–GTP. This finding was further confirmed with
pMLC staining of cells seeded on fibronectin-coatedX shapes (Fig. 7f,g).
In conclusion, the Mek1/Erk2 and the RhoA/Rock/pMLC pathways are
preferentially induced by α5β1, whereas the high RhoA activity induced
in pKO-αv cells is not coupled to Rock/pMLC.
DISCUSSION
We reconstituted pan-integrin-deficient fibroblasts with β1- and/or
αv-class integrins and correlated integrin-class-specific cellular pheno-
types with integrin-class-specific adhesome composition and signalling
events. Fibroblasts exploring fibronectin-based microenvironments en-
gage α5β1 and αv-class integrins to orchestrate membrane protrusions,
cell contractility and cell migration. Our cell line analyses revealed a se-
ries of signalling events accomplished by α5β1 integrins, which activate
Rac1, induce membrane protrusions, assemble nascent adhesions and
generate RhoA/Rock-mediated myosin II activity. In conjunction with
these events, mechanosensitive αv-class integrins accumulate in areas
subjected to high tension and reinforce adhesive sites to induce further
activation of myosin II and development of large focal adhesions and
actomyosin bundles (Fig. 8). Our study uncovers a sequence of tightly
integrated biophysical and biochemical events induced by α5β1 and
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Figure 8 Model of α5β1 and αv-class integrin cooperation during rigidity
sensing. α5β1 integrins adhere to fibronectin, and assemble Kindlin-2-
and ILK-rich small peripheral adhesions in a myosin-II-independent
manner. The protein assembly in α5β1-containing adhesions activates
Rac1, Wave and Arp2/3-driven actin polymerization to induce membrane
protrusions, and RhoA/Rock-mediated myosin II activation to induce
tension. This tension increases the adhesion lifetime of αv-class integrins
bound to ligand on stiff substrates, which reinforces and stabilizes focal
adhesions. αv-class integrins recruit GEF-H1 to focal adhesions, which
reinforces RhoA/myosin II in a α5β1-dependent manner, and increases RhoA
activity to promote mDia-mediated stress fibre formation. The combination
of αv-class integrin-mediated structure (focal-adhesion anchoring and
stress-fibre formation) with the α5β1-mediated force generation (myosin II
activity) constitutes a synergistic system, which is important for adapting
cellular contractility and architecture to the rigidity of fibronectin-based
microenvironments.
αv-class integrins that adjust fibroblast contractility to the rigidity of
fibronectin-coated substrates. The cooperation of α5β1 and αv-class
integrins to sense the rigidity of fibronectin-based microenvironments
predicts that cell migration towards a rigidity gradient, called durotaxis,
may also depend on the cooperation of both integrins. These findings
have potential ramifications for certain pathologies, such as fibrosis
and tumour metastasis where rigidity sensing of fibronectin matrices
is crucial in disease progression40.
To better understand how distinct integrin classes individually and
cooperatively probe the biophysical properties of a fibronectin-based
microenvironment, we established a cell model system and used
proteomics methods to characterize their focal adhesion composition,
phospho-signalling and proteome changes. Our comprehensive
proteomic data set of adhesion signalling revealed that integrin-
class-specific adhesomes and phospho-proteomes are enriched with
integrin-specific adapter proteins and signalling intermediates. Several
well-known integrin outside-in signalling pathways, including the
Rac1/Wave/Arp2,3 and RhoA/Rock pathways, were dominated by α5β1
integrins. Interestingly, the pKO-β1 cells developed very few stress
fibres, indicating that α5β1-induced RhoA activity was preferably used
for production of myosin-II-mediated force but not formin-mediated
stress-fibre formation. In contrast, the pKO-αv cells exhibited high
RhoA activity, which in turn induced the formation of thick stress
fibres, most likely through the activation of mDia, but did not activate
Rock/pMLC/myosin II. The coupling of active RhoA to different
downstream effectors by distinct integrin classes was unanticipated. The
underlying mechanism(s) are unclear, but probably involve specific
mark(s) either attached to active RhoA or to the effectors enabling
differential interactions with GTP-bound RhoA.
Although forces play an important role in the assembly of focal
adhesions, pKO-αv cells induced the largest focal adhesions among the
three cell lines and also exhibited the lowest myosin II activities and
traction forces. Focal adhesion size is not the sole predictor of traction
forces and the final focal adhesion size can also be determined by an
mDia-dependent mechanism41,42. Therefore, we propose that the large
size of focal adhesions in pKO-αv cells depends onRhoA/mDia-induced
stress fibres rather than on myosin II. However, although the final
focal adhesion size in pKO-αv cells was myosin-II-independent,
their formation and/or stability were strictly myosin-II-dependent,
evidenced by the pronounced destabilization of αv-class integrin
adhesions with blebbistatin. A role for αv-class integrins for focal
adhesion stabilization has also been obtained from single-protein
tracking experiments of β1 and β3 integrins, which showed that β3
integrins are immobilized in large focal adhesions, whereas β1 integrins
are more mobile29. The necessity of αvβ3 for cell stiffening following
force application has also been postulated43. Similarly, the recruitment
of GEF-H1 to focal adhesions and Erk2 activity was reported as
necessary for cell stiffening following force application35. Our results
link these observations and suggest that force-mediated stabilization
of αv–fibronectin bonds will reinforce focal adhesions, increase local
concentrations of GEF-H1 and activate RhoA following α5β1-induced
Erk2 activation. Therefore, αv-class integrins could be capable of
forming stronger extracellular catch bonds with fibronectin than α5β1
integrins do44, resulting in longer bond lifetimes of αv-class integrins
with fibronectin when force is applied. However, as the influence
of force on the on and off rates of α5β1 and αv-class integrins with
fibronectin have not been systematically studied, this hypothesis awaits
future testing. 
METHODS
Methods and any associated references are available in the online
version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Antibodies. Information about antibodies is provided in Supplementary Table S6.
Isolation, immortalization, viral reconstitution and transfection of cell
lines. Mouse pKO fibroblasts and reconstituted pKO-αv, pKO-β1 and pKOαv/β1
cell lines were generated from fibroblasts (floxed parental) derived from the kidney
of 21-day-old male mice carrying floxed αv and β1 alleles (αflox/floxv , β
flox/flox
1 ),
and constitutive β2 and β7 null alleles (β
−/−
2 , β
−/−
7 ; ref. 21). Individual kidney
fibroblast clones were immortalized by retroviral delivery of the SV40 large T.
The immortalized floxed fibroblast clones were then retrovirally transduced with
mouse αv and/or β1 integrin cDNAs and the endogenous floxed β1 and αv
integrin loci were simultaneously deleted by adenoviral transduction of the Cre
recombinase. Reconstituted cell lines were FACS sorted to obtain cell populations
with comparable integrin surface levels to the parental cell clones. Transduction
of ca-RhoA (myc–RhoA pcDNA3.1) and ca-ROCK (myc–ROCKD4 pcDNA3.1)
was carried out with Lipofectamine 2000 (Invitrogen through Life Technologies)
according to themanufacturer’s instructions. The transfection control was an empty
pcDNA3.1 vector.
Adhesion and cell migration analysis. Adhesion assays were carried out as
previously described45. Briefly, cells were plated for 20min in 96-well plates coated
with varying concentrations of ECM ligands. After washing the plates the number of
adhered cells that remained on the plate was quantified using attenuance at 595 nm.
To analyse random migration, cell culture dishes were coated with fibronectin
(5 µgml−1 in PBS; 2 h at room temperature) and blocked with 1% BSA in PBS. After
seeding, video time-lapse microscopy was performed using phase contrast at ×20
magnification. A total of 12 migrating pKO-αv, 12 migrating pKO-αv/β1 and 14
migrating pKO-β1 cells from 5 independentmovies were analysed. One pixel in each
cell nucleus was marked manually and served as the cell’s coordinate. Each tracked
cell j with a track length Nj was recorded by its xj,i and yj,i position for every frame
i. A tracking point was made every Dt = 1 min. The time difference between the
tracking coordinates xj,i and xj,i+n is t = nDt , where n is the frame number. The
mean squared displacement (msd) of the cell j at time t = nDt was calculated by
msdj (t )= 1Nj−n
Nj−n∑
i=1
[(
xj,i+n−xj,i
)2+(yj,i+n−yj,i)2]
All msd values were calculated for all cells and averaged. The used propagated
uncertainty for themsd(t) is the standard deviation of the mean. For an increasing n
the number of given tracks contributes tomsd(t) decreases as well as the propagated
uncertainty caused by the tracking uncertainty increases. Therefore, the msd(t) has
been cut at n= 90. To determine the persistence time P and the diffusion constant
D, Fürths formula
msd(t )= 4D
(
t−P
(
1−exp
(
− t
P
)))
has been fitted through the data. The mean velocity of a cell j has been computed as
the average of the distance travelled each time step divided by the time step.
Micropatterning and immunostainings. Micropatterns were generated on PEG-
coated glass coverslips with deep-ultraviolet lithography46. Glass coverslips were in-
cubated in a 1mM solution of a linear PEG, CH3–(O–CH2–CH2)43–NH–CO–NH–
CH2–CH2–CH2–Si(OEt)3 in dry toluene for 20 h at 80 ◦C under a nitrogen at-
mosphere. The substrates were removed, rinsed intensively with ethyl acetate,
methanol and water, and dried with nitrogen. A pegylated glass coverslip and a
chromium-coated quartz photomask (ML&C, Jena) were immobilizedwith vacuum
onto a mask holder, which was immediately exposed to deep ultraviolet light using
a low-pressure mercury lamp (NIQ 60/35 XL longlife lamp, quartz tube, 60W
from Heraeus Noblelight) at 5 cm distance for 7min. The patterned substrates were
subsequently incubated overnight with 100 µl of fibronectin (20 µgml−1 in PBS) at
4 ◦C and washed once with PBS.
For immunofluorescence microscopy, cells were seeded on micropatterns in
DMEM (GIBCO by Life Technologies) containing 0.5 % FBS at 37 ◦C, 5% CO2.
After 90 or 180min the medium was soaked off, and cells were fixed with 3%
PFA in PBS for 5min at room temperature, washed with PBS, blocked with 1%
BSA in PBS for 1 h at room temperature and then incubated with antibodies. The
fluorescent images were collected with a laser scanning confocal microscope (Leica
SP5).
Acrylamide micropatterning. Micropatterns were first produced on glass
coverslips as previously described46. Briefly, 20mm square glass coverslips were
oxidized through oxygen plasma (FEMTO, Diener Electronics) for 10 s at
30W before incubating with 0.1mgml−1 poly-l-lysine (PLL)–PEG (PLL20K-G35-
PEG2K, JenKem) in 10mM HEPES, pH 7.4, for 30min. After drying, coverslips
were exposed to 165 nm ultraviolet (UVO cleaner, Jelight) through a photomask
(Toppan) for 5min. Then, coverslips were incubated with 20mgml−1 of fibronectin
(Sigma) and 2mgml−1 of rhodamine-labelled fibronectin (Cytoskeleton) in
100mM sodium bicarbonate solution for 30min. Acrylamide solution containing
acrylamide and bisacrylamide (Sigma)was degassed for 20min under house vacuum
and mixed with passivated fluorescent beads (Invitrogen) by sonication before
addition of APS and TEMED. A 25 µl drop of this solution was put directly
on the micropatterned glass coverslip. A silanized coverslip was placed over the
drop and left polymerizing for 30min (fluorescent beads passivation and glass
silanization were performed as previously described4). The sandwich was then put
in 100mM sodium bicarbonate solution and the gel was gently removed from
the patterned glass coverslip while staying attached to the other coverslip owing
to the silanization treatment. This process transferred the protein micropatterns
onto the gel as previously described47. Three different solutions of 3%/0.225%,
5%/0.225%, 8%/0.264% acrylamide/bisacrylamide were used. The corresponding
Young’s modulus of the gels was 1.4, 9.6 and 34.8 kPa respectively as measured using
AFM. Coverslips were mounted in magnetic chambers (Cytoo) and washed with
sterile PBS before plating cells.
AFM measurements of the Young’s modulus of acrylamide gels. We
measured gel stiffness through nanoindentation using an atomic force microscope
(Bruker Nanoscope) mounted with silica-bead-tipped cantilevers (r(bead) =
2.5 µm, nominal spring constant 0.06Nm−1, Novascan Technologies). Initially, we
determined the sensitivity of the photodiode to cantilever deflection by measuring
the slope of a force distance curve when pressing the cantilever onto a glass coverslip,
and the force constant of the cantilever using the thermal noise method included
in the Bruker Nanoscope software. For each acrylamide/bisacrylamide ratio used
in the traction-force microscopy measurements we acquired 27 force curves in 3
by 3 grids (2 µm spacing between points) at three different locations on the gels.
Before and during indentation experiments gels were kept in PBS. To obtain stiffness
values from force curves we used the NanoScope Analysis software. Specifically, we
corrected for baseline tilt, and used the linear fitting option for the Hertz model with
a Poisson ration of 0.48 on the indentation curve.
Traction-force microscopy and image analysis. Confocal acquisition was
performed on an Eclipse TI-E Nikon inverted microscope equipped with a CSUX1-
A1 Yokogawa confocal head and an Evolve EMCCD camera (Ropert Scientific,
Princeton Instrument). A CFI Plan APOVCoil×60/1.4 objective (Nikon) was used.
The system was driven by the Metamorph software (Universal Imaging).
Traction-force microscopy was performed as previously described28. Displace-
ment fields describing the deformation of the polyacrylamide substrate are deter-
mined from the analysis of fluorescent bead images before and after removal of the
adhering cell with trypsin treatment. Images of fluorescent beads were first aligned
to correct experimental drift using the Align slices in stack ImageJ plugin. The
displacement field was subsequently calculated by a custom-written particle image
velocimetry (PIV) program implemented as an ImageJ (http://rsb.info.nih.gov/ij)
plugin. The PIV was performed through an iterative scheme. In all iterations the
displacement was calculated by the normalized correlation coefficient algorithm,
so that an individual interrogation window was compared with a larger searching
window. The next iteration takes into account the displacement field measured
previously, so that a false correlation peak due to insufficient image features is
avoided. The normalized cross-correlation also allowed us to define an arbitrary
threshold to filter out low correlation values due to insufficient beads present in the
window. The resulting final grid size for the displacement field was 2.67×2.67 µm.
The erroneous displacement vectors due to insufficient beads present in the window
were filtered out by their low correlation value and replaced by the median value
from the neighbouring vectors. With the displacement field obtained from the
PIV analysis, the traction-force field was reconstructed by the Fourier transform
traction cytometry (FTTC) method with regularized scheme on the same grid
(2.67× 2.67 µm) without further interpolation or remapping. The regularization
parameter was set at 1× 10–11 for all traction-force reconstructions. The Fourier
transform traction cytometry code was also written in Java as an ImageJ plugin, so
that the whole traction-force microscopy procedure from PIV to force calculation
could be performed with ImageJ. The entire package of traction-force microscopy
software is available at https://sites.google.com/site/qingzongtseng/tfm. Contractile
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energy was then computed as the integral under the cell of the scalar product of force
and displacement vectors using a custom-written code in MatLab. Force profiles
along the cell front were generated by integration of the tractionmaps over the width
of the circular part of the pattern. Average pictures were generated after alignment
using the Align slices in stack ImageJ plugin. Focal adhesion intensity profiles were
generated by integration of the paxillin intensity along the border of the circular part
of the micropattern.
Rho–GTPase assays. Cells were serum-starved overnight, detached with
trypsin–EDTA and kept in suspension in serum-free medium for 1 h. Cells were
then plated on fibronectin-coated dishes (blocked with 1% BSA) in serum-free
medium for 45min. Cell lysis and active Rho–GTPase pulldown was performed
using the active Rac1 Pull-Down and Detection Kit or the active Rho Pull-Down
and Detection Kit (Cat#16118, 16116, Pierce) according to the manufacturer’s
instruction. The active GTPase signal was normalized to total protein level of the
GTPase. Western blots were quantified with Totallab.
RNA interference. Cells were transiently transfected with a final concentration of
300 nM siRNA (stealth RNAi; Invitrogen) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol, using the targeting sequence sense-5′-
CCCGGAACUUUGUCAUCCAUCGUUU-3′ for GEF-H1. As a control we used the
scrambled sequence sense-5′-CCCUCAAUGUUCUACCUACGGGUUU-3′.
MS. For proteome and phosphoproteome analysis fibroblasts were cultured in
lysine/arginine-free DMEM with 10% FBS (10KDa dialysed, PAA) and SILAC
labelled with light (l-arginine (R0) and l-lysine (K0))], medium (L-arginine-U-
13C6 (R6) and l-lysine-2H4(K4)) or heavy (l-arginine-U-13C6 −15 N4 (R10) and
l-lysine-U-13C6−15 N2 (K8)) amino acids (Cambridge Isotope Laboratories). For
phosphoproteome analysis, cells were serum-starved for 6 h and then plated in
serum-free medium on fibronectin-coated and BSA-blocked culture dishes for
45min. Cells were lysed in lysis buffer (100mM Tris–HCl, at pH 7.5, containing
4% SDS and 100mM dithiothreitol), boiled 5min at 95 ◦C, and sonicated. Lysate
was clarified by a 10min centrifugation at 16,000g. Cleared light/medium/heavy
proteins were mixed at a 1:1:1 ratio and digested with trypsin using the
FASP protocol48. For proteome analysis, 40 µg of peptides was separated with
strong anion exchange chromatography49. For phosphoproteome analysis, 3mg
of peptides was fractionated with strong cation exchange chromatography and
enriched for phosphorylated peptides with titanium dioxide (TiO2) as described
previously50. Peptides were then analysed on a LTQ-Orbitrap Velos equipped with a
nanoelectrospray source (Thermo Fisher Scientific). The full-scan MS spectra were
acquired in theOrbitrapwith a resolution of 30,000 atm/z 400. The tenmost intense
ions were fragmented by higher-energy collisional dissociation and the spectra of the
fragmented ions were acquired in the Orbitrap analyser with a resolution of 7,500.
Peptideswere identified and quantified using theMaxQuant software31 and searched
with the Andromeda search engine against the mouse IPI database 3.68 (ref. 51).
Phosphorylations were assigned as previously described50.
The adhesome analysis was performed as previously described19. In brief, cells
were serum-starved for 4 h and plated for either 45 or 90min in serum-free medium
on fibronectin-coated, BSA-blocked, culture dishes. Optionally, cells were treated
with 50 µMblebbistatin for 30 or 75min. Enrichment for focal-adhesion-associated
proteins was achieved by shortly fixing the ventral cell cortex using chemical
crosslinkers, followed by removal of non-crosslinked proteins and big organelles
by stringent cell lysis and hydrodynamic sheer flow washing. Quantitative mass
spectrometric analysis was performed on an LTQ Orbitrap mass spectrometer
(Thermo Electron) and analysed using the label-free quantification algorithm52,
which is embedded in the MaxQuant software31, as previously described19.
For in-gel digestion, gel bands were cut into 1mm3 cubes and washed two times
with 50mM ammonium bicarbonate in 50% ethanol. For protein reduction, gel
pieces were incubated with 10mMdithiothreitol in 50mM ammonium bicarbonate
for 1 h at 56 ◦C. Alkylation of cysteines was performed with 10mM iodoacetamide
in 50mM ammonium bicarbonate for 45min at 25 ◦C in the dark. Gel pieces
were washed two times with 50mM ammonium bicarbonate in 50% ethanol,
dehydrated with 100% ethanol, and dried in a vacuum concentrator. The gel
pieces were rehydrated with 12.5 ng µl−1 trypsin (sequencing grade, Promega) in
50mM ammonium bicarbonate and digested overnight at 37 ◦C. Supernatants
were transferred to fresh tubes, and the remaining peptides were extracted by
incubating gel pieces two times with 30% acetonitrile in 3% TFA followed by
dehydration with 100% acetonitrile. The extracts were combined and desalted using
RP-C18 StageTip columns, and the eluted peptides used for mass spectrometric
analysis.
For nanoLC–MS/MS, peptide mixtures were separated by on-line nanoLC and
analysed by electrospray tandemMS. The experimentswere performedon anAgilent
1200 nanoflow system connected to an LTQ Orbitrap mass spectrometer (Thermo
Electron) equipped with a nanoelectrospray ion source (Proxeon Biosystems).
Binding and chromatographic separation of the peptides took place in a 15-
cm fused-silica emitter (75-µm inner diameter from Proxeon Biosystems) in-
house packed with reversed-phase ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch).
Peptide mixtures were injected onto the column with a flow of 500 nlmin−1 and
subsequently eluted with a flow of 2500 nlmin−1 from 2% to 40% acetonitrile in
0.5% acetic acid, in a 100min gradient. The precursor ion spectra were acquired in
the Orbitrap analyser (m/z 300–1,800, R= 60,000, and ion accumulation to a target
value of 1,000,000), and the ten most intense ions were fragmented and recorded in
the ion trap. The lock mass option enabled accurate mass measurement in both MS
and Orbitrap MS/MS mode as described previously53. Target ions already selected
for MS/MS were dynamically excluded for 60 s.
For peptide identification and peptide quantification, the data analysis was
performed with the MaxQuant software as described previously31,54, supported
by Andromeda as the database search engine for peptide identifications. Peaks
in MS scans were determined as three-dimensional hills in the mass-retention
time plane. MS/MS peak lists were filtered to contain at most six peaks per
100Da interval and searched by Andromeda (in-house-developed software) against
the Mouse International Protein Index database. The initial mass tolerance
in MS mode was set to 7 ppm and MS/MS mass tolerance was 0.5Da.
Cysteine carbamidomethylation was searched as a fixed modification, whereas
N-acetyl protein, oxidized methionine, N -carbamidomethylated DSP protein and
carbamidomethylated DSP lysine were searched as variable modifications. Finally,
the label-free quantification algorithm implemented in the MaxQuant software was
used as described earlier52.
SILAC-based peptide pulldowns were carried out with the cytoplasmic tails of
β1 integrin (5′-HDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK-
3′) and the tails of β3 integrin (5′-HDRKEFAKFEEERARAKWDTANNPLYKEATS-
TFTNITYRGT-3′). The tail peptides were de novo synthesized with a desthiobiotin
on the amino terminus, coupled to magnetic streptavidin beads (MyOne
Streptavidin C1—Invitrogen) and pulldowns from SILAC-labelled cell lysates
were performed as described previously33. After a mild wash the bound proteins
were eluted from the magnet using 16mM biotin (Sigma-Aldrich). After protein
precipitation and in-solution digestion, LC-MS/MS and data analysis was performed
as described above. The peptide pulldown experiments were done as reverse SILAC
labelling experiments in duplicate (4 biological replicates). We generally considered
outliers with high SILAC ratios and high sequence coverage/intensity as more
significant than proteins that had only a high SILAC ratio.
Bioinformatics and statistics. ANOVA analysis of the cellular proteome and
phosphoproteome was performed using the Perseus bioinformatics toolbox of
MaxQuant (J. Cox et al.; manuscript in preparation). Multiple testing corrections
were performed using the inbuilt permutation method and significant hits were
identified at a significance level of 0.01 and 0.05, respectively. ANOVA analysis of
the 245 core adhesome proteins was performed using the statistical programming
language R (http://www.R-project.org) with the adaptive Benjamini and Hochberg
step-up false discovery rate-controlling procedure for multiple testing and a
significance level of 0.05. Hierarchical clustering was performed using an average
linkage approach and Euclidean distances. Enrichment analysis of clusters for
Gene Ontology (GO) terms, KEGG pathways and PFAM and INTERPRO protein
domains was performed with the DAVID webserver55 using the multiple testing
correction method by Benjamini and Hochberg and a significance level of 0.05.
Protein–protein interactions (PPIs) were compiled from different sources including:
PPI databases (DIP (ref. 56; version of December 2009), IntAct (ref. 57) and
MINT (ref. 58) (both downloaded on 19 May 2010), BIOGRID (ref. 59; version
3.0.64) and HPRD (ref. 60; Release 9)); the adhesome network database32;
and the KEGG pathway database61. For the adhesome network database, we
distinguished between undirected PPIs and directed activating and inhibiting
interactions as annotated in the adhesome database and in KEGG. Human and
mouse interactions were combined using the orthologue tables of the Mouse
Genome Database (MGI) to increase coverage. The high-confidence network of
PPIs from public databases contained only interactions reported in at least two
separate publications. Networks were visualized using the Cytoscape software.
Bar graphs throughout the study were generated in Microsoft Office and depict,
unless otherwise indicated, the means and standard errors of the means. Box
plots and dot plots were generated using the SigmaPlot software or the MatLab
software.
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Figure S1 Generation of pKO-αv, pKO-β1 and pKO-αv/β1 cell lines. (a) 
Workflow of the generation of pKO kidney fibroblasts (strategy 1) and integrin 
reconstituted pKO fibroblasts (strategy 2). (b) Phase contrast image of the 
floxed and pKO cells plated on FN. Scale bar 20 µm. (c) Integrin profile of 
floxed and pKO cells analysed by flow cytometry. (d) Cell surface levels of 
indicated integrins analysed by flow cytometry. (e) Relative fluorescence 
intensities of indicated integrins from three independent stainings analysed 
by flow cytometry. The means (n=3) and standard deviations are shown. (f) 
Western blots for αv and β1 integrins. GAPDH was used as loading control. 
(g) Cell lysates and immunoprecipitates of β1 integrin were immunoblotted 
for αv, α5 and β1 integrins. Note that αv does not associate with β1 in 
pKO-αv/β1 cells. (h) Adhesion assay on fibronectin (FN) or vitronectin (VN). 
Numbers of adherent cells 20 minutes after seeding are shown as relative 
values of OD=595nm. The bar graph shows the mean and s.e.m. (n=3; one 
representative out of 2 independent experiments is shown). (i)  Cells plated 
on FN and time-lapse imaged using a phase contrast microscope at 20x 
magnification. Scale bar 100 µm.  pKO-β1 (green); pKO-αv (blue);  
pKO-αv/β1 (orange);  parental β1/αv floxed cell (red).
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Figure S2 α5β1 and αv-class integrins induce different spreading areas, 
membrane protrusions and adhesion sites on FN. (a) Cells were plated on FN 
for 90 minutes and immunostained with the indicated antibodies. Arrowheads 
indicate cortactin-positive lamellipodia and arrows mark the small NAs in 
lamellipodia. Scale bar 10µm. (b) Size distribution of adhesive sites of cells 
stained with Paxillin calculated with the Metamorph software. Boxplots show 
the percentage of adhesions in the depicted size classes (pKO-αv n=15; 
pKO-αv/β1 n= 29; pKO-β1 n=23; one representative out of 2 independent 
experiments is shown). Boxplot whisker ends are at 1.5 interquartile range 
and outliers are shown as dots.  Significance was calculated using a t test 
(*=p<0.05; ***=p<10 E-06). (c) Still pictures taken from supplementary 
movies S1-S3 showing trailing edge detachment defects indicated by the 
arrows. Scale bar 100 µm. (d) Floxed cells cultured 3 hours on FN-coated 
X-shapes treated for 1 hour with indicated concentrations of blebbistatin 
(BLEB), and then stained for Paxillin, pMLC and f-actin. Scale bar 10 µm. 
(e) Fluorescence intensities of pT18/S19-MLC, (f) Paxillin (Pxn) and (g) cell 
areas after blebbistatin treatment (n=20 cells; error bars represent s.e.m.). (h) 
Cells plated on FN-coated X-shapes and stained for pMLC, Paxillin and f-actin. 
Scale bar 10 µm. (i) Fluorescence intensities of pS18/T19-MLC and (j) cell 
areas (pKO-αV n=46, pKO-β1 n=46, pKO-αV/β1 n=21, pKO-αV/β1 +Cil 
n=10; one representative out of 3 independent experiments is shown; error 
bars represent s.e.m.). Cilengitide (Cil) was used to block αv-class integrins. 
Significance was calculated using a ttest.  pKO-αv (green); pKOαv/β1 
(blue);  pKO-β1 (orange);  pKOαv/β1 + 1 µM cilengitide (black).
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Figure S3 Adhesome analysis of pKO-αv, pKO-β1 and pKOαv/β1 cells. (a) 
Workflow for isolation of FA enriched fractions and analysis of adhesome 
components. (b) Adhesomes derived from cells plated on indicated substrates 
for 45 or 90 minutes were examined by non-supervised hierarchical cluster 
analysis of Z-scores of median MS intensities (n=3-4). The labels on the right 
indicate significantly enriched gene ontology (GO) terms.
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Schiller et al.; Supplementary Fig.S4a
Figure S4 α5β1- and αv-class-specific PPIs and phosphosites. (a) The PPI 
network derived from FA-enriched samples. Integrin subunits are in the 
centre and their direct and indirect interactors are in the inner and outer 
circles, respectively. Black lines between nodes indicate high confidence 
PPI, red arrows indicate activating interactions and blue lines indicate 
inhibiting interactions. The nodes were labelled with gene symbols and 
colour-coded according to the MS intensity ratio of pKO-αv/β1 versus 
pKO-β1. Node edges were colour-coded according to the SILAC ratio of the 
maximally regulated phosphosite on each significantly regulated protein. 
(b) The PPI-network was derived as in (a). The nodes and node edges were 
colour-coded according to the MS intensity ratio of pKO-αv versus pKO-αv/
β1. (c) The PPI-network was derived as described in (a). The nodes and 
node edges were colour-coded according to the MS intensity ratio of pKO-αv 
versus pKO-β1.
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Figure S4 continued
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Figure S5 Integrin-specific differences in the “core integrin interactome”. 
The Z-scores of median MS intensities (n=3-4) of the 125 core integrin-
interactome proteins (Fig. S4) were subjected to hierarchical clustering. The 
black bars on the left indicate α5β1-dependent FA proteins, while the green 
bar indicates the αv-class integrin-dependent FA proteins selected for the 
clustering in Fig. 4c.
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Figure S6 Network analysis of actin binding proteins enriched in the 
adhesome preparations. (a) Actin binding proteins were extracted from the 
adhesome dataset using gene ontology annotations. Black lines between 
nodes indicate high confidence PPI, red arrows indicate activating and 
blue lines indicate inhibiting interactions. The nodes were labelled with 
gene symbols and colour coded according to the log2 MS intensity ratio of 
pKO-αv over the pKO-β1 sample. Node edges were colour-coded according 
to the log2 SILAC ratio of the maximally regulated phosphosite on each 
significantly regulated protein. The box marks components of the WAVE and 
Arp2/3 complex, while the arrowhead marks the formin mDia. (b) The graph 
was generated as in (a), except that the nodes were colour-coded according 
to the log2 MS intensity ratio of pKO-αv/β1 over the pKO-β1 sample.
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Figure S7 Integrin tail peptide pulldowns. (a) Sequence of synthetic 
desthiobiotinylated peptides used for the pull down experiments. (b) SILAC 
ratio plot from label inverted replicates (specific interactors have high SILAC 
ratio in the forward experiment and low SILAC ratios in the label swapped 
reverse experiment) comparing the β1-tail peptide with a scrambled control. 
The table shows the most intense β1-specific interactors with high sequence 
coverage that were reproducibly enriched versus the scrambled control 
peptide (scr) (n=4; 2 independent experiments). (c) SILAC ratios of proteins 
from inverted replicates comparing the β3-tail peptide with a scrambled 
control. The table shows the most intense β3-specific interactors with high 
sequence coverage that were reproducibly enriched versus the scrambled 
control peptide (scr) (n=4; 2 independent experiments).
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Figure S8 Cellular proteome of pKO-αv, pKO-β1 and pKO-αv/β1 cells. (a) 
SILAC labelled cells cultured on FN for several passages were analysed by 
MS. SILAC ratios of 150 significantly regulated proteins (ANOVA, Benjamini/
Hochberg FDR) were subjected to non-supervised hierarchical cluster 
analysis and colour coded. The bars depict differentially regulated clusters 
of proteins. (b) Gene names of the 3 differentially regulated groups (a) are 
shown. Known FA proteins are marked with an asterisk. (c) Scatter plot 
showing SILAC ratios. Previously annotated FA proteins are labelled in red.
© 2013 Macmillan Publishers Limited.  All rights reserved. 
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Figure 5c
Figure 6d
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Schiller et al.; Supplementary Fig. S9a
Figure S9 Uncropped western blots.
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Figure S9 continued
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Supplementary video legends
Video S1 Time-lapse movie of pKO-αv cells plated on FN. Cells were plated on FN coated (5 µg/ml; blocked with 1% BSA) tissue culture dishes in presence 
of 10% serum and video tracked over 20 hours with a frame rate of 1 picture every 4 minutes. Pictures were acquired with a phase contrast microscope at 
magnification 20x.
Video S2 Time-lapse movie of pKO-αv/β1 cells plated on FN. Cells were plated on FN coated (5 µg/ml; blocked with 1% BSA) tissue culture dishes in 
presence of 10% serum and video tracked over 20 hours with a frame rate of 1 picture every 4 minutes. Pictures were acquired with a phase contrast 
microscope at magnification 20x.
Video S3 Time-lapse movie of pKO-β1 cells plated on FN. Cells were plated on FN coated (5 µg/ml; blocked with 1% BSA) tissue culture dishes in presence 
of 10% serum and video tracked over 20 hours with a frame rate of 1 picture every 4 minutes. Pictures were acquired with a phase contrast microscope at 
magnification 20x.
© 2013 Macmillan Publishers Limited.  All rights reserved. 
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Integrin-mediated activation of small GTPases polymerizes g-Actin into different Actin structures. Here 
we report that the g-Actin pools correlated with low nuclear MAL levels and MAL/SRF activities in αV 
single, intermediate in β1 single and high in αV, β1 double expressing cells. Integrin-mediated activation 
of MAL/SRF induced expression of the ubiquitin-like modifier interferon-stimulated gene 15 (ISG15) 
resulting in the ISGylation of integrins, Actin, Focal Adhesion and Actin binding proteins. The increased 
stability and/or activity of these proteins enhanced kidney fibroblast but also human breast cancer cell 
invasion and correlated with poor patient survival. Our findings show that integrin adhesions, MAL/SRF 
and ISG15 constitute a new autoregulatory feed-forward loop that precisely adjusts actin- and adhesion-
based functions required for cell spreading, migration and invasion. 
 
INTRODUCTION 
Integrin-mediated cell adhesion and signalling control numerous cellular processes, which are crucial for 
development, postnatal homeostasis and pathology. Integrin signalling is a multistep process that is 
initiated with integrin activation and ligand binding, followed by integrin clustering and the progressive 
assembly of signalling platforms consisting of adaptor, signalling/catalytic and cytoskeletal proteins. The 
first integrin-induced signalling platforms are small and unstable nascent adhesions (NAs), which 
eventually mature into large focal adhesions (FAs) that are connected to filamentous (f-) Actin. 
Integrin signalling induces both short- and long-term effects. The short-term effects consist of 
cytoskeletal rearrangements that allow cells to adopt their characteristic shape and initiate migration, 
and are caused by the activation of Rho family GTPases and actin-binding proteins (Danen et al., 2002). 
Long-term effects of integrin signalling result from changes in gene expression, which regulate cell 
proliferation and differentiation. Integrin-dependent regulation of gene expression is primarily thought 
to arise from cross talk with growth factor receptors (GFR) that increase the activity of mitogen 
activating protein (MAP) kinase pathways. A recent study, however, reported that β1-class integrins can 
change gene programs of mesenchymal stem cells involved in lineage commitment to bone, fat or 
cartilage by activating Rho GTPase signalling cascades, which result in the nuclear localization of the 
transcriptional co-activators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-
binding motif (TAZ) (Tang et al., 2013). In addition to the control of YAP/TAZ, Rho family GTPases can 
also control gene transcription by releasing the association of the transcriptional co-activator 
Megakaryocyte Acute Leukemia protein (MAL; also known as MRTF-A or MKL1) from monomeric or 
globular (g-) Actin. Once g-Actin is assembled into Actin networks, free MAL translocates into the 
nucleus, where it associates with and activates the transcription factor Serum Response Factor (SRF), 
which regulates the expression of cytoskeletal proteins including Actin and Focal Adhesion proteins. 
Thus it is possible that integrin-mediated activation of Rho GTPases regulates cytoskeletal dynamics but 
also adhesion through effector proteins and the control of MAL`s nucleo-cytoplasmic shuttling in order 
to initiate target gene transcription. 
To test this hypothesis we investigated whether and which integrins regulate MAL/SRF-mediated gene 
expression. To achieve this goal, we used recently engineered cell lines that express Fibronectin (FN)-
binding integrins of the αV- (αVβ3, αVβ5) and/or β1-class (α5β1) that allowed us to assign stress fibre 
formation to αV-class integrins and myosin II activation and lamellipodia formation to α5β1 integrin 
(Schiller et al., 2013). We report that αV- and β1-class integrins synergize to regulate expression of 
MAL/SRF target genes. One new MAL/SRF target is the ubiquitn-like modifier Interferon-specific gene 15 
(ISG15), which becomes covalently attached to specific lysine residues of numerous known MAL/SRF 
target gene products including Vinculin, Talin and Eplin. ISG15 modifications are known and thought to 
negatively impact ubiquitination by a) inhibition of ubiquititin-specific E2 enzymes (Malakhova and 
Zhang, 2008; Okumura et al., 2008; Zou et al., 2005) and b) possible occupation of lysine residues also 
used by Ubiquitin through ISGylation . Thus it is possible that ISG15-linked proteins could be protected 
from proteasomal targeting (Liu et al., 2003). Our findings identify a new synergistic activity of 
fibronectin-binding integrins that controls cell invasion by regulating transcription and subsequent 
ISGylation. 
  
RESULTS 
FN bound α5β1 and αV-class integrins control f-Actin and nuclear MAL levels 
We generated immortalized fibroblast cell lines lacking the expression of all integrins (pan-knockouts, 
pKO) and re-expression of β1 and/or αV integrin cDNAs produced cells expressing αV- (pKO-αV), β1- 
(pKO-β1) or αV- and β1-class integrins (pKO-αV,β1) ((Schiller et al., 2013) Fig.S1A). When the three cell 
lines were seeded on FN-coated, circular micropatterns separated by non-adhesive polyethylene glycol, 
pKO-αV cells expressing the FN-binding αVβ3 and αVβ5 integrins preferentially formed large focal 
adhesions (FAs) that were shown with labelled phalloidin to be connected by thick radial stress fibres. In 
contrast, pKO-β1 cells expressing the FN-binding α5β1 integrin preferentially formed small, nascent 
adhesions (NAs), thin stress fibres and a dense subcortical actin network, and pKO-αV,β1 cells developed 
both large FAs and small NAs with thick and thin stress fibres and a dense subcortical actin meshwork 
(Fig.1A, B; Fig.S1A). To visualize non-polymerized Actin in the cytoplasm of the three cell lines, we 
stained the cells with fluorescently labelled DNaseI (Gabbiani et al., 1984; Heacock and Bamburg, 1983; 
Hitchcock, 1980). Surprisingly, we observed that also the cytoplasmic g-Actin pool was highest in pKO-
αV, intermediate in pKO-β1 and lowest in pKO-αV,β1 cells (Fig.1A, 1C). This finding was further 
confirmed by separating the cells into soluble (S, validated with GAPDH), nuclear (N) and cytoskeletal (C, 
validated with Vimentin) fractions and determining their β-Actin contents (Fig.1D). The experiment 
demonstrated that Actin contents in the soluble (representing g-Actin), cytoskeletal (representing f-
Actin) and nuclear fraction as well as the calculated g-/f-Actin ratios were significantly higher in pKO-αV 
cells compared to pKO-β1 and pKO-αV,β1 cells (Fig.1D-F). The increased Actin contents in all fractions of 
pKO-αV cells indicated that the total Actin levels are higher in pKO-αV cells compared to pKO-β1 and 
pKO-αV,β1 cells, which was indeed confirmed by western blotting and immunostaining of cells with anti-
β-Actin antibodies (Fig.S1B). To precisely determine the g-Actin levels in cytoplasm and nucleus, we 
performed precipitation assays with soluble and nuclear fractions using DNaseI coupled to beads and 
found significantly higher g-Actin contents in the cytoplasm and nucleus of pKO-αV compared to pKO-β1 
and pKO-αV,β1 cells (Fig.1G, H). FACS analysis excluded differences in nuclear size in our cell lines as 
cause for the different actin contents (Fig.S1C). 
Next we consulted our published whole cell proteome and phospho-proteome of pKO-αV, pKO-β1 and 
pKO-αV,β1 cells (Schiller et al., 2013) to evaluate whether a differential expression and activity of Actin 
sequestering, polymerizing and depolymerizing proteins either further aggravates or compensates for 
the different amounts of free g-Actin. Our analysis revealed significantly increased levels of Thymosin β4 
(Tβ4) and phosphoSer3-Cofilin in pKO-β1 cells (Fig. S1D-F) indicating that g-Actin is significantly more 
sequestered and f-Actin significantly less severed in pKO-β1 and pKO-αV,β1 cells compared to pKO-αV 
cells. 
The pool of g-Actin regulates nuclear translocation and activity of the transcriptional transactivator MAL, 
whose binding to the transcription factor SRF induces the expression of genes encoding “immediate-
early”, cytoskeletal and focal adhesion proteins. Therefore, the different free g-Actin levels in pKO-αV, 
pKO-β1 and pKO-αV,β1 cells suggested that their nuclear MAL levels should also be different. To test 
this hypothesis, we seeded the three cell lines on FN and immunostained them with specific rabbit 
polyclonal anti-MAL antibodies. The results revealed lowest nuclear MAL levels in pKO-αV, intermediate 
in pKO-β1 and highest in pKO-αV,β1 cells (Fig.1I, S1G). Importantly, treatment with Jasplankinolide, 
which diminishes free g-Actin by stabilizing Actin filaments, increased nuclear MAL in the three cell lines 
(Fig.1I, S1G). Conversely, treatment with Latrunculin A, which increases free g-Actin by disassembling f-
Actin, decreased nuclear MAL in the three cell lines (Fig.1I, S1G). Altogether these results show that FN-
binding integrin classes differentially regulate cellular g-/f-Actin content, which significantly influences 
nuclear levels of MAL. 
αV- and β1-class integrins cooperate to control SRF/MAL activity 
To test functional consequences of the different nuclear MAL contents in the three cell lines, we first 
measured SRF/MAL activity with SRF luciferase reporter assays. Whereas pKO-αV cells showed low SRF 
reporter activity, pKO-β1 cells displayed 4-fold higher and pKO-αV,β1 cells ~10 fold higher SRF reporter 
activities. Importantly, Jasplankinolide treatment increased SRF activities to a similar extent in all three 
cell lines, while Latrunculin A (which had to be short due to cell lethality) showed as light opposite effect 
(Fig.2A). Treatment with serum (to induce nuclear translocation of MAL) or Leptomycine B (to inhibit 
nuclear export of MAL) increased SRF reporter activities in pKO-β1 and pKO-αV,β1 cells to a much higher 
extent as compared to pKO-αV cells (Fig.S2A, S2B). Expression of a dominant-negative MAL reduced SRF 
reporter activity to basal levels in the three cell lines (Fig.S2C), while overexpression of a g-Actin binding-
deficient MAL (∆N MAL, lacking the N-terminal G-actin binding motif) and a constitutive active mDia 
increased SRF/MAL induced luciferase activities to similar extents in the three cells (Fig.2B). 
To exclude that cell spreading defects (Connelly et al., 2010) caused the reduced nuclear MAL levels and 
SRF/MAL reporter activities in pKO-αV cells, we seeded the three cell lines  on FN-coated circular 
micropatterns with 28μm and 40μm diameters, respectively, and performed SRF reporter assays and 
immunostainings. The results of these experiments revealed that pKO-αV cells displayed similar SRF 
reporter activities and nuclear MAL levels on small and large FN-coated circular micropatterns, while 
pKO-β1 and pKO-αV,β1 cells increased SRF activities and nuclear MAL levels on 40µm sized 
micropatterns compared to 28µm sized micropatterns (Fig.2C-E) indicating that the reduced cell 
spreading of pKO-αV cells is not responsible for the reduced MAL/SRF activity. 
Next we performed experiments aimed at testing whether changes in the expression levels and/or 
activities of FN-binding integrin classes affect SRF reporter activity. First, Mn2+ treatment, which 
increases integrin activities, significantly elevated SRF reporter activity in all three cell lines, most 
prominently in pKO-β1 cells, intermediate in pKO-αV,β1 and lowest in pKO-αV cells (Fig.2F). Second, 
overexpression of αV- or β1-class integrins revealed that elevation of αV in pKO-αV did not change SRF 
activity, whereas elevation of β1 in pKO-β1 cells induced a small, significant increase of SRF activity and 
elevation of β1 in pKO-αV and αV in pKO-β1 cells induced a more prominent increase of SRF activity 
(Fig.2G). Similarly, overexpression of either αV or β1 in pKO-αV,β1 cells also significantly increased 
SRF/MAL activity. Third, pKO-αV,β1 cells were seeded on FN (bound by αV- and β1-class integrins), 
Vitronectin (VN) and Gelatin (both ligands bound by αV-class integrins only), treated with either anti-
α5β1 blocking antibodies or the αV-class specific small molecule inhibitor cilengitide and immunostained 
for MAL and assayed for SRF reporter activity (Fig.2H, 2I). The experiments showed that inhibition of 
α5β1 or αVβ3 Integrins on FN adherent pKO-αV,β1 cells significantly reduced nuclear MAL levels and 
SRF activities and hence phenocopied the pKO-αV cells indicating efficient activation of SRF requires the 
cooperation of both FN-binding integrin classes. Similarly, when pKO-αV,β1 cells were seeded on VN and 
Gelatin, respectively, they showed low nuclear MAL activity, which was not further decreased with the 
inhibition of α5β1 integrin. As expected, treatment of VN- or Gelatin-seeded pKO-αV,β1 cells with 
cilengitide blocked adhesion (Fig.2H). Finally, loss of the integrin activator proteins in FN-adherent 
fibroblasts double deficient for either Kindlin-1 and -2 or Talin-1 and -2 abolished SRF reporter activities 
(Fig.S2D). Altogether these results show that FN-binding integrin classes cooperate to activate SRF/MAL. 
αV- and β1-class integrins induce transcription of SRF/MAL target genes 
The high nuclear MAL content and SRF activity in pKO-αV,β1 cells suggest that MAL/SRF-induced gene 
transcription is controlled, at least in part, by integrins. To test this hypothesis, we compared published 
MAL/SRF transcriptomes (Balza and Misra, 2006; Cooper et al., 2007; Descot et al., 2009; Philippar et al., 
2004; Selvaraj and Prywes, 2004; Sun et al., 2006; Zhang et al., 2005) with the whole cell proteome of 
pKO-αV, pKO-β1 and pKO-αV,β1 cells (Schiller et al., 2013) and found a large number of MAL/SRF target 
genes including SRF and FA proteins such as Filamins, Vinculin, Talin, Eplin and integrins enriched in pKO-
β1 and pKO-αV,β1 cells (Table 1). The increased levels of SRF, Talin, Vinculin and Eplin (Lima1) mRNA 
and protein in pKO-β1 and pKO-αV,β1 cells were confirmed by qRT-PCR and western blotting (Fig.3A, 
3B).  
We also noted that ISG15 mRNA, dramatically down-regulated in SRF-deficient ES cells (Philippar et al., 
2004), was significantly elevated in pKO-αV,β1, intermediate in pKO-β1 cells and  low in pKO-αV cells 
(Fig.3A; Table 1). Western blotting confirmed high ISG15 levels in pKO-αV,β1, intermediate levels in 
pKO-β1 and low levels in pKO-αV cells but no secretion of ISG15 (Fig.3C, S3F). Similar results were 
obtained with immunostainings, which revealed ISG15 co-localisation with f-Actin fibres and the Actin 
cortex beneath membrane protrusions (Fig.3D) and with Paxillin in FAs of unroofed cells (Fig.3E). ISG15 
is an ubiquitin-like modifier, whose expression is induced by type I (α and β) interferons (Farrell et al., 
1979; Haas et al., 1987). ELISA and qRT-PCR excluded endogenous interferon α and β expression in pKO-
αV,β1 cells as cause for the high ISG15 levels. Importantly, however, poly I:C  treatment, which triggers 
endogenous interferon α and β expression, induced a strong ISG15 expression (Fig.S3A-E). To directly 
show that ISG15 and the FA protein Talin are new SRF/MAL target genes, we performed SRF and MAL 
chromatin-immunoprecipitation (CHIP) assays. SRF CHIPseq experiments performed in murine HL-1 cells 
(http://deepbase.sysu.edu.cn/index.php) identified potential SRF consensus binding sites (CArG box), 
which allowed designing primers to PCR amply the immunoprecipitaed DNA fragments (Fig.3F). The 
vinculin gene, as a known MAL/SRF target, and the gapdh gene not regulated by MAL/SRF were used as 
controls (Vartiainen et al., 2007) (Fig.3G, 3H). Immunoprecipitations of chromatin using either MAL or 
SRF antibodies resulted in a positive CHIP. In contrast, neither precipitation control rabbit IgG nor the 
gapdh gene resulted in a positive signal (Fig.3G, 3H).  
ISG15 is an ubiquitin-like modifier, which might compete with Ubiquitin at specific lysine residues and 
hence stabilize target proteins, modify the Ubiquitin E2 enzyme Ubc13 and Nedd4 leading to its 
inhibition, and alter the function of proteins by inducing or preventing the recruitment of binding 
partners (Jeon et al., 2009; Malakhova and Zhang, 2008; Takeuchi et al., 2005; Zou et al., 2005). Since 
protein levels of Talin and Eplin are higher in pKO-αV,β1 cells than predicted from their mRNA levels 
(Fig. 3A, 3B), we hypothesized that they might be modified with ISG15 and protected from degradation. 
To test this hypothesis we precipitated ISGylated proteins in pKO-αV,β1 cells with an ISG15-specific 
antibody and subsequently analysed them by mass spectrometry (Table S1). This analysis revealed a 
large number of focal adhesion and cytoskeletal proteins including Talin and Vinculin. These findings 
indicate that αV-class and α5β1 integrin-mediated SRF/MAL activation triggers the expression of 
SRF/MAL targets that include cytoskeletal proteins, integrins, focal adhesion proteins and ISG15, which 
modifies SRF/MAL targets to stabilize them and/or change their activity. 
αV- and β1-class integrin induced SRF/MAL activity and ISG15 levels to promote cell invasion 
MAL/SRF and ISG15 promote tumour cell invasion and are up-regulated in cancer (Desai et al., 2012; 
Kressner et al., 2013). To test whether the invasive properties of MAL and ISG15 are associated and 
triggered by β1 integrin-mediated adhesion we analysed integrin, nuclear MAL and ISG15 levels of the 
non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cell lines. FACS analysis revealed 
significantly higher α5 and β1 levels and higher Integrin β1 activity (by probing 9EG7 antibody) on MDA-
MB-231 cells compared to MCF-7 cells (Fig.4A). The levels of αV integrin were significantly elevated in 
MCF-7 cells compared to MDA-MB-231 cells (Fig.4A). To test whether the high β1 integrin levels and 
activity are associated with high nuclear MAL activity in MDA-MB-231 cells we immunostained for f-
Actin and MAL, and investigated MAL/SRF activities. We observed that MCF7 cells formed tight cell-cell 
contacts with f-Actin accumulating at these sites and contained MAL in the cytoplasm and nucleus. In 
contrast, MDA-MB-231 were not adhering to each other, contained numerous stress fibres and almost 
the entire pool of MAL protein in the nucleus (Fig.4B, 4C). In line with high nuclear MAL levels, MDA-MB-
231 cells also displayed significantly higher SRF/MAL reporter activity (Fig.4D) expressed significantly 
higher levels of SRF/MAL target gene transcript levels (Fig.4E). The high levels of ISG15 resulted in an 
elevated ISGylation of target proteins in MDA-MB-231 compared to MCF-7 cells (Fig.4F). 
The invasive properties of MDA-MB-231 cells depend on the expression of MAL (Hu et al., 2011; 
Medjkane et al., 2009). To test whether ISG15 is required for SRF/MAL-induced cell invasion, we 
depleted ISG15 or overexpressed the de-ISGylase UBP43 in MCF-7 and MDA-MB-231 cells and 
performed invasion assays with a basement membrane model (Fig.4G, H). While MCF-7 cells were 
unable to invade through the basement membrane model, MDA-MB-231 cells efficiently moved through 
the membrane. siRNA-mediated depletion of ISG15 or overexpression of the de-ISGylase UBP43 almost 
completely prevented the invasion of MDA-MB-231 cells (Fig.4G, H). 
Next we tested whether high β1 integrin and ISG15 levels are prognostic markers for breast cancer 
patients. To this end, we consulted microarray data of breast cancer samples and correlated αV, β1 
integrins and ISG15 transcript levels with patient survival. The analyses revealed that patients with high 
expression of αV, β1 integrin or ISG15 displayed a significant increase in the hazardous ratio (HR) and p-
value compared to patients with low levels of either transcript (Fig.5A, 5B). Interestingly, patients with 
high levels of αV, β1 integrin and ISG15 transcripts in their cancer specimen show a significantly reduced 
survival rate compared to patients with low ISG15 levels (Fig.5C). To corroborate these in silico findings, 
we performed MAL and β1 integrin immunostainings of human breast cancer samples classified 
according to the Bloom-Richardson scale and modified by Elston and Ellis (1991) as grade 1 (G1), grade 2 
(G2), and grade 3 (G3). Hereby the grading system involves a semi-quantitative evaluation of three 
morphological features a) the percentage of tubule formation, b) the degree of nuclear pleomorphism 
and c) an accurate mitotic count using a defined field area. By the usage of a numerical scoring system, 
the overall grade is derived from a summation of individual scores for the three grades (Elston and Ellis, 
1991). (Fig.5D, 5E). Importantly to note, these patient biopsies also include normal healthy tissue next to 
pathologic malformations. In line with our findings, the overall expression of β1 integrin and nuclear 
MAL levels increased concomitantly from G1 to G2 and to G3 stage (Fig.5D, 5E, S5). Altogether our data 
show that integrin-mediated MAL/SRF/ISG15 signaling is elevated in cancer cell invasion in vitro and in 
vivo. 
  
DISCUSSION 
 
Tumour metastasis is initiated with the detachment of an individual tumour cell from a tumour cell 
aggregate followed by invasion into the surrounding tissue, entry into the circulation and finally 
settlement in a distant organ. The process of tumour cell invasion is critically dependent on the selection 
of tumour cells that are able to survive without tumour stroma, on the release of proteases that 
degrade and remodel the tumour- and tissue-derived ECM, and on cell adhesion molecules such as 
integrins (Hood and Cheresh, 2002). Integrins constitute the core components of the invasive machinery 
of tumour cells. They regulate the activity of small GTPases, Actin binding, bundling and modifying 
proteins to allow for cytoskeletal dynamics, membrane protrusions and invadopodia formation (Bishop 
and Hall, 2000; Hall, 2012; Hoshino et al., 2013; Murphy and Courtneidge, 2011). Since tumour cells 
express different types of integrins, it is unclear whether, and if yes, how they co-operate to achieve 
maximal efficiency in tissue invasion. The task of the present study was to define the integrin subfamily 
and the signalling pathways involved in tumour cell invasion. 
We have recently engineered a fibroblast-like cell line that allows expressing the FN-binding integrin 
αVβ3 and/or α5β1. These cell lines were used to demonstrate that αVβ3 and α5β1 integrins control 
actomyosin-based cell contractility in a cooperative manner. In the present study we also observed that 
cells expressing αVβ3 and α5β1 integrins (pKO-αV,β1 cells) most pronouncedly decrease their g-Actin 
pool, which results in the nuclear translocation of the g-Actin binding transcriptional transactivator MAL 
(also referred as MRTF-A). The consequences of the nuclear accumulation of MAL include binding to the 
transcription factor SRF and the transcription of MAL/SRF target genes, which comprise known genes 
such as Actin, Vinculin, Filamin, etc, as well as novel genes such as Talin, EPLIN and ISG15, which all 
contain functional CArG boxes that bind SRF and are required for responding to the active MAL/SRF 
complex. 
Our findings show that ISG15 is particularly highly elevated when αVβ3 and α5β1 bind FN. ISG15 is a 
ubiquitin like modifier protein and thought to be induced exquisitely by type I interferons (Farrell et al., 
1979; Haas et al., 1987). ISG15 is highly expressed in all tumours investigated so far 
(www.oncomine.org). Since the tumour stroma is infiltrated by immune cells it is believed that they are 
the source of interferon α/β production and hence the trigger for the high expression of ISG15 in cancer 
cells (van der Veen and Ploegh, 2012). While immune cell-derived interferon α/β strongly promotes 
expression of ISG15 in tumours it is unknown why ISG15 remains upregulated in tumour cells isolated 
and cultured ex vivo in the absence of immune cells and interferon α/β (Han et al., 2002; Hermeking et 
al., 1997; Lock et al., 2002). Based on our findings we propose that αVβ3/α5β1-induced nuclear 
translocation of MAL and activation of SRF are responsible for the high ISG15 transcription ex vivo. 
ISG15 is conjugated to proteins (ISGylation) in a multistep process that requires E1, E2 and E3 enzymes 
comparable to the protein-ubiquitination pathway (Haas et al., 1987; Lenschow et al., 2005; Loeb and 
Haas, 1992; Morales and Lenschow, 2013; Okumura et al., 2008; Yuan and Krug, 2001). Furthermore, a 
protease called Ubp43 removes ISG15 resulting in deISGylation of proteins (Malakhov et al., 2002). 
Protein ISG15lyation can alter protein function. Rac1 and MAPK, for example, dissociate from ISG15-
modified Filamin-B. This dissociation can terminate JNK signalling and inhibit apoptosis (Jeon et al., 
2009). It has also been shown that ISG15 modification can stabilize proteins either by ISGylation and 
inhibition of ubiquititn-specific E2 enzymes (Desai et al., 2006; Malakhova and Zhang, 2008; Okumura et 
al., 2008) or by competing with free ubiquitin for lysine residues on target proteins (Liu et al., 2003). 
Finally, ISGylation was shown to inhibit protein translation by either increasing the cap structure-binding 
activity of the ISGylated translational suppressor 4EHP (Okumura et al., 2007) or by down-regulating 
elF2α through ISGylation of dsRNA-dependent protein kinase (PKR) (Okumura et al., 2013).  
The expression of ISG15 is high in tumour cells in vivo and ex vivo indicating that ISG15 modification 
represents a tumour promoting and oncogenic function in primary tumours where interferon α/β levels 
are high as well as during and after invasion when interferon levels decrease. Hence, it is conceivable 
that αVβ3/α5β1 signalling kicks in to compensate low interferon levels and to sustain high ISG15 
expression. Our mass-spectrometry analysis of ISG15 modified protein (ISGylome) in pKO-αV,β1 cells 
revealed that numerous proteins including integrins, FA proteins (Talin, Vinculin, EPLIN, etc.) and Actin 
become ISGylated upon FN binding. We therefore, propose that αVβ3/α5β1 integrin-mediated signalling 
has two major consequences for tumour cell invasion; αVβ3/α5β1 integrins activate GTPases leading to 
polymerization of f-Actin networks and stress fibers, which are essential for membrane protrusions, cell 
contractility and adhesion reinforcement. In addition, the consumption of g-Actin for the f-Actin 
network formation results in liberation and nuclear translocation of MAL, binding to SRF and 
transcription of cytoskeletal, FA proteins and ISG15. ISG15 modifies integrins, FA proteins and Actin to 
increase their stability and/or improve their function (Fig. 6). This novel feed forward loop operates in 
fibroblasts as well as in invading cancer cells. The highly metastatic breast cancer cell line MDA-MB-231 
expressed significantly more α5β1, contained higher levels of nuclear MAL and ISG15 modified proteins, 
and performed significantly better in invasion assays than the non-metastatic MCF7 cell line. Most 
importantly, transcriptome analyses of breast cancer samples from large cohorts of patients revealed a 
statistically highly significant association between patient survival and high β1 integrin, MAL and ISG15 
levels. These findings indicate that the selection of tumour cells for high integrin levels in a tumour 
aggregate renders them independent of decreasing interferon and growth factor levels. This 
independence is facilitated with an increased strength of integrin signalling, which has the principal task 
in a metastasizing tumour cells to establish and maintain an efficient invasive machinery that 
compensates essential cues from the tumour stroma and eventually allows a long and harshly journey to 
distant and extraneous organ to succeed. 
  
EXPERIMENTAL PROCEDURES 
Isolation, immortalization, viral reconstitution and transfection of cell lines. 
Mouse pKO fibroblasts and reconstituted pKO-αV, pKO- β1 and pKO-αV,β1 cell lines were generated 
from fibroblasts (floxed parental) derived from the kidney of 21-day-old male mice carrying floxed αV 
and β1 alleles (αV flox/flox, β1flox/flox), and constitutive β2 and β7 null alleles (β2−/−, β7−/−). Individual 
kidney fibroblast clones were immortalized by retroviral delivery of the SV40 large T. The immortalized 
floxed fibroblast clones were then retrovirally transduced with mouse αV and/or β1 integrin cDNAs and 
the endogenous floxed β1 and αV integrin loci were simultaneously deleted by adenoviral transduction 
of the Cre recombinase. Reconstituted cell lines were FACS sorted to obtain cell populations with 
comparable integrin surface levels to the parental cell clones(Schiller et al., 2013) or to have high or low 
integrin expression levels. Fibroblasts homozygous for floxed kindlin-1 and -2 or talin-1 or -2 genes were 
isolated from kidneys of 21-day-old double-floxed mice (whose generation will be described elsewhere), 
immortalized as described above and cloned. To obtain Kindlin-1 and -2 double-null or Talin-1 and -2 
double-null cells, the floxed kindlin alleles were removed by adenoviral Cre transduction. The breast 
cancer cell lines MDA-MB-231 and MCF-7 were purchased from ATCC (http://www.lgcstandards-
atcc.org/Products/Cells_and_Microorganisms/Cell_Lines.aspx?geo_country=de). 
Patient samples/biopsies 
For histological and immunostaining analysis, staged human breast cancer samples were kindly provided 
by Prof. Ferdinand Hofstädter, Institute of Pathology, 93053 Regensburg, Germany. 
Immunostainings and surface coating 
For immunofluorescence microscopy, cells were seeded on micropatterns or coated glass surfaces 
(Coating: 5 µg/ml Fibronectin (Calbiochem) or 1% Gelatin (Sigma) or 1% Collagen (Advanced BioMatrix) 
or 10 µg/ml Laminin (Roche) or 10 µg/ml Vitronectin (STEMCELL technologies) in PBS or 0.01% Poly-L-
lysine (Sigma)) in DMEM (GIBCO by Life Technologies) containing 10 % FCS at 37 °C, 5% CO2. For 
micropatterns the cell culture medium contained 0.5% FCS. After indicated time points the medium was 
soaked off, and cells were fixed with 3% PFA in PBS for 10 min at room temperature, washed with PBS, 
blocked with 1% BSA in PBS for 1 h at room temperature and then incubated with antibodies in a 
solution of 0.1% Triton X-100, 3% BSA in PBS. The fluorescent images were collected with a laser 
scanning confocal microscope (Leica SP5). For visualization g- and f-Actin structures, we followed a 
protocol published earlier (Small et al., 1999). H&E staining was performed according to standard 
procedures.  
 Antibodies 
All antibodies are listed in Supplementary Information Table S2. 
 
Crosslinking 
Enrichment for focal-adhesion-associated proteins was achieved by shortly fixing the ventral cell cortex 
using DSP crosslinker (DTSP; Dithiobis[succinimidyl propionate]), followed by removal of non-crosslinked 
proteins and big organelles by stringent cell lysis and hydrodynamic sheer flow washing. 
 
Cell fractionation  
For cell fractionation a kit (ProteoExtract® Cytoskeleton Enrichment and Isolation Kit purchased from 
Millipore) was used according to the manufacturer´s instructions or a centrifugation-based method. For 
the centrifugation-based method to isolate the nuclei, cells were washed with PBS and harvest in a 
buffer containing 250 mM Sucrose, 10 mM HEPES and 1.5 mM EDTA. With the help of a syringe and a 
26Ga needle (Terumo) cells were opened further. After centrifugation the pellet (nuclei fraction) was 
washed 5 times with a buffer containing 20 mM Tris, 0.1 mM EDTA and 2 mM MgCl2. The pellet was 
resuspended in FACS buffer or staining solution for immunostaining. 
 
G-Actin-DNaseI pulldown 
DNaseI (Sigma-Aldrich) was covalently linked to CNBr-activated Sepharose beads (Sigma-Aldrich) at a 
concentration of 1 mg/ml according to the manufacturer´s protocol. BSA-Sepharose beads, which served 
as control, were prepared in the same way. For g-Actin pulldown 15µg protein lysate in RIPA buffer was 
incubated with 35µl of DNaseI- or BSA-coupled Sepharose beads in a volume of 300 µl over night at 4°C 
in an end-over-end-mixer. Next day, the beads were washed five times with cold wash buffer (1% NP-40, 
0.1 % SDS, 1mM DTT, 1mM PMSF in PBS). Beads were dried with a syringe and needle and SDS-sample 
buffer was added for subsequent western blot analysis. 
 
Constructs and transfections 
Constitutive active MAL (∆NMAL), dominant negative MAL (DN MAL: ∆N1B1 and ∆N∆C), SRF:MAL 
reporter constructs were provided by Prof. Guido Posern, Institute of Physiological Chemistry, 06114 
Halle, Germany. Constitutive active myc-mDia1 construct (myc-mDia1 FH1FH2) expression construct was 
amplified from an existing plasmid with forward primer 5’-gcc aag aat gaa atg gct tc-3’ and reverse 5’-tgc 
aga gct tct aga aga ct and the PCR product was cloned into the pCRII-TOPO vector and sequenced. The 
integrin αV-mCherry and integrin β1-mCherry were provided by Ralph Böttcher. The knockdown 
constructs for stable knockdown of murine ISG15 were purchased from Origene and the UBP43 
overexpression construct was purchased from Addgene. All transfections were carried out with 
Lipofectamine 2000 (Invitrogen through Life Technologies) according to the manufacturer’s instructions. 
 
SRF/MAL reporter assay  
Cells were plated on FN coated 12-well plates (6.0 x 105 cells per well) before transient transfection with 
0.5 µg of MAL/SRF reporter (p3DA.luc) reporter (Sotiropoulos et al., 1999), indicated expression plasmid 
and 25 ng thymidine kinase-driven renilla (Promega) for controlling transfection efficiency. The total 
amount of transfected plasmid DNA was kept constant at 1.5 µg per well by using pEGFP-C1 expression 
vector (Clontech). After 24h luciferase activity was analyzed with a Dual Luciferase reporter assay 
system (Promega). Jasplankinolide (100 nM, #420107-50UG from Merck Millipore) and Latrunculin A 
(500 nM, L5163 from Sigma) treatment was performed 3h prior to reporter read-out. 
 
Micropatterning 
Micropatterns were generated on PEG-coated glass coverslips with deep-ultraviolet lithography(Azioune 
et al., 2010). Glass coverslips were incubated in a 1 mM solution of a linear PEG, CH3–(O–CH2–CH2)43–
NH–CO–NH–CH2–CH2–CH2–Si(OEt)3 in dry toluene for 20 h at 80 °C under a nitrogen atmosphere. The 
substrates were removed, rinsed intensively with ethyl acetate, methanol and water, and dried with 
nitrogen. A pegylated glass coverslip and a chromium-coated quartz photomask (ML&C, Jena) were 
immobilized with vacuum onto a mask holder, which was immediately exposed to deep ultraviolet light 
using a low-pressure mercury lamp (NIQ 60/35 XL longlife lamp, quartz tube, 60 W from Heraeus 
Noblelight) at 5 cm distance for 7 min. The patterned substrates were subsequently incubated overnight 
with 100 μl of fibronectin (20 μg ml−1 in PBS) at 4 °C and washed once with PBS. 
FACS analysis 
For FACS analysis s suspension of fibroblasts was incubated for 1 h with primary antibodies on ice and 
then washed twice with FACS-PBS (3 mM EDTA, 2% FCS in PBS). Cell viability was assessed by propidium 
iodide staining. FACS analysis was carried out using a FACSCalibur Cytometer (BD Biosciences) and cell 
sorting with an AriaFACSII high-speed sorter (BD Biosciences), both equipped with FACS DiVa software 
(BD Biosciences). Purity of sorted cells was determined by post sort FACS analysis and typically exceeded 
95%. Data analysis was conducted using the FlowJo program (Version 9.4.10). 
 
Real-time PCR 
Total RNA from cells was extracted with RNeasy Mini extraction kit (Qiagen) following manufacturer’s 
instructions. cDNA was prepared with a  iScript cDNA Synthesis Kit (Biorad). Real Time PCR was 
performed with an iCycler (Biorad). Each sample was measured in triplicates and values were 
normalized to gapdh. PCR primers are listed in Supplementary Information Table S1. 
 
Mass spectrometry 
The mass spectrometry was performed and analyzed as previously described (Schiller et al., 2013). For 
the investigation of ISG15 target proteins, a Flag-murineISG15 construct was used for overexpression 
followed by a FLAG pulldown by using ANTI-FLAG® M2 Affinity Gel according to manufacturer´s 
instructions (Sigma, product #A2220), SDS PAGE gel electrophoresis and subsequent treatment for mass 
spectrometry analysis. 
 
Interferon ELISA 
Cells were plated on FN-coated tissue culture dishes for three days and the cells` supernatant was 
analyzed. To induce interferon production cells were transfected with 100 µg/ml Poly(I:C). ELISA for 
interferon α and interferon β secretion was performed with the VeriKineTM Mouse IFN-α and Mouse IFN-
β ELISA kit (PBL Interferon Source, product #42120 and #42400) according to manufacturer´s 
instructions. 
 
Invasion assay 
Invasion assay was purchased (Merck Millipore’s QCM™ Boyden chamber, 8 µm pore size) and 
performed according to manufacturer´s instructions 24 hours post-transfection with either shScr 
control, shISG15 or UBP43 constructs.  
 
CHIP 
For each immunoprecipitation, pKO-αV,β1 cells were used. Cross-linking, nuclei preparation and 
nuclease digestion of chromatin was performed according to manufacturer`s advice (SimpleCHIP 
Enzymatic Chromatin IP Kit (Magnetic Beads, #9003, Cell Signaling Technology). Then, 500 ml of 
chromatin was incubated overnight at 4°C with 1 to 50 dilution of anti-SRF (#5147; Cell Signaling 
Technology) or 30 µl home-made anti-MAL rabbit serum (#79). After washing of the 
Immunoprecipitated chromatin, the DNA– protein complexes were eluted with supplied CHIP elution 
buffer. Crosslinks were reversed overnight at 65°C, and DNA purified via columns also provided in the 
kit. Quantification was done by quantitative real-time PCR and is shown as the percentage of input 
chromatin. Gene-specific primers for amplification of immunoprecipitated DNA are listed in 
supplementary material Table S3. Primers for Gapdh and Srf were published previously (Vartiainen et al., 
2007). 
 
RNA interference 
Cells were infected with retroviral 29mer shISG15 expression constructs purchased from Origene 
(#TG502956). The pGFP-V-RS plasmid vector was created with an integrated turboGFP element to 
readily verify transfection efficiency and with a puromycine selection cassette to select for cells carrying 
integrations. 
 
Kaplan Meier analysis of gene expression microarray 
To analyze the prognostic value of integrin αV, integrin β1 and ISG15 gene the Kaplan-Meier plotter was 
used (http://kmplot.com/analysis/). The patient samples were split into two groups according to various 
quantile expressions of the proposed biomarker (low and high expression). The two patient cohorts 
were compared by a Kaplan-Meier survival plot, and the hazard ratio with 95% confidence intervals and 
logrank P value were calculated. 
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FIGURE LEGENDS 
 
Figure 1. FN bound α5β1 and αV-class integrins control f-Actin and nuclear MAL levels. (A) 
Superimposed picture (confocal stack) of indicated cell types immunostained for f-Actin (Phalloidin), g-
Actin (DNaseI) and DAPI plated on FN-coated glass surfaces. The intensity map shows the cytoplasmic 
distribution of g-Actin. Scale bar, 20 µm. (B, C) Quantification of cytoplasmic g-Actin by DNaseI (B) and f-
Actin fibres by Phalloidin (C) relative fluorescence intensities (n>20; 3 independent experiments). (D) 
Cell fractionation into soluble (S), nuclear (N) and cytoskeletal (C) components followed by western blot 
analysis with a β-Actin antibody. Antibodies against Vimentin and GAPDH confirm efficiency of 
subcellular protein fractionation (representative western blot of four independent experiments is 
shown). (E, F) Ratio of g-Actin versus GAPDH (E) and g-Actin versus f-Actin (F) of the indicated cell types 
is shown (n=4; 4 independent experiments). (G) Western blot analysis by Profilin and β-Actin antibody of 
g-Actin pulldown experiment with DNAseI- or BSA-coupled Sepharose beads (representative western 
blot of three independent experiments in technical duplicates is shown). (H) DNaseI-bound g-Actin in 
nuclear (N) and soluble (S) cell fraction was analysed (n=3; 3 independent experiments). (I) 
Immunostaining of indicated cell types plated on FN-coated glass coverslips and treated with DMSO 
(control), 100 nM Jasplankinolide (Jasp) and 500 nM Latrunculin A (LatA), respectively. The merged 
images display an overlay of Paxilin, MAL, f-Actin and nuclear staining (DAPI). Scale bar, 10 µm. All p-
values were calculated using a paired Students-t-test. 
   
Figure 2. αV-class integrins cooperate with α5β1 to induce SRF/MAL activity. (A) SRF-driven luciferase 
reporter activity in cells plated on FN and treated with DMSO, 100 nM Jasplankinolide (Jasp) or 500 nM 
Latrunculin A (LatA) (3 independent experiments). (B) SRF-driven luciferase reporter activity in cells 
plated on FN transfected with EGFP, a constitutive active (ca) MAL (∆N-MAL) or a ca mDia construct (4 
independent experiments). (C) SRF-driven luciferase reporter activity in cells plated on circular FN-
coated micropatterns with either 40 µm or 28 µm diameter (3 independent experiments). (D) Z-stacks of 
immunostained cells seeded on circular FN-coated micropatterns with indicated diameters. The cartoon 
on the left illustrates the position of the indicated stack. The merged picture displays an overlay of MAL 
(yellow), f-Actin (white) and nuclear staining (DAPI). Scale bar, 10 µm. (E) Quantification of nuclear 
fluorescence intensity for MAL from superimposed images shown in (D) (n=5). (F, G) SRF-driven 
luciferase reporter activity in indicated cells treated with Mn++ (n=5) (F) or transfected with the αV or β1 
Integrin (G) (n=4). (H) Immunostaining of pKO-αV,β1 cells plated on Fibronectin (FN), Vitronectin (VN) 
and Gelatin and untreated or treated with anti-α5β1 blocking antibodies or Cilengitide for MAL (red), f-
Actin (white) and nucleus (DAPI; green). The inserts show MAL in the different settings. Scale bar, 25 
µm. (I) SRF/MAL luciferase reporter activity (n=3) in pKO-αV,β1 cells plated on FN and untreated (n=15) 
or treated with anti-α5β1 blocking antibodies (n=22) or Cilengitide (n=27). All error bars represent 
+SEM. All p-values were calculated using a paired Students-t-test.   pKO-αV (green);  pKO-β1 
(orange);  pKO-αV,β1 (blue). 
Figure 3. αV- and β1-class integrins induce transcription of SRF/MAL target genes. 
(A) Quantitative realtime-PCR of the SRF/MAL target genes srf, talin, flnb, vcl, lima1 but also mrtf-a and 
isg15. mRNA levels are shown relative to GAPDH transcript levels (n>3; minimum of 3 independent RNA 
isolations, double blind). (B) Western blot analysis of SRF, Talin, Filamin B (FLN B), Vinculin (VCL), Lima1 
but also MAL (or MRTF-A). GAPDH was used to control protein loading. (C) Densitometric analysis of free 
ISG15 protein in the indicated cell lines (5 independent experiments). (D) Immunostaining for Paxillin 
(Pxn), ISG15, f-Actin and DAPI. Arrowheads indicate co-localization of f-Actin and ISG15. Scale bar, 10 
µm. (E) Immunostaining of ISG15, Paxillin, f-Actin and nucleus (DAPI) in FAs of cross-linked and unroofed 
indicated cells. The merged images display an overlay of ISG15, Paxillin, f-Actin and DAPI. Scale bar, 10 
µm. (F) Scheme to illustrate location of CArG boxes (SRF binding sites; Blue boxes) in isg15, vcl as control 
and tln-1 gene along Exons (Black boxes;). (G, H) Chromatin immunopreciptiation was performed with 
MAL, SRF or rabbit IgG antibody as control. Isg15, vcl, tln and gapdh as control CArG boxes were 
amplified by conventional PCR and visualized by agarose gel electrophoresis (G). Real-time PCR was 
performed from three independent chromatin preparations and IPs. Shown is the relative quantitation 
of isg15, vcl and tln relative to input chromatin (H). All error bars represent +SEM. All p-values were 
calculated using a paired Students-t-test.   pKO-αV (green);  pKO-β1 (orange);  pKO-αV,β1 (blue). 
Figure 4. αV- and β1-class Integrin induced SRF/MAL activity and ISG15 levels to promote 3D cell 
invasion. (A) FACS analysis of integrin α5, αV and β1 surface levels and β1 activity by 9EG7 staining MCF-
7 and MB231. (B, C) Immunostaining of non-invasive MCF-7 and highly invasive MB231 breast cancer 
cell lines seeded on FN (B). A representative example for threshold used for nuclear MAL 
quantification(C) is shown (In two independent experiment a minimum of 129 cells per cell line were 
analysed). The merged images display an overlay of MAL, f-Actin and nuclear staining (DAPI). Scale bar, 
10 µm. (D) SRF/MAL luciferase reporter assay of MCF-7 and MDA-MB-231 cells (n=3; three independent 
experiments). (E) Quantitative real-time PCR was performed for itgaV and SRF/MAL targets itgb1, isg15, 
srf, and lima1 but also for mrtf-a. Shown is the quantitation relative to gapdh (n=3, from 3 independent 
isolations, double blind). (F) Western blot of MDA-MB-231 and MCF-7 with ISG15 specific antibody. 
GAPDH was used to control loading. (G-H) FN-coated transwell cell invasion assay with MDA-MB-231 
and MCF-7 cells upon ISG15 knockdown, UBP43 overexpression or scrambled shRNA control (n=3; 3 
independent experiments). Immunostaining of transmigrated cell by Phalloidin and DAPI (G). 
Quantification of transmigrated cells compared to scrambled control (H). Scale bar, 100 µm. All error 
bars represent +SEM. All p-values were calculated using a paired Students-t-test.    pKO-αV (green);  
pKO-β1 (orange); and  pKO-αV,β1 (blue);  MCF-7 (white);   MB231 (black);  
Figure 5. αV- and β1-class integrin induced ISGylation of SRF/MAL targets results in bad breast cancer 
patient prognosis. (A, B) Kaplan Meier analysis indicates that breast cancer patients with high integrin 
β1 (A), or high ISG15 levels (B) die earlier. (C) Kaplan Meier analysis indicate bad patient outcome at high 
compared to low ISG15 transcript amounts by constant high α5 and β1 Integrin levels. (D) H/E staining 
of indicated breast cancer samples. Approximate area used for immunostaining (IF) is indicated. (E) 
Immunostaining of indicated patient samples for MAL, integrin β1 and f-Actin. The merged images 
display an overlay of MAL, integrin β1 and f-Actin and nuclear staining (DAPI). Scale bar, 50 µm.  
 
Figure 6. Model of how α5β1/αV-class integrins synergistically induce MAL/SRF, leading to multi-
layered protein ISGylation and enhanced 3D migration and invasion of tumour cells. Both, αV-class 
integrin induced RhoA/mDia and β1-class integrin induced Rac/WAVE/Arp2/3 activities are combined in 
FN-adherent pKO-αV,β1 cells leading to low g-Actin levels, the release and nuclear translocation of MAL, 
binding to SRF and transcription of target genes such as ISG15 and FA proteins. Production of ISG15 and 
its coupling machinery results in multi-layered protein ISGylation and subsequent stabilization of FA- 
and cytoskeletal-related proteins. Advanced cell migration properties leads to improved 3D migration 
and invasion of tumour cells.  
 
TABLE 
Table 1. Qualitative Comparison of SRF/MAL target genes to the proteome data of pKO-αV, pKO-β1 
and pKO-αV,β1 cells published in Schiller and Hermann et al., NCB, 2013. Data mining and comparison 
of seven different SRF/MAL target gene screening approaches were manually filtered for association 
with FA and actin functions and co-localization. A qualitative comparison with the pKO-cell proteome 
was performed. Data sources were cited by numbers: (1) Balza R. O. et al., JBC, 2006; (2) Philippar et al., 
MolCell, 2004; (3) Selvaraj A. et al., BMC, 2004; (4) Sun Q. et al., Genome Res, 2006; (5) Zhang S. X. et al., 
JBC, 2005; (6) Descot A. et al., MolCell, 2009; and (7) Cooper S. J. et al., Genome Res, 2007;   
enrichment in pKO-αV cells (green);  enrichment in pKO-β1 cells (orange); and  enrichment in pKO-
αV,β1 cells (blue);   not found in pKO-cell proteome list;   not enriched in the indicated cell type.  
SUPPLEMENTARY INFORMATION 
Figure S1. Different total Actin levels and distribution in pKO-αV, pKO-β1 and pKO-αV,β1 cells. (A) 
Immunostaining of indicated cell types for Paxillin and f-Actin plated for 90 minutes on circular FN-
coated micropatterns. The merged images display an overlay of Paxillin, f-Actin and nuclear (DAPI) 
staining. Scale bar, 25 µm. (B) Cell lysates were immunoblotted for total Actin. GAPDH was used as a 
loading control. Densitometric quantification of western blots (n=3) is depicted as fold changes below 
the corresponding blot with +/- SEM values. (C) FACS analysis of indicated cell types by propidium iodide 
staining to measure nuclear size. (D) Box plot of all actin modifying proteins (Schiller et al., 2013) in 
indicated cell lines classified into their effect on g-Actin pool: Neutral (black), decrease (blue), increase 
(yellow). Protein abundance is presented by Log2 ratios. Thymosin beta 4 (Tmsb4), Cofilin-1 (Cfl-1) and 
Advillin (Advil) were highlighted. (E) Log2 ratio of Tmsb4 expression in indicated cell lines (n=3; 3 
independent experiments). (F) Western blot of Cofilin and phospho-Cofilin (Ser3) (representative 
western blot of 4 independent experiments is shown). (G) Microscopy of indicated cells upon 
Latrunculin A (LatA) or Jasplankinolide (Jasp) treatment. DMSO was used as control. Dashed lines 
highlight lamellipodia and long protrusions caused by Jasp treatment. Scale bar, 20µm. 
Figure S2. αV-class integrins cooperate with α5β1 to induce SRF/MAL activity. (A-C) Reporter activity 
measurements of a SRF-driven firefly normalized to a thymidine kinase-driven renilla luciferase of cells 
plated on FN-coated culture dishes. Cells were starved and serum boosted with 40% FCS (A) and in (B) 
treated with Methanol (MeOH) as a control and Leptomycin B (LeptoB) to inhibit the nuclear export of 
MAL or (C) transfected with EGFP only or a dominant negative MAL (DN MAL) construct. (D) Reporter 
activity measurements of a SRF-driven firefly normalized to a thymidine kinase-driven renilla luciferase 
of Kindlin-1 and -2 or Talin-1 and -2 wild type (WT) and knockout cells (KO) seeded on FN. All error bars 
represent SEM and p-values were calculated using a paired Students-t-test.   pKO-αV (green);  pKO-
β1 (orange);  pKO-αV,β1 (blue); 
Figure S3. Type I interferon response independent but SRF/MAL dependent ISG15 transcription in 
pKO-αV, pKO-β1 and pKO-αV,β1 cells. (A-C) Quantitative real-time PCR of Interferon α (IFNα; A), 
Interferon β (IFNβ; B) and ISG15 upon 100µg/ml poly I:C stimulation (C) (n=3; 3 independent isolations). 
(D, E) ELISA-based quantification of IFNα (D) or IFNβ (E) levels in supernatants of indicated cells treated 
with Poly I:C. Error bars represent +SEM. p-values were calculated using a paired Students-t-test. (F)  
Western blot of free ISG15 in total cell lysate or supernatant of 72h cultured indicated cells. GAPDH was 
used to control protein loading. FN was used as a secreted protein control. Densitometric quantification 
of western blots (n>3; >3 independent experiments) is depicted as fold changes below the 
corresponding blot with +/- SEM values.  
Figure S5. αV- and β1-class integrin induced ISGylation of SRF/MAL targets results in bad breast cancer 
patient prognosis. Quantification of nuclear MAL in grade (G) 1 to G3 breast cancer sections (G1: n=10, 
G2: n=12, G3: n=20). 
 
SUPPLEMENTARY TABLES 
Table S1. ISG15 pull-down mass spectrometry analysis 
Table S2. List of primer sequences 
Table S3. List of antibodies 
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Gene Name Annotation Source
ACTA1 Skeletal alpha actin 1,2,6
ACTA2 Smooth muscle alpha actin 1,2,6
ACTC Alpha-cardiac actin 2
ACTC1 Actin, alpha cardiac muscle 1 1,5,6
ACTG Actin, cytoplasmic 2 2
ACTN1 Alpha-actinin-1 4
CAPZA3 F-actin-capping protein subunit alpha-3 4
CFL1 Cofilin, non-muscle isoform 4
CFL2 Cofilin2, muscle 1,4
DSTN Destrin, Actin-depolymerizing factor, ADF 4,6,7
ENAH, MENA Protein enabled homolog 1
EPLIN LIM domain and actin-binding protein 1 6
FBLN5 Fibulin-5 4
FHL1 Four and a half LIM domains protein 1 4,6
FHL2 Four and a half LIM domains protein 2 2,4
FLNA Filamin A 4
FLNC Filamin C 4
FNBP1 Formin-binding protein 1 1
IQGAP Ras GTPase-activating-like protein IQGAP1
ISG15 Interferon-induced 15kDa protein 2
ITGA1 Integrin alpha 1 7
ITGA5 Integrin alpha5 4,6
ITGA9 Integrin alpha 9 1,5
ITGB1 Integrin beta 1 1
ITGB1BP2 Integrin beta 1 binding protein 2 (melusin) 1,4,7
LPP LIM domain-containing preferred translocation partner in lipoma 2,6
MAP3K14 Mitogen-activated protein kinase kinase kinase 14 5,6
MAP3K4 Mitogen-activated protein kinase kinase kinase 4 5
MAPK10 Mitogen-activated protein kinase 10, JNK3 5
MYH11 Myosin heavy chain, smooth muscle isoform, SMMHC 7
MYH6 Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha 1
MYH7 Myosin heavy chain, cardiac muscle beta isoform, MyHC-beta 1
MYH9 Non-muscle myosin heavy chain A, NMMHC-A, NMMHC-Iia 6,7
MYL3 Myosin light chain 1, slow-twitch muscle B/ventricular isoform, MLC1SB 1,5
MYL4 Myosin light chain 1, atrial/fetal isoform, MLC1A 1
MYL9 Myosin light chain 9, smooth muscle 1,5
PDLIM5 Enh, Enigma homolog 4
PDLIM7 Enigma 1,6
PFN1 Profilin-1 4
SRF Serum response factor 1,3
SVIL Supervillin 1,7
TLN Talin 4
TRIP6 Zyxin-related protein 1 4
VCL Vinculin 2,3,6,7
VIL1 Villin-1 6
ZYX Zyxin 3
SRF target genes Proteome 
Enriched
